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ABSTRACT 
 
AMINOOXY REAGENTS FOR SYNTHESIS AND ANALYSIS:   
EXPANDING THE ROLE OF OXIMATION 
April 17, 2013 
 
Sébastien Laulhé 
 
The reaction between an aminooxy moiety (RONH2) and a carbonyl group of 
either an aldehyde or a ketone — known as an oximation reaction — is a versatile click 
chemistry coupling that generates a robust oxime ether linkage.  The oximation reaction 
is chemoselective and can be performed under mild conditions in a large variety of 
solvents, including water.  
The attractive properties of the aminooxy group and derived oximation reactions, 
reviewed in Chapter 1, inspired us to use this chemistry as a key feature of our research.  
Specifically, we prepare functionalized aminooxy compounds so that the oximation 
chemistry can then serve as a prelude to new synthetic or analytical methods.  For 
example, Chapter 2 presents an improved preparation of O-
(diphenylphosphinyl)hydroxylamine (DPPH), an aminooxy-containing reagent, using the 
classic Schotten-Baumann conditions.  We show how DPPH can then be used as a 
chemoselective nitrogen transfer reagent for a one-pot aldehyde-to-nitrile functional 
group transformation.  Sixteen aldehydes were smoothly transformed to their 
!! viii!
corresponding nitriles by heating at 85 °C with DPPH in toluene.  The reaction can be 
accomplished in the presence of alcohol, ketone, ester, or amine functionality. 
In another application, we use functionalized aminooxy reagents to achieve 
quantitative multiplexed gas chromatography-mass spectrometry (GC-MS) analysis. 
Specifically, we chemoselectively derivatize carbonyl (aldehyde and ketone) metabolites 
using the aminooxy-containing reagents.  Chapter 3 presents a focused fundamental study 
of the propensity of oxime ethers to undergo MS-induced fragmentations, such as the 
McLafferty rearrangement.  In particular, we studied structural factors that promoted α,β-
fragmentation in oximes of both ketones and aldehydes, as well as the derived silyl ethers 
of these adducts.  We determined that 1) the propensity of the McLafferty rearrangement 
was greatly enhanced by oxygen at the b-position of silyl oxime ethers, 2) the McLafferty 
rearrangement is more prominent for E-isomers of oxime and silyl oxime ethers than for 
the corresponding Z-isomers, and 3) Z-isomers of silyl oxime ethers with CH2 at the b-
position generate nitrilium ions to a greater extent than their corresponding E-isomers. 
Chapter 4 describes the 3-step synthesis of a new class of stable isotope-labeled 
derivatizing reagents –– aminooxyethyl propionate reagents (AEP) –– that enable 
multiplexed GC-MS analysis of small molecule carbonyl compounds.  The AEP reagents 
contain 1) an aminooxy moiety, and 2) a propionate ester moiety that generates a reporter 
isotope-labeled mass spectral tag (MST) in the form of an ethyl carbenium ion via an 
ester a-cleavage.  The AEP MSTs appear in an m/z zone of minimal interference (ZMI) in 
the range m/z 32-34.  This is a key feature in that unobstructed observation of reporter 
MSTs in this zone significantly improves simultaneous quantitation of carbonyl analytes 
from multiple samples without recourse to MS peak deconvolution strategies.   Also, and 
!! ix!
in contrast to known isotope coding reagents for GC-MS, AEP reagents are not affected 
by the chromatographic isotope effect.  The versatility of the technology for carbonyl 
metabolite profiling and absolute quantification is demonstrated by an analysis of 
turmeric extract, serving as a representative complex biological sample.  A series of 
analogous methyl ketones were profiled from characteristic MS fragmentations of the 
AEP-derived oxime ether adducts, and two members, 2-nonanone and 2-undecanone, 
were quantified using AEP-labeled external standards.    
Finally, Chapter 5 concludes with additional demonstrations of click chemistry. 
We used oximation to ligate linker molecules to fluorophores and gold nanoparticles 
(AuNPs) to generate a fluorescent nano-entity for breast cancer location and diagnosis.  
Five homologous linkers, each consisting of a thiol-terminated hydrophobic domain 
coupled to an aminooxy-terminated PEG-based domain, were prerared using a 6-step 
synthesis in 7-25% overall yield.  The aminooxy end subsequently was reacted with an 
aldehyde-functionalized cypate fluorophore, and the thiol end was used for attachment to 
gold nanoparticles.  Linker attachment to cypate in this manner was superior to 
previously investigated amide coupling involving linker amines and cypate carboxylic 
acid. 
Collectively, the results from these investigations demonstrates a novel strategy 
that employs functionalized aminooxy substrates and reagents to first exploit the high 
yielding and selective click coupling with carbonyl substrates to set the stage for 
secondary synthetic or analytical operations.  Approaches developed in this multifaceted 
study appear to be applicable to a variety of synthetic problems ranging from those of a 
purely chemical nature to other impacting biological systems. 
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1.A.  Introduction to Click Chemistry 
1.A.1  General 
The concept of click chemistry was promoted by Prof. K. Barry Sharpless (The 
Scripps Research Institute) in 2001 as a call to chemists to conduct simple-to-perform, 
high-yielding reactions between select and complementary functional groups.1  Click 
reactions ideally should also generate inoffensive byproducts, be wide in scope, and not 
require chromatographic purification of products.  In particular, the reactions should be 
insensitive to water or oxygen.  Mainly, this concept was promoted as a way to mimic 
nature’s ability to join small molecular units with high efficiency.  Instead of attempting 
traditional synthetic carbon-carbon bond formations, Sharpless advocated forming robust 
and physiologically stable carbon-heteroatom bonds.   
 In the click chemistry manuscript by Prof. Sharpless, four main classes of 
chemical transformations embraced the above criteria: 1) cycloadditions of unsaturated 
species, such as 1,3-dipolar cycloaddition reactions and also the Diels-Alder family of 
transformations; 2) carbonyl chemistry of the “non-aldol” type, such as formation of 
oxime ethers, hydrazones, and amides; 3) nucleophilic substitution chemistry of SN2 type, 
like ring-opening reactions of strained heterocyclic electrophiles such as epoxides and 
aziridines; and 4) additions to carbon-carbon multiple bonds, especially oxidative cases 
such as epoxidation, dihydroxylation and aziridination, but also thiol-ene and thiol-yne 
reactions.  Figure 1.1 shows reaction examples for each of the four families as defined by 
Sharpless et al.1 
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Figure 1.1.  The four classes of click chemistry transformations and reaction examples. 
 
Although some of the criteria for a click chemistry reaction are subjective, the 
four main linking reactions that have been consistently associated with the “click” 
concept are:  1) The azide-alkyne cycloaddition that, in presence of a copper catalyst, 
generates triazoles at room temperature;2 2) the oximation reaction between aminooxy 
functionality (ONH2) and an aldehyde or ketone carbonyl group to form oxime ethers; 3) 
the nucleophilic ring-opening of epoxides;3 and 4) the thiol-ene and thiol-yne reaction, a 
sulfur version of hydrosilylation that requires a radical initiator or UV irradiation.4 
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Of these four reactions, the azide-alkyne cycloadddition is by far the most used 
and the most associated with the term click chemistry.  Indeed, many of the starting 
materials for the azide-alkyne cycloaddition are available commercially, and their 
cycloaddition reactions selectively give 1,2,3-triazoles.  Compared to the original 
Huisgen 1,3-dipolar cycloaddition that requires elevated temperature and often produces 
mixtures of two regioisomers,5 the copper-catalyzed variant features reaction rates 7 to 8 
orders of magnitude higher and can be conducted at room temperature and even under 
aqueous conditions.  Additionally, the copper-catalyzed reaction allows the synthesis of 
the 1,4-disubstituted regioisomers (Scheme 1.1),6 while a later developed ruthenium-
catalyzed reaction gives the opposite regioselectivity with the formation of 1,5-
disubstituted triazoles.7 
 
 
Scheme 1.1.  Copper-catalyzed azide-alkyne cycloaddition mechanism.4 
 
The mechanism for the reaction starts with the coordination of Cu(I) to the alkyne 
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displacement (Scheme 1.1).  An unusual six-membered copper(III) metallacycle 1.2 then 
forms and undergoes a ring contraction to form triazolyl-copper derivative 1.3.  
Hydrolysis delivers the triazole product and closes the catalytic cycle. 
Recently, Worrell et al. proposed a new mechanism for the copper(I)-catalyzed 
azide-alkyne cycloaddition in which two copper atoms are involved in the catalytic 
cycle.8  Using copper isotopes and mass spectrometric analysis, they were able to 
determine that both copper atoms bind equivalently in a reaction intermediate. 
The interest in these three reactions has been growing constantly over the past 
decade as a result of the high-yielding ease with which two molecules of interest may be 
selectively joined.  A SciFinder® literature search conducted on March 29, 2013 revealed 
a total of 7451 publications containing the key words “Click Chemistry” or “Click 
Reaction”. 
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1.A.2.  Aminooxy-Carbonyl Oximation 
The oximation reaction between the aminooxy group and carbonyl compounds 
has the advantage of not requiring a catalyst.  Indeed, the aminooxy functionality reacts 
chemoselectively with aldehyde and ketone carbonyl groups at room temperature in a 
large variety of solvents, including water, and the resultant oxime ether linkage is 
extremely robust. The resistance to hydrolysis differentiates the oxime ether from imine 
or enamine linkages.  Table 1.1 shows some of the chemical differences between an 
aminooxy group and the structurally similar primary amine. 
 
 Table 1.1.  Comparison between aminooxy and primary amine. 
 
Aminooxy Primary Amine 
  
 
At room temperature and under neutral 
conditions, the aminooxy moiety reacts 
chemoselectively with aldehydes and 
ketones to form E/Z oxime ethers. 
 
At room temperature and under neutral 
conditions, primary amines react with 
aldehydes, ketones to form imines, and 
react with esters to form secondary amides. 
 
The oxime ether linkage is very robust and 
is not readily hydrolyzed in water. 
 
The imine linkage is reversible and is 
readily hydrolyzed in water. 
 
These differences in reactivity between primary amine and aminooxy are due to 
the α-effect.9  The term α-effect was first introduced in 1962 by Edwards and Pearson10 
to describe the anomalously high nucleophilic reactivity of compounds having one or 
more lone pair electrons at an atom adjoining (i.e., in the α-position) the nucleophilic 
center.  Among the major influences of the α-effect in aminooxy compounds and 
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hydroxylamine is the lower pKa (i.e. pKa = 5-6)11 of the protonated form, compared to the 
pKa of a primary aminium ion (i.e., pKa = 9-10).  The α-effect in aminooxy compounds is 
affected by the electronegative nature of the oxygen.  Indeed, despite an α-effect, 
hydrazines have a higher pKa (i.e., pKa = 8).  Similarly, hydrazine derivatives react with 
ketones and aldehydes to yield relatively stable hydrazones, but they also react with 
esters, phthalimides, and anhydrides.  Both hydrazones and oximes possess greater 
intrinsic hydrolytic stability than do imines.  This can be explained by the contribution of 
the resonance form in alkylhydrazones and oxime ethers.  As shown in Figure 1.2, the 
resonance form increases the electron density on carbon C1, hence reducing its 
electrophilicity and imparting greater hydrolytic stability.12 
 
 
Figure 1.2.  Resonance structures of oxime ethers and hydrazones. 
   
Winberg et al. also proposed that the greater stability of hydrazones and oximes is 
due to the reduction of lone-pair repulsion relative to the hydrazine and aminooxy state.13  
This second explanation better correlates with the fact that oxime ethers are superior to 
hydrazones with respect to stability since their hydrolytic rate is nearly 103 fold lower.  
Hydrolysis of oximes and oxime ethers occurs at a convenient rate at low pH (pH range 
0-4) in concentrated solutions of HCl and HClO4.  A kinetic and mechanistic study by 
More O’Ferrall et al. shows that the hydrolysis reaction is acid-catalyzed above pH 2, but 
remains pH independent below pH 2.14 
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Under neutral conditions at room temperature, the aminooxy group reacts 
chemoselectively with aldehydes and ketones. This property has been exploited to attach 
polymers to proteins,15 and also to ligate small molecule probes to the cell surface 
ketones.  However, for some applications the rates of reaction of the aminooxy group are 
not sufficient under normal conditions.16  To overcome this problem, Dirksen et al. 
showed that the reaction rates and yields for oximation were substantially enhanced by 
aniline catalysis (Scheme 1.2).17  Under these conditions, they were able to effectively 
ligate aldehydes at concentrations as low as 10 µM.  Thygensen et al. used the aniline 
catalysis to accelerate the reaction of carbohydrates with aminooxy substrates.18 
 
 
Scheme 1.2.  Main pathways of aniline catalysis as proposed by Thygensen et al.18 
 
Recently, Crisalli and Kool have indentified water-soluble catalysts that enhance 
the rates of the oximation reaction.19  Rashidian et al. discovered a new catalyst, m-
phenylenediamine (mPDA), for oxime ligation.19b  According to their study, mPDA is 15 
times more efficient than aniline for the catalysis of oximation.  Importantly, this new 
catalyst is more soluble in aqueous media, which makes it very attractive for some 
biological applications. 
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Although aminooxy groups undergo chemoselective oximation under mild 
conditions, there are many examples in the literature of other forms of reactivity for the 
aminooxy moiety.  Due to the α-effect the aminooxy group remains a good nucleophile 
and can react as such with a variety of electrophiles (Table 1.2).  The reactivity trend for 
reaction with these non-oximation electrophiles is: acyl chlorides > activated carboxylic 
acids > anhydrides and imides > esters > epoxides > alkyl halides. 
 
Table 1.2.  Non-oxime forming reactions of aminooxy species. 
 
Aminooxy reacts readily with acyl 
chlorides at room temperature and 
even even at 0 °C in the presence of 
base.20   
Reaction of aminooxy with 
carboxylic acids requires coupling 
conditions.  Once activated, the 
carboxylic acid and the aminooxy 
group react at room temperatures 
within hours.21 
 
Anhydrides and imides react at room 
temperature with aminooxy moieties 
in aqueous media or polar solvents.  
The reaction is slow but quantitative 
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group prior to reaction with the 
ester.23  
An epoxide ring-opening reaction can 
be achieved with aminooxy.  This 
requires base at room temperature for 
48h or Lewis acid catalysis for 6 
days.24  
There are some examples of halogen 
displacement by aminooxy in basic 
conditions.  Yields for these 
transformations can vary drastically 
on reaction time and base use, but 
remain moderate (20-80%).25 
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As shown in Table 1.2, the aminooxy group can react as a nucleophile with a 
variety of different electrophiles.  Acylating the aminooxy moiety with protecting groups 
such as Boc (tert-butoxycarbonyl) is common.22b,c,d  On the other hand, the reaction of 
aminooxy with alkyl halides is more rare and low-yielding.25  To achieve the same 
hydroxylamine intermediates in higher yields, many groups prefer the two-step 
(oximation and reduction) pathway (Scheme 1.3).26  
 
 
Scheme 1.3.  Oxime ether reduction using NaBH3CN as performed by Daher et al.26c 
 
The aminooxy group can also behave as an electrophile when activated by an 
electron-withdrawing group, enabling electrophilic amination reactions.  This reactivity 
of the aminooxy moiety will be described in detail in Chapter 2.  Briefly, an activated 
aminooxy group can undergo a nucleophilic attack to transfer the nitrogen to the 
nucleophile (Figure 1.3), thereby forming primary amines, hydrazines, etc.   
 
 
Figure 1.3.  Representation of an aminooxy-based electrophilic amination reaction. 
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of rearrangements.  For instance, oximes under acidic conditions or electrophilic 
activation undergo the classic Beckmann rearrangement.27  This reaction proceeds by 
protonation of the oxime hydroxyl, which is then eliminated as water by the migration of 
an adjacent alkyl substituent to nitrogen.  The preferred migrating group is trans to the 
oxime hydroxyl group. The N-O bond cleavage happens simultaneously with the 
expulsion of water, so that formation of a free nitrene is avoided (Figure 1.4).  Ganguly et 
al. showed that electrophilic activation of oximes by elemental iodine can also lead to the 
Beckman rearrangement.27c  
 
 
Figure 1.4.  Beckmann rearrangement mechanism and reaction example. 
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group and give a 2H-azirine (Figure 1.5).  If an aqueous work up is performed, the 2H-
azirine is converted into an alpha-aminoketone. 
 
 
Figure 1.5.  Neber rearrangement mechanism and reaction example. 
 
Activated hydroxamic acids rearrange via the Lossen rearrangement to form 
primary amines when the reaction is performed in aqueous media, or carbamates or ureas 
if the reaction is respectively performed in presence of alcohols or amines (Figure 1.6).29 
The reaction proceeds by generating a reactive isocyanate intermediate that undergoes 
nucleophilic attack by water to form the primary amine; by alcohols to form the 
corresponding carbamates; or by amines to form the corresponding ureas.   
 
 
Figure 1.6.  Lossen rearrangement mechanism and reaction example. 
R
N
R'
OTs
R
N
R'
OTs
BaseBase N
R
R'
2H-azirine
R
O
R'
H2O
NH2
Neber rearrangement mechanism
Recent example by Ooi et al.28c
Ph
N
Ph
OH
p-TsCl (1.2 eq.), KOH
chiral phase transfer reagent
toluene / H2O
Ph
O
Ph
NH2
86%
O
R N
H
OTs Base
O
R N OTs
O
C
N R
O
N
H
OHR
CO2
R NH2
Lossen rearrangement mechanism
Recent example by Dubé et al.29c
H2O
R' YH
Y = O, N
O
N
H
YR R'
O
N
H
OH carbonyldiimidazole
MeCN, rt, 30 min
60 °C, 15 min
N
C
O
BnOH
reflux, 16h
H
N
O
OBn
82%
! 13!
 Finally, a less known rearrangement of N-phenylhydroxylamines is the 
Bamberger rearrangement.30  Under acidic conditions the hydroxyl group of aromatic 
aminooxy groups is protonated and generates an imine cation on loss of water, with the 
positive charge residing principally in para-position.  Nucleophilic attack by water is 
determined by sterics and electronics, leading to the regioselective addition to the para-
position, to afford the 4-aminophenol (Scheme 1.4). 
 
 
Scheme 1.4.  Bamberger rearrangement mechanism. 
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1.A.3.  Current Uses for the Aminooxy Group 
 Traditional organic synthesis is not readily adapted to the easy and rapid 
construction of macromolecules.  Moreover, traditional ligation reaction conditions, such 
as the labeling of a cell surface, are generally not compatible with physiological 
conditions.31  Thus, there is a need for chemoselective ligation reactions between 
complementary functional groups (electrophile-nucleophile pairs) that proceed under 
mild and aqueous conditions.  Since the oximation reactions—aminooxy-aldehyde or 
aminooxy-ketone—have such properties, many biological applications have been 
developed.   
In the development of functional proteins, Canne et al. performed an oximation 
reaction for the assembly of two peptide segments for the total synthesis of a transcription 
factor-related protein (cMyc–Max).32  The strategy (Figure 1.7) initially formed a 
thioester between peptide segments to form two larger domains, followed by the further 
ligation between a ketone and an aminooxy group to form the final oxime-linked product 
in 21% yield. 
  
 
Figure 1.7.  Final step in the chemical synthesis of a modified protein construct derived 
from the heterodimeric transcription factor cMyc–Max. 
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Glycopeptide and oligosaccharide couplings have also been accomplished using 
the click properties of the oximation reaction.  Indeed, the synthesis of glycopeptides is a 
difficult task due to the weakness of the glycosidic linkage and the need for selective 
protection of several functional groups.33  Cervigni et al. synthesized N-terminal 
aminooxy-peptides and then coupled them with maltotriose to generate glycopeptides in 
yields ranging from 60% to 75% (Figure 1.8).34  The same peptides were also coupled 
with decanal to form lipopeptides.   
 
 
Figure 1.8.  Synthesis of glycopeptides as developed by Cervigni et al.34 
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containing an aminooxy moiety.  Under such mild conditions, Zeng et al. found that the 
viability of the cells (from the combined periodate and oxime ligation reaction) was 93%.  
This example shows that the reactions involving the oximation of aldehydes and ketones 
are so highly selective that they do not affect significantly living cells during the time 
frame of the experiments.  Figure 1.9 is a schematic representation of the experiment 
conducted by Zeng. 
  
 
Figure 1.9.  Periodate oxidation followed by aniline-catalyzed oximation of surface-
aldehydes with biotin-ONH2 in living cells. 
 
 Combining material science and biological applications, Thygesen et al. prepared 
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reactions between the linkers and the carbohydrates (glucose, maltose, and maltotriose) 
were performed at room temperature for 16 hours, and gave the desired products in high 
yields (74-88%). 
 
 
Figure 1.10.  Reaction of bifunctional aminooxy-thiol linkers with glucose, followed by 
loading onto gold nanoparticles. 
 
 In another example relating to nanoparticles, Chan and Yu used the ligation 
properties of aminooxy to immobilize gold nanoparticles onto self-assembled 
monolayers.37  They proposed the use of chemoselective ligation as a means to 
immobilize a variety of nanoparticles that are specific for the ligands presented on the 
surface.  Ideally, this immobilization can be achieved with spatial control.  Chan and Yu 
decorated their gold nanoparticles using a mixture of dodecanethiol and 11-mercapto-2-
undecanone.  The thiol functionality of the linkers enabled attachment onto the gold 
nanoparticle. However, only the ketone functionality of 11-mercapto-2-undecanone 
would react with the aminooxy moiety present on the linkers of a gold surface in which 
the nanoparticle monolayer was formed (Figure 1.11).  The functionalized gold 
nanoparticles then were added to the aminooxy functionalized gold surface to form the 
S O NH2Tr 4
OHO
OH OH
OH
HO OHHO
OH N
OH
HO O STr
OHHO
OH N
OH
HO O S Au4
1. trityl deprotection
2. loading onto 
    Au nanoparticle
gluconanoparticle
Acetonitrile/water
acetic acid (cat.), rt 16h 74%
! 18!
self-assembling monolayer.  After 12 hours, rinsing the substrate with dichloromethane 
and ethanol to remove unreacted gold nanoparticles afforded the self-assembled 
nanoparticle monolayer. 
   
 
Figure 1.11.  Nanoparticle-conjugated self-assembling monolayer using chemoselective 
oximation. 
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N,N,N-trimethylammonium iodide (ATM).38f  The direct analysis of the mixtures were 
analyzed by Fourier transform-ion cyclotron resonance mass spectrometry (FTICR-MS).  
Figure 1.12 shows both reagents and their respective analytical methods. 
 
 
Figure 1.12.  Examples of aminooxy reagents for mass spectrometry purposes. 
  
The aminooxy group was used to specifically target carbonyl compounds by 
Hovinen to attach aminooxy-tethered lanthanide(III) chelates (Figure 1.13).39  According 
to Hovinen, such chelates could be suitable for the introduction of MRI contrast agents or 
luminescent lanthanide(III) to bioactive carbonyl molecules. 
 
 
Figure 1.13.  Aminooxy-functionalized Lanthanide(III) chelates for carbonyl-group 
conjugation. 
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Recently, aminooxy chemistry was found to have a promising role for drug 
discovery and development. Bahta et al. proposed a general approach for the rapid 
generation of libraries using oximation.40  In particular, they applied the concept to 
multidentate inhibition of protein tyrosine phosphatase, and also to the optimization of 
peptide-antagonist-targeting interactions between Tsg101 and HIV-1 Gag.  The main idea 
is to use an inexpensive aldehyde as a building block to generate a library of oxime ethers 
(as suggested by Sharpless so many years ago).  Because the reactions are highly 
chemoselective and the products are sufficiently stable, the solutions can be evaluated 
biologically without purification.  In their work, Bahta et al. synthezised 12 different 
aminooxy-containing peptides (P1-P12) that then were subjected to oxime-based library 
diversification by reacting each peptide with a series of 12 commercially available 
aldehydes (A1-A12) to generate 144 different peptide-oxime ethers (Figure 1.14).  As a 
result of the biological assay and the structure-activity relationship (SAR) studies, they 
found a peptide-oxime with 15- to 20-fold binding enhancement as compared with the 
wild-type parent peptide. 
 
 
Figure 1.14.  Design of the Combinatorial Screening Assay based on oximation. 
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1.B.  Transformations Affording the Aminooxy Moiety 
1.B.1.  Alcohol to Aminooxy Transformations 
 The transformation of alcohol moieties has been the primary mode for 
introduction of an aminooxy group into a molecule. The alcohol-to-aminooxy methods 
can be divided into two main groups:  1) those displacing the hydroxyl group after its 
activation, and 2) those directly aminating the alcohol functionality.   
In the first group, one of the most commonly used transformations is a 
modification of the Mitsunobu reaction41 by Grochowski et al.42  Primary alcohols 1.4, 
and to a lesser extent secondary alcohols, are first transformed into the O-alkyl 
phthalimides 1.5.  Hydrazinolysis of the phthalimide group using hydrazine generates the 
desired aminooxy product (Scheme 1.5). 
 
 
Scheme 1.5.  Alcohol to aminooxy transformation using Mitsunobu conditions followed 
by hydrazinolysis. 
 
 This Mitsunobu approach follows the mechanism shown in Scheme 1.6.43  The 
initial nucleophilic attack of triphenylphosphine upon diisopropyl azodicarboxylate 
(DIAD) generates betaine 1.6, which then proceeds to deprotonate N-hydroxyphthalimide 
to form the ion pair 1.7 (Scheme 1.6).  Nucleophilic attack of the phosphonium ion by the 
primary alcohol leads to the formation of the oxyphosphonium ion 1.8.  SN2 displacement 
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of triphenylphosphine oxide 1.9 by N-hydroxyphthalimide anion gives the desired 
product.  Hughes et al. have found that the formation of the ion pair 1.7 is very fast, and 
that the rate determining step in the reaction changes depending on the basicity of the 
carboxylate anion (in this case – ONphth).44  They showed that with weak acid anions, the 
rate-determining step is the alcohol activation, not the SN2 step.  When using acetic acid, 
Hughes et al. observed the accumulation of oxyphosphonium ion 1.8, which made the 
SN2 attack the rate-determining step.  On the other hand, when using trifluoroacetic acid, 
they did not observe build up of the oxyphosphonium 1.8, which implied that the rate-
determining step was the alcohol activation. 
  
 
Scheme 1.6.  Mitsunobu reaction mechanism. 
 
 Using the Mitsunobu reaction, Nicolaou et al. added the aminooxy functionality 
to an oligosaccharide fragment for the click chemistry construction of calicheamicin 
analogs.45 The reaction conditions for this transformation are shown in Scheme 1.7.  
Reduction of 1,2-enone 1.10 undergoes an expected in situ ester migration to 1.11.  
Immediate treatement of 1.11 with Mitsunobu conditions affords the β-glycoside 
phthalimide 1.12 in 53% yield over the two steps.  Presumably, the reaction proceeds via 
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the oxyphosphonium intermediate, which undergoes SN2 displacement and configuration 
inversion.  Hydrazinolysis and coupling with a ketone gave 1.12 in 92% yield over two 
steps. 
 
 
Scheme 1.7.  Nicolaou et al. synthesis of aminooxy functionalized oligosaccharide. 
 
 Karshkela et al. doubly functionalized the branching unit of what would become a 
larger oligonucleotide glycoconjugate (Scheme 1.8).46  The reaction yield was 53% for 
the formation of 1.14, which averages an alcohol-to-N-hydroxyphthalimide 
transformation at 73% yield per alcohol. 
 
 
Scheme 1.8.  Double aminooxy functionalization. 
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A very interesting application of the Mitsunobu reaction applied to aminooxy 
functionalization was developed by Su et al.47  Acknowledging the increasing demand for 
aminooxy functionalized molecules, but conscious of the lengthy purification process, 
they developed a polymer containing reactive N-hydroxyphthalimide for a Mitsunobu-
based solid phase synthesis of aminooxy molecules (Figure 1.15).  The lack of 
purification needed in solid phase synthesis in both synthetic steps—Mitsunobu and 
hydrazinolysis—make this approach very appealing for the synthesis of aminooxy 
products.   
 
 
Figure 1.15.  Polymer-supported N-hydroxyphthalimides for solid phase aminooxy 
functionalization. 
 
A second method involving the displacement of a hydroxyl group of tertiary 
alcohols was developed by Palandoken et al.48 This method enables the formation of the 
tertiary aminooxy groups in good yields.  Contrary to the Mitsunobu reaction where the 
hydroxyl group is displaced via an SN2 mechanism, the preparation of tertiary aminooxy 
following Palandoken’s method involves an SN1 mechanism.  Such a transformation 
mechanism leads to a loss of chirality if the starting alcohol was enantiopure  (Scheme 
1.9).  Hydrazynolysis of the phthalimide forms tertiary aminooxy 1.17 (scheme 1.9). 
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Scheme 1.9.  Tertiary aminooxy preparation. 
 
Mixing the tertiary alcohol 1.15 with boron trifluoride at 0 °C allows the 
formation of the tertiary carbocation that can then be attacked by N-hydroxyphthalimide 
to afford the O-alkyl phthalimide 1.16.  Yields for the transformation are good and range 
from 45-80% (Scheme 1.10). Only in cases where the alcohol elimination would generate 
a conjugated alkene, were the yields low (0-20%).  
 
 
Scheme 1.10.  Examples of transformations using Palandoken et al. procedure. 
 
As a novel approach to the alcohol-to-aminooxy transformation, Choong et al.49 
were the first to propose the use of electrophilic amination reagents for the direct 
amination of the hydroxyl group of alcohols other than phenoxide.  This method involves 
the electrophilic amination of alkoxide nucleophiles using oxaziridines 1.18 (Scheme 
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1.11).  Primary, secondary, and tertiary alcohols can be transformed into their 
corresponding nitriles.  More importantly, this method has the advantage of retaining the 
stereochemistry of the alcohol, which is not possible in the case of the Mitsunobu 
approach or in Palandoken’s method.   
 
 
Scheme 1.11.  Aminooxy synthesis using oxaziridines. 
 
It is important to note that the byproduct generated by the oxaziridine after 
reaction with the alcohol is the highly sterically hindered ketone 1.19.  This feature was 
cleverly designed by Choong et al. to avoid further reaction of the formed aminooxy with 
the byproduct of the oxaziridine reagent.  Indeed, in their search for aminating reagents to 
generate aminooxy groups, Choong et al. realized that the traditionally used 
cyclohexanespiro-3′-oxaziridine (1.20), although capable of forming aminooxy, would 
generate a byproduct that would react to form oxime ether (Scheme 1.12).  To circumvent 
this problem, they surmised that the oximation reaction could be impeded if the resulting 
ketone was highly sterically hindered.  They were gratified to find that this approach also 
yielded a more stable oxaziridine that could be stored at room temperature for months 
without signs of decomposition. 
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Scheme 1.12.  Formation of aminooxy using non-hindered oxaziridines generates 
oximes. 
 
As shown in Scheme 1.13, the yields for transformation of primary and secondary 
alcohols using oxaziridine 1.18 are good and range from 51-86%.  However, the 
transformation only afforded 10% yield in the case of tertiary alcohols.   
 
 
Scheme 1.13.  Examples of transformations using Choong et al. procedure. 
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1.B.2.  Halogen to Aminooxy Transformation 
 Aminooxy functionality can also be introduced via SN2 displacement of halides.  
In this case, the N-hydroxyphthalimide, N-hydroxysuccinimide, or other N-protected 
hydroxylamine derivatives is used directly as the nucleophile in a substitution reaction. 
Selective deprotection affords the corresponding aminooxy derivative. 
 
 
Figure 1.16.  Transformation of alkylhalides into N-(tert-butyloxycarbonyl)aminooxy 
esters. 
 
Displacement of halogens by N-(tert-butyloxycarbonyl)aminooxy has been 
investigated by Jones et al. (Figure 1.16).50 In their search for developing bifunctional 
linkers, it appeared that conventional Mitsunobu (halide displacement by N-
hydroxyphthalimide or N-hydroxysuccinimide) was not adaptable, and they needed a 
different method of accomplishing the transformation.  Halide displacement to obtain O-
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alkylated N-(tert-butyloxycarbonyl)hydroxylamine was therefore developed.  The 
reaction times for these room temperature transformations were long; the yields of the 
transformations varied from 26% to 80%, with the exception of chloro-alkyl compounds 
where no product was isolated. 
In a similar transformation to obtain bifunctional aminooxy and amine 
compounds for use in bioconjugation, Carrasco  et al. functionalized bromo-alkyl chains 
with Boc-protected aminooxy group (Scheme 1.14).51 Employing similar conditions but a 
different solvent, Carrasco obtained good to excellent transformation yields.  
 
 
Scheme 1.14.  Transformation of bromo-alkyl chains by Carrasco et al. 
 
In a different approach to displace halogens, Lemieux et al.52 and Marcaurelle et 
al.53 used N-hydroxysuccinimide (NHS) to impart the compounds with the aminooxy 
moiety (Figure 1.17).  It is interesting to note how adaptable the displacement by NHS 
can be; if the functional groups present in the starting molecule are not sensitive to soft 
nucleophiles, then the reaction can be performed quickly in presence of base with heat. 
Otherwise, the reaction can be carried out under mild conditions at room temperature in 
the presence of Lewis acids. 
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Figure 1.17.  Imparting molecules with the aminooxy moiety using halogen displacement 
by N-hydroxysuccinimide (NHS). 
 
 Finally, the last main class of SN2 displacement of halides for introduction of 
aminooxy moiety into a molecule is the base-catalyzed alkylation using N-
hydroxyphthlimide.  Kim et al.54 and Mikola et al.55 reported conditions for the 
introduction of a phthalimide-protected aminooxy group using this reaction (Figure 1.18).  
In a similar manner, halides (bromo- and iodo-compounds) are displaced by N-
hydroxyphthlimide in presence of base with heat.  Deprotection of the phthalimide group 
is achieved using standard hydrazinolysis conditions.  
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Figure 1.18.  Aminooxy synthesis from halogenated compounds. 
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1.C.  Conclusion 
It is clear from the above review that aminooxy chemistry can be both versatile 
and selective.  The attractive properties of the aminooxy group and the oximation 
reaction inspired us to pursue its development as a key feature in our research.  
Specifically, we aimed to prepare functional-aminooxy compounds and reagents in which 
oxime ether linkage formation would enable new synthetic and analytical properties.  For 
example, Chapter 2 presents the use of aminooxy reagent O-
(diphenylphosphinyl)hydroxylamine (DPPH) as a chemoselective nitrogen transfer 
reagent in nucleophilic fashion (Figure 1.19).  DPPH has been used traditionally as an 
electrophilic amination reagent.  We surmised that the possible oximation reaction of this 
aminooxy reagent with aldehydes would form activated oxime ethers having new and 
unexplored synthetic properties.  Thus, after having developed an improved preparation 
of DPPH using Schotten-Baumann conditions,56 we developed a chemoselective one-pot 
aldehyde to nitrile transformation (Figure 1.19).57 
 
 
Figure 1.19.  Chapter 2 Summary: Synthesis of DPPH and use in aldehyde-to-nitrile 
transformations. 
 
Chapter 3 and Chapter 4 present a new approach to the quantitative, multiplexed 
gas chromatography-mass spectrometry (GC-MS) analysis of complex mistures.  Our 
goal here was to develop a new class of chemoselective reagents that enable the 
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simultaneous analysis of multiple samples.  In particular, we aimed to analyze carbonyl 
(aldehyde and ketone) metabolites.  Once again, to specifically target carbonyl 
metabolites, we developed an aminooxy reagent to derivatize these metabolites.  In this 
case, the derivatization reagents, and the oxime ether products, are designed for further 
reaction to impart analytical properties.  Since very little was known on the mass 
spectrometry-induced fragmentation of oxime ethers, we focused research efforts to study 
the MS-induced fragmentation of oxime ethers, and this work is presented in Chapter 3.  
Our work revealed that oxime ether fragmentations provide, through McLafferty and the 
nitrilium ion formation, a great deal of structural information (Figure 1.20).58 Thus, the 
fragmentation properties of oxime ethers could be applied to identify carbonyl 
metabolites. 
 
 
Figure 1.20.  Chapter 3 Summary: Principal MS-induced fragmentation of carbonyl, 
oxime and silyloxime ethers.  
 
Results from this fundamental study led us to develop a new class of derivatizing 
reagents, and this work is described in Chapter 4.  As shown in Figure 1.21, our 
aminooxyethyl propionate (AEP) reagents contain an aminooxy moiety to selectively 
derivatize carbonyl metabolites as well as a propionate ester to generate an isotopically 
labeled reporter mass spectral tag (MST) in a zone of minimal interference (ZMI) for 
direct mass-spectral quantitation of the derivatized metabolites.  These reagents are 
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designed to profile the carbonyl substrates in complex biological samples and also to 
perform the absolute quantification of some these metabolites.  
 
 
Figure 1.21.  Chapter 4 Summary: Development of AEP reagents for chemoselective 
derivatization of carbonyl metabolites.   
 
Finally, Chapter 5 again esplores the click chemistry properties of the aminooxy 
moiety to ligate linkers and fluorophores to gold nanoparticles (AuNPs) to generate a 
fluorescent nano-entity for breast cancer location and diagnosis.59 In this case, we show 
how the mild oximation reaction conditions enabled the self-assembly of a nano-entity 
with the extremely acid-, base-, and nucleophile-sensitive fluorescent probe cypate.  To 
do so, we synthesized peptide linkers and heterobifunctional diblock linkers that 
contained a thiol functionality at one end, for attachment onto AuNPs, and an aminooxy 
moiety at the other end, for chemoselective ligation of fluorescent probe cypate 
bis(aldehyde) (Figure 1.22).   
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Figure 1.22.  Chapter 5 Summary: Synthesis of peptide and spacers containing aminooxy 
functionality for facile ligation with cypate bis(aldehyde). 
 
 Chapter 6 presents all the experimental procedures of the chemistry described in 
Chapters 2, 3, 4 and 5.  Tabulated NMR spectra as well as other spectroscopic data of 
synthesized compounds are given.  
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Extending Click-Chemistry to Functional 
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2.A.  INTRODUCTION 
Electrophilic amination reagents have been used in a variety of reactions to add 
nitrogen to nucleophiles.1 In particular, these reagents are valuable for the synthesis of 
primary amines and hydrazines.  They differ in the electron-withdrawing group used to 
activate the electrophilic nitrogen.  The most common electrophilic amination reagents 
contain an activated hydroxylamine moiety.  These reagents can be separated into four 
groups based on structural type (Table 2.1).  The two main groups are O-
sulfonylhydroxylamines and O-phosphinylhydroxylamines.  O-Hydroxylamine sulfonic 
acid (HOSA) is known to have better aminating properties than O-
(diphenylphosphinyl)hydroxylamine (DPPH).2 However, HOSA is also more prone to 
side reactions and is derived from hazardous starting materials.  Moreover, 
sulfonylhydroxylamine compounds such as O-(mesitylenesulfonyl)hydroxylamine 
(MtsONH2) tend to decompose spontaneously during drying,1 and Keller et al. also 
reported that HOSA salts deflagrate violently.3  
 
Table 2.1.  Electrophilic amination reagents. 
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Although some literature claims that DPPH is less versatile than the sulfonyl-
based counterparts, DPPH has the most extensive track record for amination chemistry.4  
The higher stability of DPPH compared to other electrophilic amination reagents allows 
for long-term storage at low temperatures (0 °C).  DPPH can also withstand relatively 
harsh conditions before its degradation ensues.  However, its low solubility in non-polar 
solvents remains a significant drawback.5 
Table 2.2 provides some general examples from the literature of the use of DPPH 
as an electrophilic amination reagent.  DPPH is a versatile electrophilic amination reagent 
that has been used widely for the amination of a variety of nucleophiles,6 stable 
carbanions, Grignard reagents, enols,7 and π-electron-rich nitrogen heterocycles.  
 
Table 2.2.  Literature examples of DPPH as an electrophilic amination reagent. 
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Amination of nucleophilic nitrogen 
in aromatic heterocycles occurs in 
high yields.8 
 
 
Primary amines can be generated by 
reaction with Grignard reagents.9 
 
N-N ylides of tertiary amines are 
generated in-situ for the aziridination 
of a range of enones.10 
 
 
 
EWG R
Base
Ph2P(O)ONH2 EWG R
NH2
EWG= CO2R', PO(OEt)2
R= CO2R'', CN, alkyl
N
H
R' R
R'
NaH, DMF
Ph2P(O)ONH2
R = alkyl, aryl
R' = CO2Me
N
R' R
R'
NH2
RMgX
1. Ph2P(O)ONH2
2. H2O workup
RNH2
NMM, Ph2P(O)ONH2
NaOH (2 eq.)R
O
R'
N
R R'
OH
NMM = NO
! 39!
More recently, Armstrong et al. have used DPPH for the aziridination of enones 
by forming a reactive aminimine (Scheme 2.1).10 
 
 
Scheme 2.1.  Synthesis of aziridines using DPPH by Armstrong et al.8 
 
Our interest in studying DPPH comes from the common aminooxy moiety, which 
in all of these reagents serves as the electrophilic nitrogen center.  This application of 
aminooxy chemistry is in contrast to our use of this functionality; we use the aminooxy 
group as a nucleophile.  While only one application has been reported in which DPPH is 
utilized for purposes other than an amination,10 we were surprised to find that there are 
few reports in the literature using  the aminooxy functionality of DPPH as a 
nucleophile.11  We surmised that, given the right conditions, the nitrogen transferring 
properties of DPPH could be preserved after its initial reaction as a nucleophile with a 
carbonyl group.   
One main goal of our research was to explore more deeply the reactivity of these 
aminating reagents with the aim to broaden their use.  Specifically, we focused on 
developing new uses for O-(diphenylphosphinyl)hydroxylamine (DPPH).   Presented 
in this chapter are an improved synthesis of DPPH and a demonstration of its use as a 
chemoselective reagent for a one-pot aldehyde to nitrile transformation. 
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2.B.  An Improved Preparation of O-(Diphenylphosphinyl)hydroxylamine 
2.B.1.  Introduction 
As previously stated, DPPH is one of the most commonly used electrophilic 
amination reagents.  The main reasons are 1) its chemical stability, making it safe to use 
and allowing for long-term storage at 0 °C or below, and 2) its low tendency toward side 
reactions.    
Although DPPH is not commercially available, it is prepared in a single-step 
reaction from hydroxylamine hydrochloride and diphenylphosphonic chloride (2.1).  
Interestingly, although DPPH was first synthesized by Kreutzkamp and Schlindlerin in 
1960,12 it was mischaracterized as N-(diphenylphosphinyl)hydroxylamine (Scheme 2.2).  
These authors presented no chemical or spectroscopic evidence of the hydroxylamine 
structure.  Not until 1979 when Harger,11a following the Kreutzkamp procedure, and 
presumably isolating the same compound, was O-(diphenylphosphinyl)hydroxylamine 
properly characterized.  Hydroxylamine is a nucleophile exhibiting an α-effect and thus 
reacts rapidly with acylating reagents.  Although both the oxygen and the nitrogen atoms 
can react as nucleophiles, the attack by oxygen seems to be kinetically preferred.13  
Indeed, other kinetic studies have also shown that phosphorylating agents undergo initial 
attack by the hydroxyl group of hydroxylamine.14 
 
 
Scheme 2.2.  Kinetic reactivity of hydroxylamine with diphenylphosphinyl chloride. 
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The most widely used procedure to prepare DPPH was developed by Colvin et 
al.15  It involves the reaction diphenylphosphinyl chloride (2.1) in a mixture of water and 
1,4-dioxane in the presence of hydroxylamine hydrochloride and sodium hydroxide at -15 
°C.  The product is then simply filtered and further purified with a base wash.  
Unfortunately, this method is not reliable.  Yields ranging from 42% to a maximum of 
70% have been reported using this synthesis.6,16  In our hands, we found Colvin’s method 
to be sensitive to reaction scale, with multigram attempts generally delivering DPPH in 
ca. 30–60% yield.  The low yields can likely be attributed to the presence of water and 
sodium hydroxide in 1,4-dioxane.  These conditions, in which the organic solvent is 
miscible with water, may induce hydrolysis of the starting diphenylphosphonic chloride 
(2.1) prior to its reaction with hydroxylamine.  In an attempt to minimize hydrolysis, 
Klötzer et al. disclosed an alternative synthesis of DPPH that provides similar yields (ca. 
70%) but uses anhydrous dichloromethane (DCM) and hydroxylamine at even lower 
temperature (-30 °C).17  Unfortunately, there were no apparent advantages using 
hydroxylamine due to its delicate preparation and handling.18  Moreover, hydroxylamine 
is known to decompose rapidly and violently, as evidenced by the explosion of a factory 
in Japan in the year 2000 leading to the death of four people and injury of 58 others.19  In 
particular, under basic conditions, hydroxylamine decomposes into ammonia, water, and 
dinitrogen.19b  Similarly, Kreutzkamp’s synthesis also requires the initial generation of 
hydroxylamine in anhydrous benzene.  Such conditions and length of preparation are not 
convenient.  Our interest in aminooxy chemistry led us to develop a reproducible, higher 
yield synthesis of DPPH.  We developed a convenient procedure for the preparation of 
DPPH on multigram scale.   
! 42!
2.B.2.  Results and Discussion 
The main challenge for the preparation of O-(diphenylphosphinyl)hydroxylamine 
was to find reagents, solvents, and conditions that would minimize the hydrolysis of the 
starting phosphinyl chloride without reacting with the freshly formed DPPH.  Our first 
attempts using anhydrous organic solvents were aimed at avoiding the hydrolysis of the 
starting chloride while exploiting the low solubility of DPPH in organic solvents.  Hence, 
we attempted reactions in anhydrous dichloromethane (DCM) at 0 °C in the presence of 
imidazole.  The combination of hydroxylamine hydrochloride with imidazole generates 
hydroxylamine in situ for reaction with diphenylphosphinyl chloride while forming a 
poorly nucleophilic, yet soluble, imidazole salt.  Due to the low solubility of DPPH in 
organic solvent, we aimed to filter the product and leave the imidazole salt in solution.  
Unfortunately, the nucleophilicity of imidazole still led to major consumption of DPPH, 
presumably forming the hydrazinium salt of imidazole (Scheme 2.3).  Also, the poor 
solubility of hydroxylamine hydrochloride salt in organic solvent slowed the rate of 
DPPH formation, leading to overall poor yields. 
   
 
Scheme 2.3.  Consumption of DPPH in presence of imidazole. 
 
Therefore, the synthesis of DPPH required use of a non-nucleophilic, non-
nitrogen containing base (e.g. sodium hydroxide) to generate hydroxylamine in situ and a 
solvent in which the starting hydroxylamine hydrochloride and the base would be 
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soluble.  Ironically, these two requirements suggest the use of water as a solvent.  
However, the presence of water in the reaction can cause significant hydrolysis of the 
starting phosphinyl chloride.  Facing the same challenges and to compensate for the low 
yields of the reported syntheses of DPPH, other groups have developed ways to recover 
the phosphinic acid generated on hydrolysis of the phosphinyl chloride for recycling 
(Scheme 2.4).20 
 
 
Scheme 2.4.  Recycling diphenylphosphinic acid, as developed by Higgins.18 
 
We surmised that the adaptation of Schotten-Baumann conditions21 using a two-
phase solvent system would help minimize hydrolysis of starting chloride 1 while 
providing the conditions for the in situ generation of hydroxylamine (Scheme 2.5).  
 
 
Scheme 2.5.  Biphasic synthesis of DPPH.22 
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The use of the biphasic system water/Et2O (-15 °C to 0 °C) has proven to be a 
superior method for preparing DPPH (78% yield on a 10-gram scale).  The yield of 
DPPH formed using these conditions did not vary significantly when the reaction scale 
was decreased (e.g., 4-gram scale gave an 84% yield of DPPH).  The high yields 
provided by the biphasic system likely could be attributed to both the low solubility of 
water in Et2O, which prevents the hydrolysis of phosphinic chloride, as well as the very 
low solubility of DPPH in Et2O.  This latter property forces the precipitation of the 
product as it is formed and prevents further reaction with any nucleophiles in solution, 
such as the reactant hydroxylamine.  The precipitate is simply filtered and dried under 
high vacuum.  Figure 2.1 shows the 31P NMR of this crude product. 
 
 
Figure 2.1.  A.  31P NMR spectrum (CDCl3) of starting diphenylphosphinic chloride that 
contains some diphenylphosphinic acid as an impurity.  B.  31P NMR spectrum of crude 
DPPH synthesized using Schotten-Baumann conditions before basic wash.  Impurities at 
32.5 and 29.2 ppm remain unidentified. 
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1H and 13C NMR of DPPH and diphenylphosphinic analogs are very similar.  
However, 31P NMR shows different signals for these products.  As shown in Figure 2.1, 
DPPH generates a signal at 37.5 ppm while diphenylphosphinic acid generates a signal at 
28.4 ppm.  Diphenylphosphinic chloride (2.1) can be identified by its signal at 44.4 ppm.  
Figure 2.1 also shows that Schotten-Baumann conditions prevent the hydrolysis of 2.1, as 
the corresponding diphenylphosphinic acid is the smallest impurity in the crude sample. 
To obtain a high purity DPPH, a basic wash can be performed using 120 mL of a 
0.25 molar solution of sodium hydroxide in water at 0 °C for 30 minutes.  During this 
process, DPPH remains in suspension while diphenylphosphinic acid is solubilized.  
Unreacted chloride (2.1) is hydrolyzed and solubilized in the solution.  Filtration of 
DPPH from this solution affords purity above 97% as it is shown in Figure 2.2.   
 
 
Figure 2.2.  31P NMR spectrum (CDCl3) of DPPH after purification by basic wash.  
DPPH was synthesized with >97% purity.  
O
P ONH2
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To further confirm the NMR data, a high resolution mass spectrometry (HRMS) 
analysis was performed.  Figure 2.3 shows the HRMS of [DPPH+Na]+ calculated at 
256.04979.  
 
 
Figure 2.3.  HRMS (X-axis: m/z; Y-axis: intensity) of DPPH after purification.  
[DPPH+Na]+ calculated at 256.04979, and the value obtained is 256.04965. 
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2.B.3.  Conclusion 
We developed an improved preparation of O-(diphenylphosphinyl)hydroxylamine 
by using an adaptation of Schotten-Baumann conditions.  The biphasic system 
water/Et2O afforded good and reproducible yields.  This method allows for the product to 
be simply filtered for further purification with a base treatment.  Also, product purity, 
generally compromised by the presence of Ph2P(O)OH prior to base treatment, was 
readily assessed using 31P NMR (CDCl3): DPPH, δ 37.5; Ph2P(O)OH δ 28.3.  Hence, we 
were able to determine that DPPH was synthesized with >97% purity by 31P NMR. 
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2.C.  Chemoselective, One-Pot Transformation of Aldehydes to Nitriles23 
2.C.1.  Introduction 
Nitriles are versatile intermediates and valued target pharmacophores.24  They can 
be prepared either through a homologation reaction that will add one extra carbon to the 
starting functionality (Table 2.3) or through the transformation of carbon-equivalent 
functional groups (Table 2.4).   
 
Table 2.3.  Homologation reactions leading to nitriles. 
The reaction of alkyl halides with metal 
cyanides can generate the corresponding 
nitrile or the isonitrile depending on the 
metal.  
Aromatic nitriles can be generated from 
the starting aromatic halide by reaction 
with cuprous cyanide. 
 
 
Homologation reactions are generally simple SN2 displacements of alkyl halides 
by alkali cyanides such as sodium cyanide.  Metal cyanides are also used in the Kolbe 
nitrile synthesis, but lead to the formation of isonitriles as byproducts since the reaction 
partially proceeds via SN1.  Aromatic nitriles are formed via the Rosenmund-von Braun 
synthesis in which the aryl halide reacts with cuprous cyanide.  One of the major 
problems for these homologation reactions is the highly toxic nature of cyanide reagents. 
To avoid the use of toxic cyanides, chemists have preferred exploring the paths of 
carbon-equivalent syntheses of nitriles.  Diverse methodologies and reagents have been 
developed in the field.  As a result, it is now possible to transform alcohols, primary 
amines, halides, azides, amides, aldehydes, and aldoximes into nitriles.  Table 2.3 shows 
examples of these procedures.  Among the most popular approaches is the oxidation-state 
R X R CN + R NC
isonitrile
M = Ag
nitrile
M = Na, K
alkyl halide
X = Cl, Br
M-CN
X CN
aryl halide
X = Br, I
Cu-CN
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neutral conversion of carboxylic acids to nitriles via dehydration of intermediate primary 
amides (Figure 2.4). They either use traditional dehydrating reagents25 or recently 
developed metal-mediated procedures.26  With the exception of primary amide 
dehydration, all the other carbon-equivalent procedures require the oxidation of the 
carbon center.   
 
Table  2.4.  Examples of carbon-equivalent nitrile syntheses. 
Oxidative conversion of various benzylic 
alkyl halides and primary alkyl halides 
into corresponding nitriles occurs on 
treatment with iodine.    
The reagent N,N,N',N'-
tetrachlorobenzene-1,3-disulfonamide 
(TCBDA) effects formation of nitriles 
from primary amines.  The direct 
conversion of primary alcohols into 
nitriles also was successfully carried out 
using this reagent in aqueous ammonia. 
 
Primary azides, including benzylic, 
allylic, and aliphatic, are converted into 
the corresponding nitriles in the presence 
of a ruthenium hydroxide catalyst.  
The catalytic dehydration of aromatic 
and aliphatic amides using silanes in the 
presence of catalytic amounts of fluoride 
allows the synthesis of a wide range of 
aliphatic and aromatic nitriles with high 
selectivity under mild conditions. 
 
Graphite promotes the conversion of 
aldehydes into nitriles in high yields.  
The reaction proceeds through the 
dehydration of the aldoxime 
intermediate.  
 
Ar X
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An efficient complement to amide dehydration is the oxidative transformation of 
aldehydes to nitriles.  Isolation of aldoxime intermediates (Figure 2.4) generally is 
followed by activation of the oxime hydroxyl group (e.g., as a sulfonate ester derivative) 
and then its elimination to afford the nitrile.27  
 
 
Figure 2.4.  Common functional group interconversions to prepare nitriles. 
 
The appeal of the aldehyde to nitrile approach has led to several one-pot methods for 
direct synthesis of nitriles from aldehydes using either hydroxylamine or ammonia in 
combination with a variety of activating reagents.28 
Unfortunately, the accompanying reagents for these one-pot approaches, such as 
CuCl2/NaOMe/O2,28a Pb(OAc),28b oxone,28e H2O2,28h I2,28i NBS,28j IBX,28k and NaICl2,28l 
often are not tolerant of other functional groups or require somewhat harsh conditions to 
effect the transformation.  Ideally, an aldehyde-selective reagent that would facilitate the 
conversion to the nitrile under neutral conditions would greatly expand the utility of this 
direct approach.  We thus developed the use of O-(diphenylphosphinyl)hydroxylamine 
(DPPH) as such a reagent.   
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2.C.2.  Results and Discussion 
Our interest in aminooxy chemistry29 led us to consider the use of DPPH 
(Ph2P(O)ONH2) as a possible chemoselective alternative to hydroxylamine or ammonia 
for introduction of nitrogen onto the carbonyl carbon of aldehydes.  Since the reaction of 
this reagent with an aldehyde would directly form an activated oxime ester as an 
intermediate (e.g., 2.2, Scheme 2.6), we reasoned that it should be possible to thermally 
induce an electrocyclic rearrangement resulting in the elimination of diphenylphosphinic 
acid (Scheme 2.6).   
 
 
Scheme 2.6.  Electrocyclic rearrangement. 
 
Sharghi et al. proposed a similar mechanism involving elimination of 
methanesulfonic acid for the formation of nitriles from intermediate sulfonylated 
aldoximes.30 Although DPPH is well appreciated as an electrophilic reagent for the 
amination of a variety of nucleophiles,5-9 its use as a nucleophilic counterpart, especially 
in chemoselective “click” transformations, has received limited attention.11  Indeed, there 
is only one example in the literature showing DPPH condensing with acetone at room 
temperature.  This example was used by Harger to further confirm the structure of DPPH.  
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To test the action of DPPH as a suitable reagent for oxime ester formation as well as the 
subsequent elimination to the nitrile, we examined the reaction between DPPH and α-
naphthaldehyde (Scheme 2.6). 
 
 
Figure 2.5.  31P NMR (CDCl3) spectrum of 1-naphthaldehyde O-diphenylphosphoryl 
oxime (Scheme 2.6 compound 2.2).  Signal at 35.6 ppm. 
 
Reaction of DPPH with naphthaldehyde in THF gave oxime ester 2.2 in 79% 
yield.  Figure 2.5 shows the 31P NMR of compound 2.2 after purification.  The NMR 
signal at 35.6 ppm is close to the 31P NMR signal of DPPH (i.e. 37.5), which confirms the 
presence of the oxime functionality attached to the phosphorous center.  Subsequent 
heating in toluene revealed that the elimination of diphenylphosphinic acid from 2.2 
required warming to above 80 °C to achieve a significant rate of formation of 
naphthonitrile 2.3 (Scheme 2.6).  Of particular note is that no Lewis acid or base was 
N OPPh2
H
O
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required to effect the elimination; rather, simple warming under catalyst- and oxidant-free 
conditions was sufficient to afford 2.3 in 88% yield. 
 
 
 
Figure 2.6.  A. 1H NMR (CDCl3) in the aromatic region of 2.2.  The presence of the 
aldoximic proton is shown at 9.04 ppm.  B.  1H NMR in the aromatic region of 1-
naphthonitrile 2.3 generated from 2.2 after heating in toluene at 85 °C. 
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Figures 2.6A and 2.6B show the 1H NMR spectra of compound 2.2 and 2.3 
respectively.  As expected the electrocyclic rearrangement leads to the elimination of 
diphenylphosphinic acid by abstracting the aldoximic proton of the phosphonyl aldoxime 
ester.  Thus, the proton signal at 9.04 ppm in Figure 2.6A disappears when the nitrile is 
generated in Figure 2.6B. 
For all the nitriles, 13C NMR was also used to identify the product since the nitrile 
carbon has a chemical shift ranging from 120 to 116 ppm.  For some unknown 
compounds, such as entry 14 in Table 2.5, we also used infrared (IR) spectroscopy to 
confirm the functional group interconversion since nitriles have a unique absorption 
ranging from 2260 to 2220 cm-1.  
 
 
Table 2.5.  Conversion of aldehydes to nitriles using Ph2P(O)ONH2.a 
Entry Starting Aldehyde Method Major Product Yield (%)b 
1 Ph-CHO A Ph-CN 82 
2 
 
A 
 
80 
3 
 
A 
B 
 
69 
78 
4 
 
A 
B 
 
90 
87 
5 
 
A 
B 
 
37 
58 
R C
O
H
DPPH
toluene, 85 °C
R C N
CHO CN
HO
CHO
HO
CN
CH3O
CHO
CH3O
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CH3S
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CH3S
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6 
 
A 
 
80 
7  A  96 
8 
 
A 
 
81 
9 
 
A 
 
75 
10 
 
A 
 
85 
11 
 
A 
C 
 
55 
64 
12 
 
A 
 
92 
13 
 
A 
 
90 
14 
 
A 
B 
C 
 
40 
39 
44 
15  A  57 
16 
 
A 
 
78 
 
a All reactions were performed in toluene at 85 °C for 4-6 h on ≥ 0.5 mmol scale using 
1.15 equiv. reagent (method A), 2.0 equiv. reagent at 95 °C for 12h (method B), or 1.15 
equiv reagent and 1.1 equiv. trifluoroacetic acid at 95 °C for 12h (method C).  b 
Chromato-graphed (SiO2) yield. Boc = tert-butyloxycarbonyl; TBS = tert-
butyldimethylsilyl. 
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 We next examined the possibility of transforming aldehydes directly into nitriles 
without isolation of the oxime ester adducts.  Despite the partial solubility of DPPH in 
toluene, we were pleased to find that its reactions with a diverse panel of aldehydes in 
this solvent gave good yields of the corresponding nitriles upon heating at 85 °C (Table 
2.5).  The conversions to the nitriles proceeded smoothly for aromatic as well as aliphatic 
aldehydes and accommodated α,β-unsaturation.  Importantly, the aminooxy group of 
DPPH afforded a measure of chemoselectivity that enabled the selective, one-pot 
transformation of aldehydes to nitriles in the presence of other carbonyl groups, such as 
ketone, ester (including acetate), and carbamate carbonyls.  While in some cases the 
transformation of electron-rich aldehydes required an additional equivalent of reagent for 
better overall conversion (entries 3 and 5), the vinylogous formamide carbonyl of entry 
14 was only sluggishly transformed into the corresponding nitrile even when using excess 
reagent.   
 
 
Figure 2.7.  IR spectrum of the corresponding nitrile of entry 14.  IR absorption at 2223 
cm-1 confirms the presence of the nitrile group. 
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 Figure 2.7 shows the IR spectrum obtained after transformation of entry 14 into its 
corresponding nitrile.  The characteristic absorption at 2223 cm-1 confirms the presence 
of the nitrile group.  Absorption at 1740 cm-1 is characteristic of the ester functionality 
present in the molecule, which suggests, as observed for entry 10, that our transformation 
is chemoselective and can be performed in the presence of ester moieties.  As shown in 
Figure 2.8, the ester functionality remains intact from entry 14 to its corresponding nitrile 
while the aldehydic proton disappears from the 1H NMR. 
 
 
Figure 2.8.  1H NMR spectra (CDCl3) of aldehyde 14 (top spectrum) and its 
corresponding nitrile (bottom spectrum).  The aldehydic proton (red) disappears in the 
nitrile.  The ester functionality (blue) remains unchanged as well as the CH2 in α-position 
of the ester (green). 
 
!
!!!
N
O
OEt
O H
N
O
OEt
CN
! 58!
 Given that diphenylphosphinic acid (pK 2.32)31 is produced during the course of 
the reaction, we examined the aldehyde to nitrile conversion in the presence of acid-
sensitive N-Boc and silyl ether protection groups.  Whereas the Boc group was not 
affected (entries 12 and 13), the TBS ether was cleaved during the reaction (entry 15).  In 
the entry 15 example, the initially formed desilylated product, 4-hydroxybutyronitrile 
(isolated in 13% yield), partially cyclized under the reaction conditions to generate γ-
butyrolactone (ca. 10% yield) after workup.  We surmise that this process occurs by 
generating an acid-catalyzed nitrilium intermediate that undergoes an intramolecular 
Ritter reaction (Scheme. 2.7).  Attempts to buffer the reaction by addition of non-
nucleophilic bases (e.g., Na2CO3) did not prevent loss of the silyl group.   
 
 
Scheme 2.7.  Generation of γ-butyrolactone via intramolecular Ritter Reaction. 
 
 To confirm that the side product of the reaction was indeed γ-butyrolactone, we 
performed both 1H NMR and GC-MS analysis.  Figure 2.9A shows the electron 
ionization (EI) mass spectrum obtained after injection in the GC-MS, while Figure 2.9B 
shows the most similar spectrum matched by the library of compounds, which is γ-
butyrolactone.  The resemblance between both spectra is 91%. 
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Figure 2.9.  A.  EI-MS (X-axis: m/z; Y-axis: intensity) of γ-butyrolactone obtained as a 
side product of entry 15.  B.  EI-MS of γ-butyrolactone matched by the GC-MS library 
with 91% resemblance. 
 
Since DPPH readily reacts with amines,8b-d,11 we noted that an acidification 
strategy, as in the case of 3-pyridinecarboxaldehyde (entry 11), improved the overall 
conversion to the nitrile, presumably by in situ pyridinium formation preventing 
electrophilic amination of the pyridine nitrogen.  Finally, as a probe to see whether the 
process could be adapted to polar protic, more green solvents, we examined the reaction 
of 3-phenylpropionaldehyde with DPPH in water and found that heating at 95 °C for 12 
hours afforded the corresponding nitrile in 73% yield.  In addition, heating 3- 
pyridinecarboxaldehyde and DPPH in acetic acid as solvent under similar conditions 
gave 3-pyridinecarbonitrile in 60% yield. 
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2.C.3.  Conclusion 
In conclusion, the present method is applicable for the one-pot conversion of 
aldehydes to nitriles in the presence of water, alcohols, and other carbonyl functionalities.  
DPPH is sufficiently selective in its reactions with aldehyde carbonyl groups that 
chemoselection is achieved on simple mixing at room temperature followed by warming 
to effect the transformation to the nitrile.  Ease of reaction, good yields, and the absence 
of base or oxidant are other features of this method. 
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CHAPTER 3 
 
 
An Approach to Quantitative Multiplexed  
GC-MS Analysis. 
Part 1: The MS-Induced Fragmentation of 
Oxime Ethers. 
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3.A.  Introduction 
 High-throughput analysis platforms are the technologies of choice for analyzing 
complex mixtures derived from biological samples, such as blood, urine, and tissue 
samples.  Technologies that facilitate the analysis of these complex mixtures have the 
potential to become personalized diagnostic tools for a large variety of diseases.  The 
fields of genomics, proteomics and metabolomics have been growing rapidly with the 
objective of obtaining a “snap-shot” of the chemical composition of biological samples to 
better understand some metabolic pathways.  Such a “snap-shot” could deliver a 
molecular profile of the sample and facilitate biomarker discovery. For example, the 
advent of quantitative mass spectrometry proteomics1 has given researchers an efficient 
tool for the discovery and study of protein-based biomarkers.   
Over the past decade, the field of metabolomics has witnessed dramatic growth.  
In 2005 the METLIN2 Metabolomics Database was established with 5,000 metabolites.  
As of today this database contains over 42,000 metabolites.  The interest in metabolite-
based biomarkers comes from the fact that metabolites are the end products of cellular 
processes and may represent dynamic changes at the cellular level.  Their profiling for 
diseases, such as cancer, is considered a tool for diagnosis of malignancy before changes 
occur to the cellular architecture.3  Therefore, in such an emerging field, further progress 
is dependent on the technical evolution of mass spectrometry (MS).  Indeed, the ability to 
analyze multiple extracts in a single assay (the process of multiplexing) and rapidly 
quantify multiple analytes from different samples (high throughput) would accelerate 
metabolite-based profiling and biomarker discovery.  As previous studies have emulated 
the stable isotope coding technology used in liquid chromatography-mass spectrometry 
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(LC-MS) proteomics,4 we propose to develop a new technology based on gas 
chromatography-mass spectrometry (GC-MS) to be compatible with high throughput and 
multiplex methodologies.  By comparison to other existing analytical platforms, 
comprehensive two-dimensional gas chromatography mass spectrometry (GC×GC-MS) 
provides increased separation capacity, chemical selectivity, and sensitivity for the 
analysis of metabolites present in complex samples, even though the samples need to be 
derivatized first.  For example, a GC×GC-MS system can easily detect more than 1,800 
analytes from a human plasma extract in a 40-minute analysis. 
We propose to develop new derivatizing reagents containing isotopic tags for high 
throughput multiplexed metabolomics.  Initially, the prototype reagents will be fitted with 
an aminooxy group (-ONH2) to specifically derivatize carbonyl metabolites.  As shown in 
Scheme 3.1, the reaction of aminooxy compounds with carbonyl groups results in the 
formation of oxime ether moieties, a process known as oximation.  The GC-MS analysis 
of the oxime ethers separates the different compounds and generates for each one of them 
an electron ionization (EI) spectrum.  This spectrum is composed of the charged 
fragments that arise from the molecules. 
 
 
Scheme 3.1.  Oximation of carbonyl metabolites and their analysis through GC-MS. 
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The electron ionization-induced fragmentation of the resulting oxime ethers have 
not been thoroughly studied.5  Consequently, we report here the GC-TOF MS mass 
spectra for a panel of carbonyl, oxime, and silyl oxime ether substrates.  Our goal in this 
MS study is to understand the different fragmentation pathways that can arise from the 
electron ionization of oximes and silyl oxime ethers to better predict and help us identify 
carbonyl metabolites after derivatization using the isotopically labeled aminooxy 
reagents.  We also disclose a systematic computational investigation into the McLafferty 
rearrangements observed for most of the compound panel to obtain more insight into the 
intrinsic factors that promote and determine the nature of the McLafferty rearrangement.  
In particular, we examine the influence of oxygen substitution adjacent to the site of γ-
hydrogen atom abstraction in the McLafferty rearrangement.  
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3.B.  Carbonyl, Oxime, and Silyl Oxime Ether Substrates 
3.B.1. Significance of the Study of Carbonyl Metabolites 
The analysis of cellular aldehyde and ketone species is of considerable 
importance for the field of metabolomics.6  Indeed, carbonyl metabolites tend to represent 
the extent of oxidative stress often related to diseases including cancer.7  Aldehydes and 
ketones can be formed endogenously by various biochemical pathways.  For example, 
aldehydes can be formed by lipid peroxidation (Scheme 3.2), carbohydrate metabolism, 
and ascorbate autoxidation as well as by various enzymatic processes such as those 
involving amine oxidase, cytochrome P-450, or myeloperoxidase.8 Malondialdehyde 
(MDA), 4-hydroxynonenal (4-HNE) and other 4-hydroxyalkenals (4-HDA) are known to 
be biomarkers of oxidative stress, forming on degradation of polyunsaturated lipids 
(PUL) by the action of reactive oxygen species (ROS).9  
 
 
Scheme 3.2.  Lipid peroxidation cycle and resultant HDA products. 
 
 Endogenous ketones, such as acetone and acetoacetic acid, are molecules 
produced as byproducts when fatty acids are broken down for energy in the liver and 
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kidney.10  Other ketones, such as β-ketopentanoate, may be created as a result of the 
metabolism of synthetic triglycerides.11  Furthermore, ketone bodies, such as acetone, are 
produced from acetyl-CoA mainly within the mitochondrial matrix of hepatocytes when 
carbohydrates are so scarce that energy must be obtained from breakdown of fatty 
acids.12  Acetone is responsible for the characteristic “fruity” odor of the breath of people 
in ketoacidosis.13 
To isolate these carbonyl metabolites for analysis by mass spectrometry, their 
selective conversion into labeled oximes or oxime ether analogs by water-based click 
chemistry (i.e., oximation, Scheme 3.2) has become an elegant and highly chemospecific 
approach.5i,5k  Oxime chemistry and subsequent silylations to form silyl oxime ethers 
have been used to detect and analyze natural and synthetic steroids,5j 
trisaccharides5b,5C,5g,5h and other classes of compounds5d,5f by gas chromatography-mass 
spectrometry (GC-MS).  Oximation proceeds rapidly under mild conditions and is 
chemoselective in that the aminooxy reaction with the carbonyl groups of aldehydes and 
ketones is preferred over the majority of other functionalities.  Among other advantages, 
oxime ethers are potentially suitable as components of dynamic libraries.5e  The study of 
the major MS fragmentations of these carbonyl derivatives, however, has not received 
due attention.  One predictable MS-fragmentation of this carbonyl derivative is the 
McLafferty rearrangement.  The next section describes in detail this fragmentation and 
our efforts to examine its prevalence among various oxime ethers and silyl oxime ethers. 
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3.B.2.  Introduction to the McLafferty Rearrangement 
In 1959, Fred W. McLafferty published14 an article entitled “Mass Spectrometric 
Analysis. Molecular Rearrangements” in which mechanistic concepts for mass 
spectrometry were described that remain valid to this day.  The characteristics of the 
McLafferty rearrangement have been described extensively and in great detail.15  Briefly, 
the McLafferty rearrangement involves the transfer of an aliphatic hydrogen atom in γ-
position to an acceptor group followed by a β-cleavage (Figure 3.1).   
 
Figure 3.1.  Proposed McLafferty fragmentation pathways 
 
Carbonyl groups in ketones, aldehydes, carboxylic acids, esters, amides and other 
derivatives are the most common acceptor groups, but aromatic and heteroaromatic rings 
can also act as acceptors.  Not only does the γ-hydrogen atom have to be bound to an sp3-
hybridized carbon atom, it also has to be sterically accessible to the acceptor group.  
Hydrogen atom transfer is accompanied by the cleavage of the α-β bond, resulting in the 
formation of an odd-electron positive ion (enol ion) and a neutral molecule (Figure 3.1).    
In addition, the McLafferty rearrangement is known to occur with a reverse charge 
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distribution, i.e., generating the neutral enol and the charged alkene fragments.16 
The McLafferty rearrangement can proceed through either a concerted or stepwise 
mechanism.15  Various elegant experiments have been performed to probe the 
mechanistic nature of the McLafferty rearrangement, and to date, in all cases, the results 
point toward a stepwise mechanism.17  Various theoretical studies have been performed 
that confirmed the stepwise mechanism, but some also identified systems that should or 
could proceed through a concerted mechanism.18  Finally, in addition to the single 
hydrogen transfer McLafferty rearrangement, consecutive rearrangements that proceed 
by a double hydrogen transfer have been reported.15  In general, one would expect that 
the McLafferty rearrangement would have to compete with other fragmentation 
pathways, such as simple bond cleavages that are entropically more favorable.15  The 
relative importance of the various fragmentation pathways is determined by their 
respective kinetics inside the ion source, which is related to the thermochemistry and can 
be calculated fairly accurately by applying the Rice-Ramsperger-Kassel-Marcus (RRKM) 
theory.19  In most cases, the potential energy surfaces of the different fragmentation 
pathways need to be known, and quantum chemical calculations can provide the input 
parameters for the RRKM calculations.10a 
Although the McLafferty rearrangement20 of carbonyl compounds has been the 
focus of extensive and continuous research,21 studies on oximes and their silyl oxime 
ether derivatives have been limited.5  Surprisingly, to date, only one article has reported 
the McLafferty rearrangement for ketoximes.  Bowen and Maccoll observed both single 
and double McLafferty rearrangement fragments in the mass spectra of various 
ketoximes under low-energy (12eV) and low-temperature (350 K) ionization.5a 
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3.B.3.  Synthesis of Carbonyl and Oxime Substrates 
We prepared the panel of carbonyl substrates shown in Figure 3.2 and examined 
their incidence of McLafferty rearrangement to guide the future development of 
aminooxy derivatizing agents.  We examined two key structural variables: (a) ketone vs. 
aldehyde and (b) β-CH2 vs. β-O.  These variables were examined in both carbonyl and 
oxime analogs.   
 
 
Figure 3.2.  Carbonyl, oxime, and silyl oxime ether analogs. 
 
We surmized that the α-β bond cleavage of the McLafferty rearrangement might 
be increased by introduction of an oxygen atom at the β-position (Compounds 3.3-4, 3.7-
8, 3.11-12,).  Indeed, if the McLafferty rearrangement proceeds via a stepwise radical 
mechanism (Figure 3.1 and Scheme 3.3), then placing an oxygen in the β-position would 
stabilize the radical intermediate X, and ensure a fast γ-hydrogen transfer.  The 
O
H
3.1
N
H
3.5 (E, Z)
HO N
H
3.9 (E, Z)
TBSO
β
parent 
carbonyl oxime
silyl
oxime
O
H3C 3.2
N
H3C 3.6 (E)
HO N
H3C 3.10 (E, Z)
TBSOβ-CH2
O
H O
3.3
N
H O
3.7 (E, Z)
HO N
H O
3.11 (E, Z)
TBSO
β
O
H3C
O
3.4
N
H3C
O
3.8 (E)
HO N
H3C
O
3.12 (E, Z)
TBSOβ-O
! 70!
McLafferty rearrangement would be expected to result in the β-cleavage of the α-alkoxy 
oxime as shown in Scheme  3.3.11 
 
 
Scheme 3.3.  Expected McLaffery rearrangement of carbonyls with β-oxygen. 
 
The first set of aldehyde and ketone substrates with a β-CH2 were synthesized 
without much difficulty using modifications of known synthetic processes established by 
Mokhtari et al. for the oximation using hydroxylamine hydrochloride,22 and Ortiz-
Marciales et al. for the silylation of oximes.23  Starting heptanal (3.1) and 2-heptanone 
(3.2) were purchased from Aldrich.  Reaction with hydroxylamine hydrochloride in 
methanol in the presence of base generated the corresponding oximes in 89% yield for 
the aldehyde and 74% yield for the ketone (Scheme 3.4).  The yields in this step, 
although good but not excellent, may be explained by the decomposition of the 
hydroxylamine in solution prior to reaction with the carbonyl group.  Indeed, it is known 
that hydroxylamine decomposes into various gases under basic conditions including 
ammonia, water, and dinitrogen.24  Silylation of the oximes proceeded in 
dichloromethane in the presence of imidazole and tert-butyldimethylsilylchloride 
(TBSCl).  Yields for this step are moderate (65% for the aldoxime and 66% for the 
ketoxime) probably due to premature hydrolysis of the silyloxime ethers. 
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Scheme 3.4.  Reagents and Conditions: a. HONH2•HCl, NaHCO3, MeOH, 24h, rt.  b. 
TBSCl, imidazole, CH2Cl2, 12h at rt. 
 
NMR analysis of the product mixture provides a relative ratio of both the E- and 
Z-isomers.  For the oxime and silyloxime ether adducts of hexanal, the downfield 
aldehydic proton (7.62 ppm) corresponds to the E-isomer, while the aldoximic proton at 
6.85 ppm corresponds to the Z-isomer (Figure 3.3).25  The shielding effect observed for 
the Z isomer is, most likely, the result of the lone pair of electrons on the nitrogen.    
 
 
Figure 3.3.  1H NMR spectrum (CDCl3) showing E vs Z silylaldoxime ether isomers. 
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The aldehyde substrates containing a β-O (compounds 3.3, 3.7 and 3.11) were 
obtained in overall poor yield (7% in 4 steps, Scheme 3.5).   Propoxy aldehyde 3.3 was 
prepared by reaction of bromoacetaldehyde dimethyl acetal with sodium hydride and n-
propanol in THF (25% yield) to afford propoxy acetal 3.13. Hydrolysis of the acetal 
using para-toluene sulfonic acid (PTSA) in water gave the desired propoxy aldehyde 3.3 
(81% yield).  Aldoxime 3.7 and silylaldoxime ether 3.11 were prepared using the same 
standard reaction conditions as described above with similar yields (56% for the 
oximation and 62% for the silylation step). 
 
 
Scheme 3.5.  Reagents and Conditions: a. NaOH, propanol, reflux, 24h.  b. PTSA (2 
equiv.), water, rt, 4h.  c. HONH2•HCl, NaHCO3, MeOH, rt, 24h.  d. TBSCl, imidazole, 
CH2Cl2, rt, 12h. 
 
Our initial synthesis of propoxy ketone 3.4 iterated closely the steps used to 
prepare propoxy aldehyde 3.3.  We attempted the SN2 displacement of bromine from 1-
bromo-2,2-dimethoxypropane using sodium propoxide (Scheme 3.6, step a) followed by 
acetal hydrolysis (Scheme 3.6, step b) to obtain 3.4.  
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Scheme 3.6.  Reagents and Conditions: a. NaOH, propanol, reflux, 24h.  b. PTSA (2 
equiv.), water, rt, 4h.  c. NaOH, propanol, reflux, 24h. 
 
Unfortunately, the SN2 displacement (step a, Scheme 3.6) was not achieved. 
Figure 3.4 shows the Newman projections for the reactions leading to the propoxy 
aldehyde acetal and to the propoxy ketone acetal.  Although the SN2 displacement 
occurred to give the propoxy aldehyde acetal in poor yields, steric hindrance from the 
methyl group apparently deterred SN2 displacement of bromine.  Similarly, the SN2 
displacement of bromine from bromoacetone (Scheme 3.5, step c) using the same 
conditions did not generate propoxy ketone 3.4. 
 
 
Figure 3.4.  Newman projections for the SN2 attack of the acetal versus the ketal. 
 
 We opted to circumvent the above problems by attempting an SN2 displacement 
of bromine from bromoacetic acid (Scheme 3.7).  The reaction of bromoacetic acid with 
n-propanol and sodium hydroxide gave the displacement product 3.14 in moderate yield 
(51% yield, Scheme 3.6, step a).  The resulting acid 3.14 was converted to methyl ketone 
3.4 by treatment with methyl lithium in dry ether at -78 °C (37% yield, Scheme 3.7, step 
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b).  Standard oximation and silylation conditions described previously generated 
ketoxime 3.8 and silylketoxime ether 3.12 (44% and 68% yield, respectively). 
 
Scheme 3.7.  Reagents and Conditions: a. NaOH, propanol, reflux, 24h; b. MeLi (2 eq), 
THF, -78 °C to rt, 4h; c. HONH2•HCl, NaHCO3, MeOH, rt, 24h; d. TBSCl, imidazole, 
CH2Cl2, rt, 12h. 
 
NMR analysis of the product mixture provides a relative ratio of both the E- and 
Z-isomers.  Silylketoxime ethers can be identified by the CH2 signal on α-position of the 
oxime moiety.  The downfield CH2 protons (4.42 ppm) correspond to the Z-isomer, while 
the CH2 protons at 3.99 ppm correspond to the E-isomer (Figure 3.5).  
 
Figure 3.5.  1H NMR spectrum (CDCl3) showing E vs Z silylketoxime ether isomers with 
β-O. 
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3.C.  Results and Discussion on the MS-Fragmentations 
3.C.1.  Electron-Ionization Mass Spectral Comparisons 
In all, the fragment ions resulting from the McLafferty rearrangement are present 
to varying extents. Our GC-TOF MS spectra showed high similarities with the known 
mass spectra of compounds 3.1 and 3.2 from the NIST database.  In all mass spectra, 
except of compound 3.2, no molecular ions (M+•) can be observed.  As expected, 
numerous fragment ions have been generated from the excited molecular ions (M+•*) that 
were generated due to electron ionization in the ion source, especially those resulting 
from simple and favorable bond cleavages.  Due to the presence of numerous fragment 
ions, it is challenging to determine the normalized intensity of McLafferty rearrangement 
fragment ions and to perform some kind of semiquantification to compare the various 
entries.  However, by comparing compounds 3.1 and 3.2, it is clear that ketone 
functionality enhances the McLafferty rearrangement compared with the aldehyde 
functionality.  A similar pattern is observed when comparing compounds 3.3 and 3.4, and 
this pattern is in agreement with the relative basicity of the carbonyl oxygens.  However, 
in contrast to expectations, when comparing compounds 3.1 and 3.3, it seems that 
introduction of oxygen on the β-position suppresses the McLafferty rearrangement, and a 
similar observation can be made when comparing compounds 3.2 and 3.4, although to a 
much lesser extent.  In the case of ketone 3.4, the β-oxygen appears to promote 
significant fragmentation via carbonyl alpha cleavage to generate the corresponding 
acylium ion H3CCO+ (m/z = 43) by stabilization of the leaving radical fragment 
•CH2On-Pr. 
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The synthesis of the oximes 3.5–8 and silyl oxime ethers 3.9–12 gave rise to both 
the (E)- and (Z)-isomers (except for ketoximes 3.6 and 3.8 that were formed in lower E/Z 
ratios).  As presented in Figure 3.5, unique 1H NMR signals could be observed and used 
to determine the E/Z ratio.  Data are summarized in Table 3.1. 
 
Table 3.1.  1H NMR ratios of E- and Z-isomers, their characteristic 1H NMR shifts, and 
their GC-MS retention times. 
Class Compound 
1H NMRa 
E:Z ratio 
1H NMR 
shiftb (ppm) 
GC-MS retention time(s) 
E, Z  
Oxime 
3.5 
aldoxime 1.5 : 1.0 
-HE: δ 7.42 
-HZ: δ 6.72 
468, 486 
3.6 
ketoxime 
1.0 : 0.3 (-CH2-)E: δ 2.17 
(-CH2-)Z: δ 2.36 
506 
(E)-isomer only 
3.7 
aldoxime 
1.2 : 1.0 -HE: δ 7.50 
-HZ: δ 6.92 
510, 515 
3.8 
ketoxime 
1.0 : 0.17 (-CH2O-)E: δ 3.98 (-
CH2O-)Z: δ 4.32 
527 
(E)-isomer only 
Silyl-oxime 
ether 
3.9 
aldoxime 1.0 : 1.0 
-HE: δ 7.49 
-HZ: δ 6.85 
488, 479 
3.10 
ketoxime 
1.0 : 0.3 (-CH2-)E: δ 2.17 
(-CH2-)Z: δ 2.34 
490, 473 
3.11 
aldoxime 
1.0 : 1.0 -HE: δ 7.56 
-HZ: δ 7.03 
512, 501 
3.12 
ketoxime 
1.0 : 0.2 (-CH2O-)E: δ 3.99 
(-CH2O-)Z: δ 4.31 
500, 494 
a 400 MHz, taken in CDCl3; b values given for oximyl-H (3.5, 3.7, 3.9, 3.11), C(3) 
methylene (3.6, 3.10), or C(3) methylene (3.8, 3.12). 
 
In the total ion chromatograms of the GC-TOF MS experiments, two peaks could 
be observed (except for 3.6 and 3.8, where only the (E)-isomers were detected), 
originating from the (E)- and (Z)-isomers.  There was only partial agreement between the 
E/Z ratios determined by 1H NMR and by GC- MS.  We concluded that extensive (Z)-to-
(E) isomerization might have taken place in the GC column or in the heated transfer line.  
In the case of the isolated oxime fragment (aldehyde system), the (Z)-isomer is 
0.1kcal/mol lower in energy than the (E)-isomer.  The barrier height for (E)-to-(Z) 
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isomerization is predicted to be 16.2 kcal/mol in the ionized state, although it is predicted 
to be 18.5 kcal/mol for the ketone system [UB3LYP/6-31G(d)].  These results do not 
confirm or exclude isomerization in the ion source as an alternative.  In the case of 
compounds 3.5–3.8, the McLafferty rearrangement is more pronounced in the mass 
spectra of the (E)-isomers than in the (Z)-isomers.  No direct McLafferty rearrangement 
fragment ions can be observed in the mass spectra of the silyl oxime ethers 3.9–3.12.  
However, fragment ions derived from loss of t-butyl radical after McLafferty 
rearrangement are observed in the mass spectra of compounds 3.11 and 3.12 (Table 3.2). 
Loss of the t-butyl radical followed by McLafferty rearrangement does not seem 
plausible, for the first loss would create an even electron ion.  Although the McLafferty 
rearrangement has been observed for even electron systems, it seems unlikely to be of 
great importance for these systems; but it cannot be excluded because we did not 
investigate this possibility in more detail.  The loss of just the t-butyl radical was also 
observed as the peaks at the highest m/z values, as well as abundant formation of 
[HOSi(CH3)2]+ (m/z = 75).  These reactions will be discussed in more detail in the next 
sections. 
In addition to the conventional McLafferty rearrangement reaction, the fragment 
ions corresponding to the McLafferty reverse charge rearrangement were observed.  For 
compound 3.4, the fragment ions of both reactions have the same m/z values and cannot 
be distinguished, and neither can their relative contributions be estimated.  The 
occurrence of the McLafferty reverse charge rearrangement is an indication that the 
McLafferty rearrangement actually took place, and so the relative contributions should be 
added to obtain a quantitative estimate of the overall contribution of the McLafferty 
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rearrangement reaction. For compounds 3.1,3,5,7 and 3.9–12, the McLafferty reverse 
charge rearrangement had contributions of >25% relative to the McLafferty 
rearrangement.  For 3.5 and 3.7, the relative contributions were different for the (E)- and 
(Z)-isomers.  
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3.C.2.  Computational Results and Analysis 
Professor Dean Tantillo and his graduate students Osvaldo Gutierrez and Jason 
Harrison performed all theoretical calculations as part of a collaboration effort.26  Data 
shows that the oxygen atom at the β-position (Y=O, Scheme 3.8) and the aldehyde 
functionality (R=H) strongly favor the McLafferty reverse charge rearrangement 
energetically compared with Y=CH2 and R=CH3.  The identity of the acceptor group 
(X=O, NOH and NOSiH3) was of less importance.  Surprisingly, the relative stabilities of 
the ionic and neutral products of the two reactions do not always determine which 
process is more favorable or explain the close competitiveness.  For 3.1, 3.3, and 3.8, the 
McLafferty reverse charge rearrangement is energetically more favorable, whereas the 
McLafferty rearrangement is more abundant for all other entries except 3.9 and 3.10.  
However, it was beyond the scope of our study to theoretically investigate the McLafferty 
reverse charge rearrangement in more detail, which would be needed to provide a more 
quantitative discussion and comparison. 
 
 
Scheme 3.8.  Computed McLafferty fragmentation.  Concerted mechanism in black. 
Stepwise mechanism in red. 
 
X
R Y
H
A
B X
R Y
C
H
D
X H
R
E
+ Y
F
R = H, CH3
X = O, NOH, NOSiH3
Y = O, CH2
G
! 80!
As shown in Scheme 3.8, fragmentation can proceed through a concerted 
McLafferty rearrangement (A•+!G•+‡!E•++F) or via a stepwise hydrogen 
transfer/cleavage process (red; A•+!B•+‡!C•+!D•+‡!E•++F).  Prof. Tantillo’s 
calculations indicate that for all systems, with the exception of ethoxyethanal (R=H, 
X=Y=O; Table 3.3, compound 3.3), the stepwise pathway is favored.i  Barriers for both 
steps are somewhat sensitive to the identity of X and Y (Table 3.3).  Among the three 
classes of compounds studied, aldehydes/ketones are predicted to have the largest overall 
energy barriers, whereas oximes have the lowest.  Introduction of a more electronegative 
group at the β-position is expected to facilitate the cleavage of the α-β bond, and this is 
the case for all systems examined herein (Y=CH2 vs Y=O).  Consequently, for the 
oximes and silyl oxime ethers with Y=O, the rate-determining step is predicted to be the 
initial hydrogen transfer step.  Although changing from Y=CH2 to Y=O might be 
expected to help the hydrogen transfer step as well, because an oxygen can interact 
favorably with an attached carbon radical, we do not see evidence for this effect.  
Although fragmentation reactions take place from initially excited molecular ions, an 
extensive treatment of excitation processes is beyond the scope of this study.  
Nonetheless, our results reveal the underlying potential energy surfaces for the 
fragmentation reactions.  For entries (3.9-3.12), calculations were also performed using 
the larger 6-311++G(2d,2p) basis set; qualitatively similar results were observed (Table 
3.3). !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
i (a) All attempts to find concerted transition state structures for the other systems failed 
at the UB3LYP/6-31G(d) level of theory.  (b) For comparison, using SCS-UMP2/6-
31G(d) calculations, relative energies for entry (3.5) are predicted to be: A•+ = 0.0, B•+‡ = 
–4.7, C•+ = –14.0, D•+‡ = 5.4 (all in kcal/mol).  (c) UM06-2X/6-31G(d) was also used and 
similar reactivity trends were obtained, although, as shown in Figure 3.5, geometries for 
hydrogen transfer transition state structures vary slightly. 
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Representative computed transition state structures are shown in Figure 3.6.  For 
the one system where a concerted process was predicted to be energetically preferred 
(X=Y=O), this process was found to involve asynchronous hydrogen transfer and 
cleavage events. In the transition state structure for this process (3G•+‡! in Figure 3.6), 
hydrogen transfer is nearly complete, whereas the C–O bond cleavage has not yet begun.  
As mentioned earlier, changing the identity of X and/or Y leads to a stepwise mechanism 
where hydrogen transfer occurs first.  A representative transition state structure for 
hydrogen transfer (5B•+‡) is also shown in Figure 3.6.  In contrast to 3G•+‡, this transition 
state structure is early with respect to the hydrogen transfer event; the migrating 
hydrogen is closer to the carbon from which it originates than to its destination on 
nitrogen (note that an even earlier transition state structure is predicted with UM06-2X).  
Changing from Y=CH2 to Y=O (7B•+‡) leads to a later transition state structure, however, 
in which the C–H and H–N distances are similar (Figure 3.6).  The identity of Y also 
affects the degree of bond breaking in the transition state structures for cleavage.  For 
example, C–C cleavage is well advanced in 5D•+‡ but has barely begun in 7D•+‡ (Figure 
3.6). 
Why are the barriers for oximes and silyl oximes lower than those for aldehydes 
and ketones?  From the energies shown in Table 3.3, it appears that having X=NOR 
rather than X=O pulls down the energies of B•+‡, C•+ and D•+‡ relative to that of A•+.  This 
is likely due to a combination of effects, whose magnitudes are difficult to assess: 
differences in O–H and N–H bond strengths (note that N–H bonds tend to be slightly 
shorter than do the corresponding O–H bonds in intermediates C•+),27 differences in the 
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ability of OH and HONH groups to stabilize adjacent carbocations, and changes in 
interactions across the O–N bond upon hydrogen transfer to oximes and silyl oxime 
ethers.  From the energies shown in Table 3.3, it also appears that having Y=O promotes 
the cleavage process.  This is likely due in large part to the greater strength of C=O bonds 
than C=C bonds, but it may also be due in part to increased σC–R ↔ σ*C–Y interactions, 
which should help to break the C–Y bond, when Y=O. 
 
 
Figure 3.6.  Representative computed transition state structures. 
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3.C.3.  Mechanistic Summary of the Fragmentations of Oxime Ethers 
In the 70eV electron ionization mass spectra of silyl oxime ethers 3.11 (R=H, 
Scheme 3.9) and 3.12 (R=CH3), a variety of interesting fragmentation pathways were 
observed, and the proposed mechanisms are depicted in Scheme 3.9. 
 
 
Scheme 3.9.  The proposed fragmentation mechanisms for silyl oxime ethers 3.11 (R=H) 
and 3.12 (R=CH3). 
 
The tert-butyl radical (t-Bu•) is lost from both isomers of the odd-electron silyl 
aldoxime and ketoxime species to form corresponding silenium ions (Scheme 3.9, m/z 
174, 188).  The (Z)-silenium ions A and (E)-silenium ions B are observed in the spectra 
of the respective (Z)- and (E)-aldoximes as well as ketoximes.  Silenium ions A are 
stabilized by the proximal ether functionality, and these intermediates give rise to the 
iminium dioxosilacycles C (m/z 132, 146) on loss of the propyl chain either by 
elimination of propene, as shown, or possibly by loss of the propyl cation.  Formation of 
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C through an ion- neutral complex instead of the 1,2-elimination is also a possibility that 
cannot be ruled out,28 but we have not investigated this option theoretically in more 
detail.  Finally, it is also possible that C could arise via cyclization of the ionized ether 
linkage [M•+ ether] (Scheme 3.9).  The observed formation of the α-ether cleavage 
fragment D (m/z 73) supports reaction along this path.  Whereas silenium ions B are not 
structurally predisposed to undergo a similar cyclization path, their precursors, the odd 
electron (E)-isomers (R=H, R=CH3), can form silacycles C by isomerization to the (Z)-
isomers prior to loss of t-Bu•.  The isomerization of ionized oximes is known for 
condensed phase acidic solutions.29  It has to be stated that this might not be applicable in 
the gas phase and that [M + H]+ oximes might behave differently than M+• oximes.  
However, gas-phase 1H NMR studies on rotational barriers of neutral amides30 and N,N-
dialkylformamide31 showed that barrier heights of ~20 kcal/mol do not preclude 
isomerization, and so it seems reasonable to assume that the (E)-to-(Z) isomerization 
barrier height in the ionized state of 16.2 kcal/mol is not prohibitive in the gas phase.  
The odd-electron (E)-isomers are structurally poised for γ-hydrogen atom abstraction.  
Subsequent loss of propanal via α,β-bond scission occurs to give the McLafferty 
rearrangement fragments.  The facile loss of t-Bu• occurs here as well to yield E, which 
likely forms the isomeric 5-membered silacycles (m/z 116, 130) as depicted, whereas a 
three-membered silacycle was excluded as a realistic option.  The McLafferty 
rearrangement with loss of t-Bu• is observed for both aldoxime isomers and both 
ketoxime isomers, although the propensity for cleavage via the McLafferty 
rearrangement is higher for the (E)-isomers. 
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Figure 3.7.  The proposed fragmentation mechanism for the N–O bond cleavage 
followed by loss of RCN from the silyl ketoximes 3.10 and 3.12. 
 
As reported previously,32 a characteristic fragmentation observed in the mass 
spectra of silyl ketoxime ethers is the N–O bond cleavage (Figure 3.7).  The observed 
fragment ion is presumably a nitrilium ion derived via a 1,2-shift33 of the alkyl side-chain 
concomitant with loss of the silyloxy radical.  Nitrilium ions commonly are derived from 
iminium species.34  Whereas both isomers of silyl ketoxime ether 3.10 undergo major N–
O bond cleavage, this mode of fragmentation is not significant for any of the ketoximes 
(Figure 3.7).  Furthermore, the (Z)- and (E)-isomers of silyl ketoxime ether 3.12 appear to 
undergo N–O cleavage to only a small extent, possibly because the migratory aptitude of 
the oxygen-containing side-chain is diminished.28  However, the scarcity of the nitrilium 
ions for these isomers may be due to the facile loss of acetonitrile, giving the more stable 
oxonium ion species (m/z 73).  The m/z 73 fragment is also populated by the paths 
described earlier (e.g. species D in Scheme 3.9).  Along these lines, the m/z 73 fragment 
derived from oxime 3.8 is the result of the McLafferty rearrangement, which was shown 
to be the predominant fragmentation for all oximes.  The N–O cleavage mode is 
negligible for all aldoximes and silyl aldoximes (Figure 3.7, where R=H).  Figure 3.8 and 
Figure 3.9 clearly show the impact of oxygen substitution adjacent to the radical-forming 
R
N
Z
Y-O–
N–O cleavage
  3.6: Y = H, Z = C4H9
3.10: Y = TBS, Z = C4H9
  3.8: Y = H, Z = OC3H7
3.12: Y = TBS, Z = OC3H7
nitrilium ion
112: minor
112: (E) 120; (Z) 280
114: minor
114: (E) 16; (Z) 14
R
N
for R = CH3
ZO–Y
RCN–
71: 20
71: (E) 470; (Z) 203
m/z : ion count
73: 1000 (McLafferty)
73: (E) 620; (Z) 130
C5H11  (fr. 3.6, 3.10)
or
H2C=OC3H7  (fr. 3.8, 3.12)
m/z : ion count
! 87!
center during McLafferty rearrangement.  Indeed, the McLafferty fragment is almost 
non-existent for the silyl oxime ethers with β-CH2, while it is clearly present for the 
analogs containing β-O. 
 
 
 
Figure 3.8.  EI-MS (X-axis: m/z; Y-axis: intensity).  The influence of β-CH2 versus β-O 
on the fragmentation of (E)-silyl oxime ethers.  The ketoxime (E)-isomer (A) do not 
exhibit significant α,β-bond scission (McLafferty rearrangement), unlike the oxygen-
substituted isomer (B). 
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Figure 3.9.  EI- MS (X-axis: m/z; Y-axis: intensity).  The influence of β-CH2 versus β-O 
on the fragmentation of (Z)-silyl oxime ethers.  The ketoxime (Z)-isomer (A) do not 
exhibit significant α,β-bond scission (McLafferty rearrangement), unlike the oxygen-
substituted isomers (B). 
 
 Figures 3.8 and 3.9 also show the differences between (E)- and (Z)-isomers: the 
McLafferty rearrangement is favored by the E-isomer; the generation of a nitrilium ions 
is favored by the Z-isomer.  
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In summary, we have shown experimentally and theoretically that a set of model 
carbonyl compounds comprised of aldehydes and ketones, as well as their derivative 
oxime and silyl oxime ethers, undergo a McLafferty rearrangement to varying extents 
upon electron ionization. The silyl oximes that lacked γ-radical stabilization (e.g., β-
oxygen substitution) had the lowest incidence of such rearrangement.  The McLafferty 
rearrangement is enhanced, relative to other primary fragmentation processes, by oximes 
(vs carbonyl), oxygen at the β-position (vs β-methylene) and in ketones (vs aldehydes).  
The McLafferty reverse charge rearrangement was also observed. The results of density 
functional calculations indicated that most compounds undergo a stepwise McLafferty 
rearrangement and that both C–C bond breaking and H-transfer could be the rate-
determining step.  Only HC(O)CH2OC3H7 was predicted to undergo fragmentation via a 
concerted mechanism.  For the silyl oxime ethers, the McLafferty rearrangement was 
accompanied by the subsequent loss of the t-butyl radical.  Finally, we observed that 
oximes and silyl oxime ethers were obtained as both the (E)- and (Z)-isomers and that the 
extent of the McLafferty rearrangement was higher in the (E)-isomers.   
 This fundamental study provides essential tools for the identification of carbonyl 
metabolites that have reacted with aminooxy-containing derivatization reagents.  The 
relative incidence of McLafferty fragments versus nitrilium ions can help assign 
stereochemistry of the metabolite adducts in future studies.  Also, by better understanding 
the fragmentation of such oxime ether adducts, we will be able to predict MS-induced 
cleavages that provide structural information on the derivatized metabolite.  This 
information potentially can help identify metabolites that may be molecular biomarkers. 
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3.D.  Discovery of a Zone of Minimal Interference 
3.D.1.  Mass Spectral Observation of the ZMI 
 Mass spectral fragments below m/z 50 generally are not noted when analyzing 
high molecular weight compounds due to the excessive noise generated by ionized gases 
in this range.  Moreover such low molecular weight fragments generally do not provide 
useful structural information for the identification of the parent compound using the 
searchable libraries.  However, during the course of our oxime ether study, while 
analyzing the 70eV electron ionization mass spectra of the panel of carbonyl substrates, 
we noted that the compounds had similar fragmentation behavior within the range m/z 
31-37.  Shown in Figure 3.10 are the electron ionization (EI) mass spectra of compounds 
3.2, 3.4, 3.5, and 3.11.  Highlighted in the red box is a region of the spectrum in which 
these compounds did not generate any ion fragments.  To emphasize the lack of signal 
generation within this range, we labeled the range m/z 31-37 the Zone of Minimal 
Interference (ZMI).  At first look, the ZMI seems to be independent of the nature of the 
parent compound, as seen with the spectra of the noted ketone, oxime, and silyloxime 
ether given in Figure 3.10.   
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Figure 3.10.  EI-MS (X-axis: m/z; Y-axis: intensity) spectra of compounds 3.11 (A), 3.5 
(B), 3.4 (C) and 3.2 (D).  The red box delineates a range m/z 31-37 in which the 
compounds generate few, if any, fragments. 
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3.D.2.  Tabulation of the NIST Library 
To better delineate the m/z gap of the ZMI and to elucidate whether or not this 
observation is common among small organic molecules (i.e., Mw < 500), professor Xiang 
Zhang and Dr. Bing Wang consulted the NIST compilation of the EI mass spectra of 
163,198 organic compounds and provided a tabulation (Figure 3.11).   
 
 
Figure 3.11.  Delineation of the zone of minimal interference.  A: Fragment ion 
frequency for the compound library (NIST/EPA/NIH NIST 08 Mass Spectral Library).  
B: corresponding summed ion count (peak intensity) for a given m/z. 
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Tabulation of the incidence for every m/z signal in the library of compounds 
reveals several gaps where the frequency of a signal is minimal (Figure 3.11A).  Note 
that the gap between m/z 19-24 (see Figure 3.11A insert) is sparsely populated, as well as 
our initially observed ZMI gap between m/z 31-37.  Although the 31-37 zone is more 
populated that the 19-24 zone, the intensities of any fragment ions that register within the 
31-37 ZMI remain quite low as indicated by the summed ion count for each m/z (Figure 
3.11B).   
To obtain accurate relative quantification information by measuring the intensity 
of reporter mass spectral tags (MSTs), it is important to have as little background noise as 
possible to avoid higher than expected intensities.  Could these low noise zones be used 
to observe reporter tags to obtain quantitation information?  The gap between m/z 19-24 
is too low for synthetic application.  However, the zone of minimal interference m/z 31-
37 is suitable for engineering a mass spectral tag (MST) based on 13C and 2H isotopes.  
Based on this observation, we set out to design a derivatization reagent that generates 
isotopic MSTs in the mass range m/z 31-37 for distinct observation after electron 
ionization.  This work is described in the next chapter. 
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4.A.  Introduction 
 With the discovery of a zone of minimal interference (ZMI) that enables the 
unobstructed observation of isotopic reporter ions, we next turn our attention to designing 
reagents that could generate reporter fragment ions within that region of the mass 
spectrum.  Our goal is to develop reagents for the profiling of endogenous and exogenous 
small molecules with molecular weights below 1500 Da, known as metabolites.1  These 
“metabolites” typically contain diverse chemical structures and functional groups that 
make analyte extraction, enrichment, separation, and analyses difficult.2  Profiling 
molecules in the search for biomarkers of disease in biological samples, such as blood, 
urine, or tissue, has led to numerous advances in analytical technologies.3  Mass 
spectrometry4 (MS) and its tandem combinations with principal separation techniques, 
such as liquid chromatography5 (LC-MS) and gas chromatography6 (GC-MS), currently 
are among the most applied analytical tools for metabolomic profiling.7 
Stable isotope coding is a strategy that has been used to streamline LC-MS 
analyses in metabolomics.8  Analyte samples containing common functional groups are 
first derivatized with differentially coded isotope reagents and then the derivatized 
mixtures are combined and analyzed simultaneously by LC-MS.  The relative 
concentrations of the coded analyte adducts are provided by an isotope ratio analysis of 
the isotopic molecular ions (M+) obtained on electrospray ionization.  Isotopic 
derivatization reagents have been applied in this way for the quantification of carboxylic 
acid,8a,d amine,8b,c and fatty acid8e metabolites.  Table 4.1 shows the structure of some of 
the labeled reagents used for isotope coding strategies in LC-MS.  These reagents come 
only as two versions, the light- or heavy-isotope derivative.  This binary set of reagents is 
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used either for absolute quantification from a known standard or for relative 
quantification between two samples.  Whether coded isotopologues co-elute affects how 
the quantitation analysis can be achieved.  If isotopologues exactly co-elute, their isotope 
ratio from the mass spectra provides the relative quantification between the two adducts.  
If they do not, each analyte must be quantified independently based on the chromatogram 
peak area measurements. 
 
Table 4.1.  Isotope coding reagents for LC-MS.  The location and nature of the isotopes 
are shown in blue, while the reactive center that enables derivatization is shown in red.  
 
Tsukamoto et al. proposed the use of 
DBD-PZ-NH2-(D6) as a derivatizing 
reagent for carboxylic acids for the 
quantification of fatty acids by high 
performance LC-MS.  Shown in red is the 
primary amine functionality that reacts 
with the activated carboxylic center.8a,b  
DBD-PZ was used for the derivatization 
of ketoprofen and ibuprofen followed by 
analysis using LC-electrospray MS.  
DBD-PZ proved to be less reactive than 
DBD-PZ-NH2.8b   
 
Protonated methyl acetimidate was used 
as a labeling reagent for amines.  
Quantification of amino acids from seed 
extracts was performed via LC-MS.8c  
Cholamine-(d0) and -(d9) were used for 
the relative quantification of carboxylic 
acids by LC-MS.8d   
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labeled 2-bromo-1-methylpyridinium 
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In contrast with LC-MS, stable isotope coding strategies for GC-MS analyses are 
scarce.9  The ionization method employed in a GC-MS system is electron ionization (EI), 
in which the electron energy (~70 eV) is so high that metabolite adducts are directly 
fragmented to yield mass spectra that are considerably more difficult to quantify.  Given 
that GC-MS and comprehensive two-dimensional GCxGC-MS are the principal 
analytical platforms for metabolomics due to their superior chromatographic resolution 
and reproducibility,2 and that EI enables the use of searchable mass spectra libraries,10 an 
isotopic coding strategy for GC-MS addressing the aforementioned quantification 
challenge is very much needed.  Table 4.2 summarizes the currently published isotope 
coding strategies for GC-MS.  
 
Table 4.2.  Isotope coding reagents for GC-MS.  The location and nature of the isotopes 
are shown in blue, while the reactive center that enables derivatization is shown in red.  
 
Huang and Regnier synthesized the (d6)- 
labeled version of tert-butyldimethylsilyl 
trifluoroacetamide (MTBS-TFAm).  This 
silicon-based reagent can derivatize 
alcohol, amine, and carboxylic 
metabolites.  The acid chromatographic 
isotope effect led to partial resolution of 
isotopologues via GCxGC-MS.9a   
Kvitvang et al. used (d3)-labeled methyl 
chloroformate (MCF) to derivatize amine 
metabolites, and quantify amino acids.  
Although this method uses GC for the 
separation of complex mixtures, it uses 
positive chemical ionization to impart a 
positive charge, and does not use 
traditional EI methodology.9b  
 
Lien et al. used (d9)-labeled trimethylsilyl 
trifluoroacetamide (MS-TFAm) for the 
derivatization of alcohol, amine, and 
carboxylic metabolites.  In the same 
manner as Huang and Regnier, they 
encountered the chromatographic isotope 
effect.9c 
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As with traditional GC-MS analyses, the isotope coding reagents utilize silicon-
based derivatization reagents that help make polar metabolites more volatile and more 
thermally stable by generating silyl ethers.  Silylating procedures also enhance GC 
separation by avoiding the tailing of the compounds in the column, and often produce 
more diagnostic fragments with more abundant ions to facilitate detection and 
identification of the derivative.  Also, contrary to LC-MS reagents, these silylating 
reagents and their adducts are moisture sensitive and can hydrolyze rapidly if not handled 
properly.11  However, the main challenge that remains for the GC-MS coding reagents 
presented in Table 4.2 is that the coded isotopologues do not co-elute in the GC column 
due to chromatographic isotope effect.  Coded molecules that differ in numbers of heavy 
atoms (isotopes) can be partially or even completely resolved during liquid- and gas-
chromatography, particularly in the case of deuterium labeling.12  This drawback prevents 
the direct use of the mass spectrum for the quantitation of the samples, which then relies 
on the chromatogram peak area. 
We present here the first isotope coding strategy that features EI-induced 
expulsion of a reporter tag for quantification using GC-MS (Figure 4.1).  Specifically, we 
have developed a panel of isotopologous aminooxyethyl propionate (AEP) reagents for 
chemoselective derivatization of aldehydes and ketones.   
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Figure 4.1.  Representation of a multiplexed GC-MS analysis using isotope-coded 
reagents designed for electron-induced expulsion of reporter mass spectral tags (MSTs).  
The derivatization reagents provide corresponding MSTs for relative quantification of 
substrates from separate sample mixtures. 
 
The reagents are fitted with 2H- and 13C-isotope labels such that EI-induced 
fragmentation of the AEP-adducts results in identifiable reporter mass spectral tags 
(MSTs) for relative quantification of individual members of a multiplex set, as depicted 
in Figure 4.1.  Derivatization of carbonyl substrates using the AEP isotopologues (Figure 
1, step A) followed by pooling the samples (step B) generates a multiplex set for a single-
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injection analysis by GC-MS.  If the isotope labeling does not influence GC elution of the 
pooled adducts (i.e., a chromatographic effect), then identical substrates that have been 
labeled with different isotope tags will co-elute on GC separation (step C).  Subsequent 
electron ionization of the eluted substrates induces fragmentation (step D) to yield 
characteristic fragment ions for substrate identification as well as release of coded 
isotopic tag ions for quantification.  Although previously published GC-MS isotope 
coding approaches have used isotopically labeled derivatizing agents,9 as discussed 
above, none of these approaches exploit a common reporter tag that enables rapid 
quantification by direct mass spectral measurements (e.g., ion count comparisons)..  
Furthermore, earlier coding strategies have relied on binary sets of reagents, and this 
limitation, as well as noted chromatographic isotope effects leading to partial GC 
resolution of derivatized substrates, impede high throughput.  A multiplex strategy that 
overcomes chromatographic separation of isotopically derivatized substrates would 
enable multiple samples to be labeled, mixed, and analyzed simultaneously to increase 
throughput and reduce technical variation. 
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4.B.  Reagent Design and Synthesis 
4.B.1.  Development of POMS Reagents: First Generation 
An important consideration to actuate such a coding strategy is the selection of an 
unambiguous reporter MST, one that can be observed free from obfuscation by other 
fragment ions.  Deconvolution approaches that align and match derived fragment ions to 
resolve MSTs using pre-processing software for MS identification and quantification 
have been shown to be error prone.13  Ideally, direct ion count comparisons of MST 
isotopologues would be most practical.  Thus, based on our previous study on the 
fragmentation of oxime substrates and the subsequent discovery of the ZMI range m/z 31-
37 (Chapter 3), we surmised that the preparation of our reagents would require the 
presence of a propionyl ester functionality for the EI expulsion of an ethyl carbenium ion 
reporter MST (C2H5+ m/z 29) via ester α-cleavage (Figure 4.2).14  As shown in Figure 
4.2, after electron ionization, the radical cation rearranges to generate an acylium ion that 
spontaneously loses carbon monoxide to form an ethyl carbenium ion at m/z 29.  Using 
different combinations of 2H- and 13C-analogs of the ethyl carbenium ion would shift the 
mass range of the reporter tags to cover the range m/z 29-36 (Figure 4.3). 
 
 
Figure 4.2.  EI-induced α-cleavage of propionate ester generates acylium ion at m/z 57 
and ethyl carbenium ion at m/z 29. 
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 To demonstrate the viability of the propionate ester to deliver a reporter mass 
spectral tag in the form of an ethyl carbenium ion via the ester α-cleavage, we decided to 
synthesize a simple compound containing both silicon and propionate moieties.  Scheme 
4.1 shows the synthesis of such template, bis-propionyloxymethyldimethyl silane 4.1.  
This one step synthesis is performed by heating bis(chloromethyl)dimethylsilane 4.0 with 
propionic acid and triethylamine to afford the bis-propionate 4.1 in 90% yield. 
 
 
Scheme 4.1.  Synthesis of bis-propionyloxymethyldimethyl silane  4.1. 
 
 In the mass spectrum of 4.1 (Figure 4.3), we can easily observe the two fragments 
m/z 57 and 29 corresponding respectively to the acylium ion and the ethyl carbenium ion 
that we were expecting to arise from the α-cleavage of the propionate ester moiety.  We 
can also identify other silicon-based fragments that provide structural information. 
 
 
Figure 4.3.  EI-MS (X-axis: m/z; Y-axis: intensity) of bis-propionyloxymethyldimethyl 
silane  4.1. 
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Figure 4.4. Ester α-cleavage of POMS derivatized metabolites delivers the labeled 
reporter tags in the in the range m/z 29-36 that overlaps with the ZMI. 
 
As a first attempt, we explored the synthesis of a silicon-based reagent to readily 
silylate N- and O-nucleophiles.  The reagent would be fitted with the stable isotope-
labeled ester moiety.  Thus, the reagent was conceived to feature a 
(propionyloxy)methylsilyl (POMS) group containing combinations of deuterium and 13C 
at C(2) and C(3) of the ester.  As illustrated in Figure 4.4, electron impact ionization of 
esters derived from reaction with POMS-Cl yields acylium ions via the facile α-cleavage 
of the POMS ester.  The acylium ions spontaneously lose CO to give the corresponding 
reporter carbenium ions. The EI-induced α-cleavage of POMS from silylated metabolites 
will result in signals in the range m/z 29-36, corresponding to the degree of metabolite 
labeling (Figure 4.4).  Initially, three unique combinations of isotope tags in POMS will 
give rise to three distinct reporter MST signals for simultaneous analyses of POMS-
derivatized metabolite mixtures.  Ultimately, up to eight isotopic reagents could be 
prepared using distinct combinations of 2H and 13C. 
We aimed to perform POMS derivatization of metabolites (HY-mtb) using either 
the chlorosilane (POMS-Cl) or the well-established trifluoroacetamide methodology 
(POMS-TFAm), seen in Figure 4.4.  As shown in Figure 4.5, once the metabolite is 
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derivatized and ionized on introduction to the MS ion beam, we expect that many 
different fragmentation pathways will compete.  Mass spectroscopy of the POMS-
metabolite adducts should furnish labeled acylium and labeled ethyl carbenium via the α-
cleavage pathway (path A).  Common to silyl-based derivatives is loss of a silyl group on 
EI ionization (path S) to give silenium ions.  In the case of POMS-labeled substrates, loss 
of the (propionyloxy)methyl radical is expected to prevail over loss of methyl radical 
(Figure 4.5).  Thus, the [Me2Si-Y-mtb]+ fragment should be a key analytical fragment of 
the present approach in addition to the expected [mtb]+ fragment arising via loss of 
POMS-Y• (Path M), another common silyl-analog fragmentation.  Both of these 
pathways should provide information for the identification of the metabolite such as the 
molecular weight and presence of functional groups. 
 
 
Figure 4.5.  POMS α-cleavage generates the reporter ethyl carbenium ion as well as 
silicon- and metabolite-specific ion fragments. 
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To demonstrate our idea and observe the propensity for the α-cleavage of our 
POMS reagent, we synthesized the unlabeled POMS derivative of benzyl alcohol 
(Scheme 4.2).  Commercially available chloromethyl(dimethylsilylchloride) (4.2) was 
reacted with benzyl alcohol to afford the silylated benzyl alcohol 4.3.  The use of 
trimethylsilyl propionic acid in presence of cesium fluoride in dry dimethylformamide 
(DMF) was used to generate the cesium propionate anion in situ.  As expected, reaction 
of compound 4.3 with cesium propionate smoothly generated POMS-OBn (Scheme 4.2). 
 
   
Scheme 4.2.  Synthesis of POMS-derivatized benzyl alcohol. 
 
In the mass spectrum of POMS-OBn (Figure 4.6), we can easily observe the two 
fragments m/z 57 and 29 corresponding respectively to the acylium cation (A1) and the 
ethyl carbenium ion (A2) arising from the α-cleavage (pathway A) of the ester moiety of 
the POMS reagent.  Pathways M and S are also observed with the fragments m/z 91 
(tropylium ion) and m/z 165.  These fragments provide information related to the 
structure of the silylated substrate (in this case benzyl alcohol) and thus can be used for 
identification of the parent substrate structure.   
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Figure 4.6.  EI-MS (X-axis: m/z; Y-axis: intensity) of POMS-derivatized benzyl alcohol.  
Shown are the fragmentation pathways predicted in Figure 4.4. 
 
With the knowledge that the model POMS-Y-R adduct did in fact provide 
reporter ions at the ZMI border, as well as fragment ions for structure identification, we 
were encouraged to consider isotope labeling and to pursue a synthesis of POMS-Cl.  The 
use of 2H-, 13C- or a combination of 2H- and 13C-labeled POMS reagent would increase 
the molecular weight of the carbenium ion and move it into the ZMI to facilitate the 
quantitative analysis and reduce the interference from metabolite fragments. 
Our first attempted synthesis of the POMS reagent is shown in Scheme 4.3.  
Commercially available chloromethyldimethylsiloxane (4.4) was heated to reflux in the 
presence of propionic acid and triethylamine to afford siloxane 4.5 in excellent yield 
(93%).15  Unfortunately, the cleavage of the siloxane 4.4 to POMS-Cl could not be 
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performed under Korlyukov’s16 or Sukeda’s17 conditions.  Instead of chlorinating the 
siloxane Si-O-Si bond, the reported conditions led to the displacement of the propionyl 
ester functionality and generated a mixture of starting chloromethyldimethylsiloxane 
(4.4) and mono-acylated siloxane. 
 
 
Scheme 4.3.  First attempted synthesis of POMS-Cl. 
 
 Shown in Figure 4.7 is the 1H NMR spectrum of mono-acylated siloxane formed 
under Korlyukov’s and Sukeda’s conditions.  Such conditions also formed the starting 
chloromethyldimethylsiloxane (4.4) shown in Figure 4.8. 
 
 
Figure 4.7.  1H NMR spectrum (CDCl3) of mono-acylated siloxane. 
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Shown in Scheme 4.4, is a mechanistic explanation for the differences observed 
between Korlyukov’s thionyl-chlorination of siloxanes and our failed attempt to 
chlorinate siloxanes in the presence of ester groups.  Displacement of the thionyl-
activated amide is more difficult than the displacement of thionyl-activated ester.  We 
surmise that the difference in pKa between the propionic acid (pKa 5) and the amide (pKa 
10) could explain the selectivity reported by Korlyukov.  
 
 
Scheme 4.4.  Mechanistic explanation for chlorination of siloxanes. 
 
Figure 4.8. shows the 1H NMR spectra of compounds starting material 4.3 and 
propionyloxymethyldimethyl siloxane (4.4) in which can be noticed the downfield shift 
of the CH2 protons after substitution of the chlorine by a propionate ester.  Interestingly 
there is also a small upfield shift of the dimethyl signal attached to the silicon.   
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Firgure 4.8.  1H NMR spectra (CDCl3) of compounds 4.3 and 4.4. 
 
The small upfield shift effect might be attributed to the formation of pentavalent 
silicon as shown in Figure 4.9.  Based on the structure proposed by Korlyukov et al. the 
silicon center of our (bis)ester siloxane 4.4 could be imparted with a partial δ-negative 
charge that would shield the surrounding protons, leading to an upfield shift in the 1H 
NMR spectrum. 
   
 
Figure 4.9.  Explanation for the observed upfield shift in 1H NMR spectrum of 4.4. 
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appropriate 1:1 ratio of 4.6 to N-trimethylsilyl-acetamide, is to establish equilibrating 
conditions that would favor the displacement of chloride from carbon by the amidate ion 
generated in situ.  Indeed, the poor stability of silylated amides generates an equilibrium 
while de displacement of chloride from terminates reactivity.  If the reagents are in a 1:1 
ratio, then the formation of the mono-acylated silane is favored.  Unfortunately, no 
product was isolated after attempting the reaction using O-silyl propionic acid. 
 
 
Scheme 4.5.  Korlyukov alternative synthesis of POMS-Cl. 
 
In a different approach, we aimed to prepare bis(ester) 4.7 using the conditions 
established by Yoder et al. for synthesis of analogous silyl esters (Scheme 4.6).18  
Reaction of silyl ester 4.6 with N-methyl-N-trimethylsilyl-trifluoroacetamide could have 
been expected to directly afford POMS-TFAm using a procedure developed by Baukov et 
al.19  
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Scheme 4.6.  Yoder alternative synthesis for POMS-Cl and POMS-TFAm 
 
Unfortunately, the high moisture sensitivity of the intermediates, including the 
POMS reagents themselves, applied in small-scale reactions, led to hydrolysis of the 
desired products.  Frustrated with the sensitivity issues involved in the preparation, 
isolation, and purification of silyl halides, we turned our attention to a less-reactive 
analog of POMS-Cl; namely, an aminooxy derivative.  The next section describes our 
efforts to use the POMS scaffold to prepare chemoselective POMS-based reagents for 
carbonyl capture. 
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4.B.2.  Development of POMS-ONH2 Reagents: Second Generation 
 The second generation (propionyloxy)methylsilyl (POMS) reagents would be 
fitted with stable isotope-labeled ester moieties in the form of the POMS group,  as the 
progenitor of EI-induced reporter tags.  However, instead of using the trifluoroacetamide 
derivatizing technology, we opted for aminooxy technology to specifically target aldo- 
and keto-metabolites (Figure 4.10).  One advantage of this change in functionality is the 
stability of the reagent in water or other protic solvents.  
  
 
Figure 4.10.  POMS-ONH2 α-cleavage generates a reporter tag as an ethyl carbenium ion 
as well as oxime- and metabolite-specific fragments. 
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Metabolite derivatization
OH3C
O
Si
*
*
 *  = stable isotope label
(R = H, akyl) O
H3C
O
Si
*
* O
MS (EI)
POMS-labeled metabolite
H3C
*
*
α-cleavage
O
CO
CH3CH2* *
labeled
acylium (A1)
labeled
carbenium (A2)
oxime group
cleavage
metabolite 
specific cleavages
[ mtb ]
A O M
2
13 ONH2
O
R mtb N
R
mtb
N mtb
R
NHOPOMS
R
nitrilium McLafferty
+
POMS-ONH2
! 113!
newly formed oxime ester group could generate, through EI (path O), nitrilium and 
McLafferty ions.  These ions were clearly observed in our previous study in Chapter 3, 
but will be dependent on the nature of the metabolite and adduct (E) vs (Z) 
stereochemistry.  Although not shown in Figure 4.10, silyl group fragmentations such as 
those observed for POMS-OBn and POMS-TFAm (e.g., path S, Figure 4.5) are also 
expected to give silenium ions either by loss of the (propionyloxy)methyl radical or by 
loss of methyl radical.  Finally, metabolite specific cleavages (Path M) can also be 
expected and should provide information on the metabolite, such as the molecular weight 
or the presence of functional groups. 
Our first attempt at synthesis of this reagent started with the reaction of 
commercially available bis(chloromethyl)dimethylsilane (4.0) with N-hydroxyphthlimide 
and triethylamine to obtain the mono-substituted phthalimide product 4.8 (Scheme 4.7).  
Then, using the same strategy we used to prepare the siloxane 4.1 (Scheme 4.1), we 
aimed to displace the chloride with the propionyl carboxylate anion to obtain 
propionyloxymethylsilyl methylphthalimide analogue 4.9.  Unfortunately, the harsh 
conditions necessary for chloride displacement by the carboxylate anion led primarily to 
the hydrolysis of the phthalimide moiety; no displacement product was isolated.  The 
sensitivity of the phthalimide group towards nucleophiles led us to attempt the addition of 
the ester functionality first to obtain the mono-esterified product 4.11,20 followed by the 
SN2 displacement of chlorine by N-hydroxyphthlimide to give compound 4.9.  However, 
this reaction also failed to provide the desired product, as the ester also was cleaved by 
the harsh conditions. 
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Scheme 4.7.  Attempts to synthesize POMS-ONH2 using an SN2 displacement approach. 
 
To overcome these problems, we developed a new synthesis pathway that could 
be performed under milder conditions (Scheme 4.8).  We transformed the starting 
bis(chloromethyl)dimethylsilane 4.0 into diol 4.13 by heating with acetic acid and 
triethylamine to afford the bisacetate 4.12 in quantitative yields (99%).21  The diester was 
then reduced to give the bis(hydroxymethyl)dimethylsilane 4.13 using lithium hydroxide 
in excellent yield (89%).  Diol 4.13 was subjected to mild Mitsunobu conditions22 to 
afford, in good yield (79%), mono-phthalimide 4.14.  Acylation of the remaining 
hydroxyl group was then performed using mild standard coupling conditions23 to afford 
the propionyloxy product 4.9 in 93% yield.  The phthalimide moiety was deprotected to 
afford POMS-ONH2 in excellent yields (92%) by hydrazinolysis (Scheme 4.8). 
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Scheme 4.8.  Synthesis of POMS-ONH2. 
 
To demonstrate the reactivity of the POMS-ONH2 reagent with carbonyl 
metabolites and to investigate the EI-induced fragmentation of POMS-ONH2-derivatized 
metabolites, we derivatized acetone as our template metabolite by simple mixing of the 
two compounds.  Figure 4.11 shows the EI-MS spectrum of the acetone adduct of POMS-
ONH2.  As expected, we observe the two fragments m/z 57 and 29 corresponding 
respectively to the acylium cation and the ethyl carbenium ion arising from the α-
cleavage (pathway A) of the ester moiety of the POMS reagent.  In addition, pathway O 
generates the nitrilium ion m/z 56, and an oximium ion m/z 73.  Pathway S is also 
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interfering ions, and the addition of 13C and 2H stable isotopes in the propionyl ester 
functionality should generate the corresponding ethyl carbenium ions within it. 
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Figure 4.11.  EI-MS (X-axis: m/z; Y-axis: intensity) spectrum of POMS-acetone adduct.  
Shown are the predicted fragment ions.   
 
Encouraged by these results, we synthesized three isotopically labeled versions of 
the POMS-ONH2 to attempt a proof of concept multiplex experiment.  The three reagents 
were synthesized following the procedure described above but using differently labeled 
propionic acid at the acylation step.  We synthesized d5-POMS-ONH2, d2-POMS-ONH2, 
and non-labeled POMS-ONH2 using the corresponding commercially available propionic 
acids.  For instance, to generate d5-POMS-ONH2 we used CD3CD2CO2H.  d5-POMS-
ONH2 should generate a reporter MST in the form of a d5-ethyl carbenium ion at m/z 34.  
d2-POMS-ONH2 was synthesized using CH3CD2CO2H and should generate a reporter 
MST in the form of a d2-ethyl carbenium ion at m/z 31.  As already demonstrated (Figure 
4.7), non-labeled POMS-ONH2 generated a tag at m/z 29.   
Figure 4.12. shows the 1H NMR spectra of POMS-ONH2, d2-POMS-ONH2, and 
d5-POMS-ONH2.  Replacing the hydrogen atoms by deuterium isotopes in the propionate 
moiety is translated by the lack of proton signals in the 1H NMR spectra.  
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Figure 4.12.  1H NMR spectra (CDCl3) of POMS-ONH2, d2-POMS-ONH2, and d5-
POMS-ONH2. 
 
Having confirmed by NMR the structures of our labeled POMS-ONH2 reagents, 
we reacted each one of them with acetone.  Then, an equimolar solution of the three 
isotopologues was prepared and analyzed by GC-MS.  Figure 4.13 shows the GC trace 
for the mixture as well as the ZMI range of the mass spectrum taken at different retention 
times for the peak corresponding to the adducts. 
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Figure 4.13.  GC-MS chromatogram and spectra of a 1:1:1 mixture of POMS-acetone 
isotopologue adducts.  The GC trace and the EI-MS taken at different retention times 
show a chromatographic isotope effect (i.e., the isotopic adducts do not co-elute).  
 
 
The results obtained for the multiplex experiment depicted in Figure 4.13 came as 
a disappointment.  Indeed, as can be observed by the shape of the GC peaks, the 
deuterium isotopologues of the POMS-acetone adduct do not co-elute.  This result is also 
reflected in the mass spectrum of the adducts when measured at slightly different 
retention times.  Thus, it appears through the presence of the reporter tag m/z 34 that the 
d5-POMS-acetone adduct elutes first at 6.07 min, followed by d2-POMS-acetone with the 
tag m/z 31 at 6.08 min, and finally POMS-acetone with the tag m/z 29 at 6.09 min.  This 
chromatographic isotope effect has been described previously in the literature,12 and 
represents a major drawback for the development of isotope coding strategies for direct 
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mass spectral quantitation.  When the isotopologue adducts of a derivatized molecule do 
not co-elute, then all differently labeled mass spectral tags cannot be obtained in a single 
mass spectrum at a given elution time.  This makes quantitation more difficult, in 
particular if the isotopologues are not entirely resolved, and limits throughput to a binary 
set of reagents.  Quantitation would need to be achieved by GC peak area measurements 
assuming the peaks are well separated.  In our case, having placed the heavy atoms near a 
polar functional group (propionate ester), we were hoping to minimize the 
chromatographic isotope effect by minimizing the interaction of the isotopes with the 
hydrophobic stationary phase of the GC column.12c  Indeed, separation in reversed-phase 
chromatography is generally explained by solvophobic theory.24  According to this 
theory, a polar group would be expected to interact more weakly with the hydrophobic 
stationary phase of a column than with an aliphatic chain.  However, based on our results, 
it seems that this method used in LC-MS to control deuterium chromatographic effect 
cannot be applied to GC-MS.   
Another drawback observed for the POMS-ONH2 reagent is the low propensity to 
generate fragments through the ester α-cleavage.  Indeed, as seen in Figure 4.11, the 
parent fragment in the EI-MS spectrum of the acetone-POMS adduct is the silenium ion 
generated after the loss of methyloxime ether radical (m/z 145).  As previously stated, this 
fragment does not provide any valuable information on the chemical structure of the 
derivatized metabolite.  The presence of the dimethylsilyl group in the POMS reagent 
increases its molecular weight and reduces its volatility.  It is essential to maintain small 
reagents that do not decrease the volatility of derivatized metabolites to a great extent.  
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To make the reagent more volatile, we attempted the synthesis of a reagent that 
would only contain the propionate ester group to generate the reporter MST, and the 
aminooxy moiety to chemoselectively derivatize carbonyl metabolites.  Scheme 4.9 
shows our synthetic approach to O-propionylhydroxylamine (4.16).  Coupling propionic 
acid to N-hydroxyphthalimide using standard coupling conditions formed 4.15 in good 
yield (61%).  However, deprotection of the phthalimide to give the O-
propionylhydroxylamine did not afford the desired product; instead, the N-
propionylhydroxylamine was obtained.  Indeed, O-acylhydroxylamines are known to 
rearrange to the thermodynamically stable hydroxamic acids.25  Isomerization can be 
minimized if a sufficiently bulky group is in the near vinicity of the carbonyl group,25a 
but Marmer et al. reported that even at -78 °C O-pyvaloylhydroxylamine decomposes 
within one week.25b 
 
 
Scheme 4.9.  Attempted synthesis of O-propionylhydroxylamine. 
 
 These results terminated our attempts to generate O-propionylhydroxylamine 
(4.16), since its high decomposition rate would make it impossible to use. 
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4.B.3.  Development of AEP Reagents 
 To overcome the chromatographic isotope effect induced by the uneven presence 
of 2H isotopes in our POMS-ONH2 reagents, as well as to increase the volatility of the 
adducts, we opted to develop a set of 13C isotopologues of the derivatizing reagent.  We 
surmised that whether the chromatographic isotope effect is a consequence of the 
hydrogen bond interaction between the products and the GC column or the result of a 
change in the physical properties of the product (different boiling point), 13C 
isotopologues of the reagent would greatly minimize these interactions.  Also, to avoid 
competitive fragmentations that reduce the propensity of the ester α-cleavage as well as 
to make the reagent smaller and therefore more volatile, we redesigned the reagent by 
removing the dimethylsilyl group.  Thus, we have developed a panel of isotopologous 
aminooxyethyl propionate (AEP) reagents for chemoselective derivatization of aldehydes 
and ketones (Figure 4.14). 
 
 
Figure 4.14.  Expected fragmentations from AEP-derivatized carbonyl metabolites. 
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Once again, we expect EI-induced ester α-cleavage as the mode for tag expulsion 
of AEP-labeled metabolites to give rise to acylium ion (A1) followed by spontaneous loss 
of CO to generate the target m/z 32 carbenium ion MST (A2).  The target ZMI suggested 
modification of the ethyl carbenium ion, C2H5+ m/z 29, to its 2H3-analog, D3CCH2+ m/z 
32.  Corresponding 13C-isotope insertions at the α- or α,β-positions of the AEP ester 
moiety yield isotopic MSTs having m/z 33 and 34, respectively.  This limits throughput to 
a 3-plex experiment, but should afford highly accurate reading of the tags as they appear 
in the middle of the ZMI.  Finally, oxime group cleavages (path O) should generate 
nitrilium and McLafferty ions, and path M should also generate metabolite specific 
fragments that provide information on the chemical structure of the derivatized 
metabolite. 
 
 
Scheme 4.10.  Synthesis of AEP reagents. 
  
Synthesis of the AEP reagents (Scheme 4.10) proceeded by SN2 displacement of 
bromide from 2-bromoethanol by N-hydroxyphthalimide to afford N-(2-
hydroxyethoxy)phthalimide 4.17 in good yield (73%).26  Carbodimide-mediated acylation 
of 4.17 with propionic acid, or 2H3-labeled propionic acid and corresponding 13C1- and 
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13C2-isomers, afforded the differently labeled phthaloyl esters 4.18a-d in good yield 
(76%-90%).  Phthalimide deprotection to unmask the aminooxy group required careful 
optimization to avoid accompanying ester cleavage.  Table 4.3 shows the different 
reaction conditions used during the optimization process.  To improve the yields given by 
hydrazine, we opted to use methylhydrazine.  Indeed, the methylated nitrogen of 
hydrazine preferably reacts with anhydrides while the non-methylated nitrogen preferably 
reacts with esters.27  Although counter-intuitive with the reactivity-selectivity principle 
(the less reactive a reagent the more selective it is between substrates), the phenomenon 
has been elegantly explained by Condon.28  Thus, we were gratified to find that treatment 
of the phthaloyl ester with a slight excess of methylhydrazine at 0 °C resulted in selective 
hydrazinolysis to give AEP-29 to AEP-34 (Scheme 4.6).   
 
 
Table 4.3.  Optimization of phthalimide deprotection. 
Entry Reagent Equiv. Temp.  (°C) 
Reaction Time 
(min) 
Product Yield 
(%) 
1 H2NNH2•H2O 5 0 °C to rt 120 35 
2 H2NNH2•H2O 3 0 °C 60 52 
3 MeHNNH2 2 0 °C 60 75 
4 MeHNNH2 1.2 0 °C 45 89 
 
Figure 4.15. shows the 1H NMR spectra of the three reagents.  The CH2 signal in 
α-position of the ester is identical for AEP-32 and AEP-33, but splits into 2 signals for 
AEP-34 due to coupling with 13C. 
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Figure 4.15.  1H NMR spectra (CDCl3) of AEP-32, AEP-33, and AEP-34. 
 
Labeled propionic acid-32 (D312C12CH2CO2H) is commercially available. 
Propionic acid-33 (D313C12CH2CO2H) and propionic acid-34 (D313C13CH2CO2H) were 
synthesized as shown in Scheme 4.11.  Commercially available 12C- or 13C-acetic acid 
was acylated using standard coupling conditions to afford the 1-
naphthalenemethylacetate esters (4.19a-b) in yields varying from 82% to 100%.  
Alkylation of the enolate esters using d3- and 13C-labeled iodomethane and lithium 
hexamethyldisilazide (LHMDS) at -78 °C to room temperature afforded the propionate 
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esters 4.20a-b in moderate yields (47%).  Saponification of the propionate esters under 
basic conditions gave the corresponding propionic acids.  The product acids were 
immediately esterified without further purification after their formation by reaction with 
alcohol 4.17 using the standard dehydrative coupling conditions shown in Scheme 4.10.    
 
 
Scheme 4.11.  Synthesis of labeled propionic acids. 
 
Figure 4.16 shows the 13C NMR spectra of naphthalene propionate esters 4.20a 
and 4.20b.  For both compounds, carbon 1 is 13C enriched while carbon 2 is 13C enriched 
only for ester 4.20b. 
 
Figure 4.16.  13C NMR spectra (CDCl3) of naphthalene propionate esters 4.20a and 
4.20b. 
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Analysis on the fragmentations of an AEP-derivatized carbonyl adduct was again 
performed using acetone.  The reaction of AEP-32 with acetone, serving as a 
representative carbonyl metabolite, was quantitative.  Figure 4.17 shows the EI-MS 
spectrum of the AEP-32-acetone adduct and its main fragments.  As expected, the d3-
labeled propionyl ester underwent α-cleavage to generate D3-labeled acylium ion at m/z 
60 (A1) and D3-labeled ethyl carbenium ion at m/z 32 (A2).  Oxime ether fragmentations 
generated the nitrilum ion at m/z 56 and a reverse charge McLafferty product at m/z 99.  
These two fragments provide structural information about the derivatized metabolite and 
could be used as finger print fragments for this adduct in a searchable mass spectral 
library.  Finally, a reagent based fragment is also generated at m/z 104.  In comparison to 
POMS-ONH2 adducts studied in the previous section, it is clear that the AEP 
fragmentation patterns are not only more simple, but they also provide more structural 
information on the derivatized carbonyl as well as a more prominent ester α-cleavage for 
future quantification studies. 
 
Figure 4.17.  EI-MS (X-axis: m/z; Y-axis: intensity) spectrum of the AEP-32-acetone 
adduct.  Shown are some of the predicted fragmentation pathways. 
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To demonstrate the applicability of the AEP reagents for multiplexed mass 
spectral-based quantitation, we still needed to confirm that the three 13C-isotopologues of 
AEP are not affected by the chromatographic isotope effect.  We surmised that the 
smaller the AEP-derivatized carbonyl, the stronger would be the chromatographic isotope 
effect.  Therefore, as previously done with POMS-ONH2 reagents, we generated an 
equimolar solution of the acetone adducts of AEP-32, AEP-33 and AEP-34.  Without 
further treatment, the solution was injected into the GC-MS and analyzed.  Figure 4.18 
shows the GC trace and the mass spectrum generated at slightly different retention times 
for the peak corresponding to the labeled AEP-acetone adduct. 
 
 
Figure 4.18.  GC-MS chromatogram and spectra of a 1:1:1 mixture of labeled AEP-
acetone isotopologue adducts.  The GC trace and the EI-MS taken at different retention 
times show that the three products co-elute to generate a single mass spectrum with a 
reporter MST in the ZMI.  
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 Conversely to the shape of the GC peak of the POMS-ONH2 adduct, the GC peak 
of the isotopic AEP-acetone adducts is uniform, sharp, and narrow, which is a good 
indicator for co-elution of the isotopic products (Figure 4.18).  More importantly, the 
spectra generated at different retention times within the GC peak are all identical.  In 
particular, since the initial mixture was an equimolar solution of three isotopologues, we 
were gratified to find that the three reporter mass spectral tags (MSTs) had the same 
intensity regardless of which segment of the GC peak was sampled for MS measurement.  
Indeed, this implies that the reporter tags in the ZMI could provide the relative ratios of a 
compound in different solutions.   
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4.C.  Results and Applications of AEP Reagent 
4.C.1.  Multiplex Experiment: Proof of Concept  
To validate the concept that release of isotopic carbenium ions on GC-MS 
analysis of AEP-derived oxime ether adducts can be used to determine relative 
proportions of carbonyl substrates in different sample mixtures, we prepared three model 
carbonyl mixtures with known substrate ratios (Scheme 4.12).   
 
Scheme 4.12.  Formulation, labeling, and pooling of carbonyl sample mixtures for 
analysis.  Depicted at bottom is the total ion chromatogram of the pooled sample mixture 
showing elution of the oxime ether adducts of the substrates indicated by name. 
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In this example, mixtures A, B, and C were formulated to contain equimolar 
quantities of hexanal, whereas the quantity of 2-heptanone in mixture B was tripled 
relative to 2-heptanone in mixtures A and C (Table entries 1-2, Scheme 4.12).  Each 
mixture was derivatized with a single AEP isotopologue by simple mixing in 
dichloromethane at room temperature, and the resultant AEP-oxime ether mixtures A32, 
B33, and C34 then were combined to yield the pooled sample that was analyzed by GC-
MS. 
 
  
Figure 4.19.  ZMI plots (X-axis: m/z; Y-axis: intensity) obtained from the eluted peaks of 
the pooled sample mixture of Scheme 3 showing the MST ion abundance (vertical) for 
the range m/z 32-34.  Shown are the mean values of three separate experiments and the 
standard deviation from the mean.  The starting A:B:C substrate ratio is given in 
brackets.  Ion counts are normalized to 100 for the parent fragments (not shown). 
 
Whereas the Z- and E-diastereomers derived from the asymmetrical substrates 
gave separate GC peaks, we were gratified to find that no GC separation occurred based 
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on stable isotope incorporation (GC trace, Scheme 4.12).29  MS analysis of the eluted 
compounds revealed that each derivatized carbonyl substrate generated characteristic 
fragment ions that enabled its structural assignment and designation of either E- or Z-
oxime ether stereochemistry.30  The isotopic MSTs at m/z 32-34 were abundant and 
clearly measurable in the ZMI of each spectrum. Relative ratios for the carbonyl 
substrates that gave diastereomeric oxime ethers were determined readily using MST 
measurements from either the Z- or E-isomer.  Importantly, direct MST ion count 
comparisons gave substrate ratios that were in close agreement with the actual 
formulation ratios of the starting compound mixtures (Figure 4.19).  The average 
accuracy of the method obtained by comparison of the MST-derived ratio to the known 
carbonyl substrate compositions in mixtures A-C is 95.1% ± 0.3%. 
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4.C.2.  Analysis of a Biologically Derived Sample 
To demonstrate additional attributes of the ZMI tag approach, we examined 
samples of the root extract of the turmeric plant (Curcuma longa) to determine 
compositions of ketones and aldehydes.  The complexity of such an extract31 makes it 
ideal for challenging the technology described above. Carbonyl metabolites from plants, 
in particular aliphatic methyl ketones, have a variety of important natural and commercial 
roles, including pheromonal and insecticidal roles in plants,32 as possible sources of 
biofuels,33 and providing scents in essential oils as well as flavorings for cheese and other 
dairy products.34  First, to profile only the carbonyl substrates in the extract, we sought to 
apply the unique ZMI reporter MSTs as selection tools to provide an extracted ion 
chromatogram (in this case, the profile of plant metabolites that had reacted with the AEP 
reagents).  Second, we aimed to quantify the prominent methyl ketone substrates 
identified in the root extract. 
 Since AEP-derivatized substrates generate reporter MSTs in such a unique m/z 
region of a mass spectrum, we theorized that the appearance of these isotopic tag ions 
might be used to identify AEP-adducts in the total ion chromatogram (TIC), thus 
providing a rapid means for profiling the carbonyl metabolites.  By using two 
isotopologues of AEP at a specified ratio in the derivatization step, we aimed to minimize 
the extraction of false-positive peaks from the TIC.  Consequently, we derivatized the 
turmeric extract with both AEP-33 and AEP-34 in a 1:1 ratio.  Subsequent profiling of 
the carbonyl adducts then was achieved by generating an extracted ion chromatogram 
(EIC) through the selection of peaks that exhibited the reporter MSTs at m/z 33 and 34 in 
a 1:1 ratio in their accompanying mass spectra (Figure 4.20). 
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Figure 4.20.  A. GCxGC-TOF-MS total ion chromatogram (TIC) of turmeric root extract 
after derivatization using AEP reagents; B. Extracted ion chromatogram (EIC) for peaks 
that exhibit MS signals at m/z 33 and 34 (same field of view as in A with lower 
threshold); C. Expanded field of view of peaks within the highlighted rectangle of B 
where circled peaks 1-6 are, respectively, the AEP-adducts of 2-nonanone, 2-decanone, 
2-undecanone, 2-dodecanone, 2-tridecanone and 2-octadecanone. 
 
The GCxGC-TOF-MS total ion chromatogram of the derivatized turmeric extract 
(Figure 4.20A) clearly is populated with a multitude of compounds.  By applying the ion 
selection tool for reporter ions at both m/z 33 and 34, an extracted ion chromatogram is 
obtained (Figure 4.20B) that profiles the carbonyl substrates (i.e., AEP-reactive). With 
the profile of carbonyls in hand, we next sought to identify the subset of aliphatic methyl 
ketones.  Given that ketoxime ethers undergo characteristic EI-MS fragmentations 
(Figure 4.21), a targeted m/z mass spectral analysis of the EIC revealed the presence of 
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several AEP-methyl ketone adducts (Figure 4.20C and Table 4.4).  The AEP-adducts 
were present as both E- and Z-isomers, and assignment of stereochemistry followed from 
analysis of the relative abundance of McLafferty fragment ion versus nitrilium ion 
formation. 
 
 
Figure 4.21.  Characteristic EI-MS fragmentations of ketoxime ethers. 
 
 
Table 4.4.  AEP-methyl ketone adducts extracted from the EIC (Figure 4.20B).  Entry 
numbers correspond to GCxGC retention properties (Figure 4.20C).  Substrates in entries 
1-3 were confirmed by comparison to AEP-derivatized standards.    
 
Entry 
AEP-Methyl Ketone 
Adduct 
(Carbonyl Parent) 
McLafferty 
Fragment Ions 
(m/z) 
Nitrilium Ion 
(m/z) 
Normalized GC 
Peak Area 
1 2-nonanone 177, 178 140 66.0 
2 2-decanone 177, 178 154 6.7 
3 2-undecanone 177, 178 168 100 
4 2-dodecanone 177, 178 182 9.4 
5 2-tridecanone 177, 178 196 5.2 
6 2-octadecanone 177, 178 266 20.4 
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Each AEP-methyl ketone adduct generated McLafferty fragment ions at m/z 177 
and 178 (one from each AEP-adduct isotopologue), and these values thus functioned as a 
convenient searchable m/z for methyl ketone substrates.  The nitrilium ion m/z is substrate 
specific and provides information on the constitution of the ketone aliphatic chain.  These 
features are illustrated by the representative mass spectra of the E- and Z-2-nonanone 
adducts (Figure 4.22).  The structural assignments for 2-nonanone, 2-decanone and 2-
undecanone were confirmed by comparison to AEP-derivatized standards (e.g., library 
spectra), and the remaining suggested methyl ketones, while likely members of the same 
linear family, may be constitutionally isomeric at positions remote to the carbonyl.  It is 
noteworthy that even when applying powerful separation conditions (i.e., GCxGC, 5 °C 
gradient) we did not observe chromatographic separation of AEP-adduct isotopologues, 
as confirmed by the observable 1:1 ratio of the reporter MSTs in the ZMI (Figure 4.22). 
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Figure 4.22.  EI-Mass (X-axis: m/z; Y-axis: intensity) spectra of AEP–2-nonanone 
adducts: (A) Z-isomer, (B) E-isomer.  Adducts were obtained by derivatization of 
turmeric root extract using AEP-33 and AEP-34 in a 1:1 ratio.  
 
Absolute quantification of the principal methyl ketone constituents in the root 
extract, 2-nonanone and 2-undecanone, followed from preparation of labeled standards.   
The standards were derivatized using AEP-34, while the turmeric extract was treated 
with AEP-33.  Known concentrations of the derivatized standards then were added to the 
derivatized extract and the resulting spiked mixtures were analyzed by GCxGC-TOF-MS.  
Once again, the direct comparison of the ion intensities for the two reporter MSTs in the 
ZMI was key and provided the measures for determining the minimal concentrations of 
both 2-nonanone and 2-undecanone in the turmeric extract at 237 ± 14 µg/mL and 315 ± 
32 µg/mL, respectively. 
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4.D.  Conclusions 
4.D.1.  General 
In conclusion, we have demonstrated a new method for the quantification of 
substrates from multiple samples using a multiplexed, single injection GC-MS approach 
enabled by direct measurement of isotopic reporter mass spectral tags.  Stable isotope-
labeled AEP reagents have been designed for this application.  We illustrated the method 
by reacting the AEP reagent panel with known ratios of sample aldehydes and ketones, 
and by applying the technology to profile tumeric extract.  We engineered the AEP 
reagents to: 1) overcome the chromatographic isotope effect, typically observed when 
heavy isotopes (in particular deuterium) are incorporated in derivatizing reagents, by 
using 13C stable isotopes; 2) generate an isotopic reporter MST in a zone of minimal 
interference (ZMI) by using the electron ionization-induced ester α-cleavage as an 
expulsion mechanism; and 3) derivatize chemoselectively carbonyl metabolites by 
functionalizing the reagent with an aminooxy moiety. 
The identification of a ZMI at the m/z range 31-37 and the engineering of an 
expulsion mechanism to form labeled ethyl carbenium ions from AEP-adducts were both 
crucial for developing a means for unobstructed detection of mass spectral reporter ions.  
Of possibly even greater significance was the success in overcoming the chromatographic 
isotope effect to enable application of the technology to high throughput multiplexing.  
These elements facilitate rapid profiling and quantification of substrates that have been 
chemoselectively derivatized, as exemplified by our turmeric extract study.  The results 
here provide a useful guideline for the development of isotopic carbenium ion- or other 
ZMI ion-producing reagents that can facilitate multiplexed GC-MS analyses. 
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4.D.2.  Future Directions 
As a logical expansion of the technology, we have begun development of new 
derivatizing reagents that use isotopic carbenium ions as reporter mass spectral tags.  In 
preliminary experiments, we have examined chemoselectively derivatizing amine-
containing metabolites, such as amino acids.  To do so, we surmised that an MS-induced 
α-cleavage fragmentation could also be generalized to the amide functional group as a 
means to generate reporter ethyl carbenium ions (Figure 4.23).  Thus, transforming 
primary or secondary amines into their corresponding isotopically labeled propionamides 
might be a viable way to derivatize amine metabolites as a ZMI-generating functional 
group. 
 
 
Figure 4.23.  Comparing ester α-cleavage and amide α-cleavage. 
 
To demonstrate the viability of an approach that uses labeled propionamides as a 
means to generate ZMI reporter MSTs, we synthesized labeled N-hydroxysuccinimide 
propionate esters (NHS) reagents (Figure 4.24).   
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Figure 4.24.  Expected fragmentations from NHS-derivatized amine metabolites. 
 
We expect NHS reagents to react with primary or secondary amines to generate 
labeled propionamides that then would undergo EI-induced amide α-cleavage to give rise 
to acylium ion (A1) followed by spontaneous loss of CO to generate the target m/z 32-34 
carbenium ion MSTs (A2).  Path M should also generate metabolite specific fragments 
that provide information on the chemical structure of the derivatized metabolite. 
 
 
Scheme 4.13.  Synthesis of NHS reagents. 
 
Differently labeled NHS reagents were synthesized in a single step using standard 
carbodiimide coupling conditions.  N-hydroxysuccinimide reacted with the corresponding 
labeled propionic acids in good to excellent yields (61-90%). 
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Analysis on the fragmentations of an NHS-derivatized amine adduct was 
performed using amino acids glycine and proline as corresponding primary and 
secondary amine templates.  The two amino acids were first derivatized in anhydrous 
pyridine with a 1:1:1 solution of NHS-32, NHS-33, and NHS-34, followed by a tert-
butyldimethylsilyl trifluoroacetimide (TBS-TFA) derivatization.  The second 
derivatizations with TBS-TFA are required to convert the carboxylic acid moieties to 
their non-polar (i.e., GC compatible) silyl esters.  Figure 4.24 shows the EI-MS spectrum 
of the NHS-TBS adducts of glycine and proline and accompanying main fragments.  As 
expected, the labeled propionamide underwent α-cleavage to generate labeled acylium 
ion at m/z 60-62 (A1) and labeled ethyl carbenium ion at m/z 32-34 (A2).  As predicted, 
the ratio of the reporter MST in the ZMI correlated with the initial ratio of the NHS 
reagents.  Loss of tert-butyl generates the silenium ion at m/z 191-193 for glycine and m/z 
231-233 for proline.  These fragments as well as metabolite specific fragments (path M) 
provide structural information about the derivatized metabolite and could be used as 
finger print fragments for this adduct in a searchable mass spectral library.  
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Figure 4.25.  EI-Mass (X-axis: m/z; Y-axis: intensity) spectra of NHS-TBS-
glycine (A) and NHS-TBS-proline (B).  Adducts were obtained by derivatization of 
glycine and proline using NHS-32, NHS-33, and NHS-34 in a 1:1:1 ratio, followed by 
derivatization with TBS-TFA. 
 
While these preliminary results are highly encouraging, further work needs to be 
done to demonstrate the viability of the amide α-cleavage as a means to generate ethyl 
carbenium ions in the ZMI.  This study does show, however, that the NHS methodology 
is a good option for amine functional group targeting and that our labeled propionate 
approach can be readily adapted to such derivatization strategies.  
 
! 142!
CHAPTER 5 
 
 
Aminooxy Linkers for Gold Nanoparticle 
Functionalization 
 
 
 
5.A.  Introduction 
5.B.  Synthesis of Heterobifunctional Diblock Linkers 
5.B.1.  Goal and Initial Synthetic Attempts 
5.B.2.  Revised Route to Heterobifunctional Diblock Linkers 
5.B.3.  Conclusion 
5.C. Synthesis of Peptide Linkers and Cypate Functionalization 
5.C.1.  Synthesis of Peptide Linkers 
5.C.2.  Aldehyde Functionalization of Cypate 
5.D.  Nano-Entity Assembly  
5.D.1.  Solid Phase Assembly 
5.D.2.  Click Chemistry Assembly 
5.D.3.  Conclusion 
! 143!
5.A.  Introduction 
 Breast cancer represents 29.0% of all cancers in women and caused ~39,510 
deaths in the United States in 2012.1  The screening for small and asymptomatic tumors 
in apparently healthy individuals to achieve an early diagnosis is based on the assumption 
that early detection will lead to more successful cancer therapy and improve survival 
rates.2  Unfortunately, early detection of breast cancer represents a diagnostic challenge 
despite the current availability of imaging and localization methods.3  Therefore, the 
development of new biocompatible imaging probes is much needed, and fluorescent 
molecules that emit in the near-infrared (NIR) could play a major role in this setting.  The 
use of strong NIR is particularly attractive since its absorption and scattering by 
endogenous biomolecules is minimal and, hence, it can propagate through tissues.4  In 
this instance, the use of a quenched, fluorescent imaging probe that can generate a strong 
near-infrared fluorescence signal after enzymatic activation (e.g., peptide cleavage by 
proteases endemic to malignant tumors) may be a viable option for cancer detection and 
diagnosis.5 
As part of a collaboration with Dr. Kyung Kang (UofL Chemical Engineering), 
we sought to prepare a gold-based fluorescing nano-entity using a click chemistry 
approach for cancer detection and diagnosis.  The nano-entity was designed to contain a 
structurally modified fluorescent probe (cypate) attached to a peptide (short linker) that 
contains a recognition element for urokinase plasminogen activator (uPA), which is a 
serine protease causally involved in cancer invasion and metastasis.6 The probe also 
features a non-cleavable diblock (hydrophobic/hydrohphilic) chain (long linker) (Figure 
5.1).  Our approach aims at enabling the formation of cypate nano-entities through simple 
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“click” mixing operations.  To do so, we opted to use oximation technology as a simple 
and efficient way to ligate the elements of our gold-based fluorescing nano-entity.  As 
shown in Figure 5.1, both the peptide linker (short linker) and the heterobifuntional 
diblock linker (long linker) have been functionalized with an aminooxy moiety for 
chemoselective ligation with the aldehyde moiety of cypate bis(aldehyde).  The thiol 
functionality at the other end of the linker enables attachment onto gold nanoparticles.  
Thus, simple mixing of the elements should lead to the efficient assembly of the nano-
entity. 
 
 
Figure 5.1.  Elements of the fluorescent nano-entity.  Highlighted in red is the 
recognition sequence for uPA.  The thiol functionality of each linker (green) enables 
loading onto gold nanoparticles (AuNPs), and the aminooxy and aldehyde functionalities 
(blue) allow chemoselective ligations of the fluorescente probe.  
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The dual-chain probe is designed so that its attachment onto gold nanoparticles 
(AuNPs) quenches fluorescent emission as long as cypate is tethered to the gold 
nanoparticle surface via the short linker (Figure 5.2A).  The quenching of fluorescence by 
metals results primarily from non-radiative energy transfer from the fluorophore to the 
metal.7 
 
 
 
Figure 5.2.  Nanoparticle-fluorophore response to an encounter with uPA. 
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When the nano-entity encounters urokinase plasminogen activator (uPA), a serine 
protease enzyme synthesized and secreted by normal and cancer cells that has been 
linked to cancer invasion and metastasis,6  the resulting enzyme-mediated peptide-bond 
cleavage (short linker scission) would allow the constrained cypate to migrate from the 
gold nanoparticle surface to the length of the long linker, where cypate fluorescence is 
restored to serve as a signal (Fig. 5.2, C).  Migration of the cypate away from the surface 
of the nanometal not only results in fluorescence emission dequenching but also may 
result in enhanced fluorescence if the distance of the long linker is appropriately 
controlled.  The enhanced fluorescence appears to arise at a certain distance from the 
surface of the nanometal where the local electromagnetic field is highly concentrated.8 
  While the Kang laboratory focused on the various gold nanoparticle, 
fluorescence, and engineering elements of the project, our research objectives were to 
secure synthetic routes to peptide- and PEG-conjugates of cypate and to develop methods 
for their attachment to gold nanoparticles. In particular, our goal was to develop a new 
synthetic route to heterobifunctional linkers with flexible control over the length and the 
functionalization.  We sought to prepare a panel of aminooxy functionalized spacers, an 
aminooxy functionalized peptide linker, and a new cypate bis(aldehyde) fluorescent 
probe for assembly of the nano-entitiy through “click” mixing operations. 
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5.B.  Synthesis of Heterobifunctional Diblock Linkers 
5.B.1.  Goal and Initial Synthetic Attempts 
Our goal was to develop a flexible synthetic route to heterobifunctional thiol- and 
aminooxy-terminated diblock (hydrophobic/hydrophilic) linkers (Figure 5.3).  The linkers 
were functionalized with a) a thiol moiety for attachement to gold nanoparticles (AuNPs), 
and b) an aminooxy group that is presented at the surface of the AuNPs for 
chemoselective ligation to subsequently added aldehyde-functionalized cypate.  Since 
AuNPs are coated with hydrophobic chains during their synthesis to avoid aggregation, 
we surmised that placing the thiol functionality at the terminal position of the 
hydrophobic domain would facilitate loading onto AuNPs.  On the other hand, placing 
the aminooxy moiety proximal to the hydrophilic PEG-domain of the linker would 
facilitate ligation with our cypate aldehyde substrate in water. 
 
 
Figure 5.3.  Stucture of the target heterobifunctional diblock linkers. 
 
Our initial synthetic approach employed a convergent strategy whereby a long 
alkyl chain with a protected thiol would be added nucleophilically onto PEG reagents 
having protected aminooxy functionality (Scheme 5.1).  Deprotections of the thiol and 
the aminooxy functionality would then be performed using standard methods to reveal 
the fully functionalized linker.   
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Scheme 5.1.  Convergent synthesis for heterobifuntional diblock linkers. 
 
Starting C(16)-bromocarboxylic acid 5.0 was reduced in high yields (93-100%) 
using borane in tetrahydrofuran (THF) to afford the corresponding bromoalcohol 5.1b.  
C(12)- and C(16)-bromoalcohols (5.1a) and (5.1b) were transformed into trityl protected 
thiols 5.2a,b by SN2 displacement of bromine.  This reaction was performed in high 
yields (ca. 98%) using the Hornillos et al. procedure.9  Reaction of 5.2 with iodo-PEG-
ON(Boc)2 reagent 5.3 to form the ether was met with great difficulty.  Indeed, the 
competing addition of the derived alkoxide with the carbamate moiety of 5.3 led to a 
transferral of one Boc protecting group to give 5.4.  Virtually no desired product 5.5 was 
formed, as indicated by the 1H NMR spectrum of the products.  Instead, a prominent 9-
proton singlet peak (red) at δ1.5 ppm in the product spectrum (Figure 5.4) showed that 
Boc transfer had occurred, thus terminating this approach. 
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Figure 5.4. 1H NMR spectrum (CDCl3) of byproduct 5.4. 
 
To circumvent the reaction between the alkoxide and bis-carbamate, we opted to 
use a dihalogenated PEG instead.  The Williamson ether synthesis under these conditions 
(Scheme 5.2) still failed to afford the desired diblock chain product.  Instead, E2 
elimination prevailed and yielded the terminal alkenes 5.7.  Bis-chloro-PEG 5.6a did 
afford the first full-length spacer, but the yield was prohibitively low (<5%). 
 
 
Scheme 5.2.  A dihalogenated PEG approach. 
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These results may be explained using a conformational argument.  Figure 5.5 
shows the favored Newman projection of a halogenated PEG.  Since the SN2 reaction 
requires nucleophilic attack via an anti-periplanar conformation, the proximal PEG 
oxygen possibly deters attack through electronic (and/or steric) repulsions.  Thus, 
nucleophilic substitution by the alkoxide on the terminal carbon is discouraged and the 
elimination reaction becomes favorable. 
 
 
Figure 5.5.  Newman projection of halo-PEG compounds and E2 elimination mechanism. 
 
Figure 5.6 shows a section of the 1H NMR spectrum between 6.5 and 4 ppm of 
the terminal alkene 5.7.  The doublet of doublet signal at 6.42 ppm corresponds to the CH 
proton near the oxygen (red). The doublet signal at 4.10 ppm with a large J coupling 
corresponds to the terminal proton in trans (blue), and signal at 3.95 ppm corresponds to 
the terminal proton in cis (green). 
 
 
Figure 5.6.  1H NMR spectrum (CDCl3) of alkene byproduct 5.7. 
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5.B.2.  Revised Route to Heterobifunctional Diblock Linkers 
Since our strategy to perform an SN2 reaction on an electrophilic PEG reagent did 
not afford the desired products, we further revised the strategy and opted to assign the 
electrophilic center to the aliphatic chain while making the PEG component the 
nucleophile.  Examination of the literature for syntheses of alcohol or amino-terminated 
diblock compounds revealed that such a HO-PEG-OH alkylation was feasible, but the 
subsequent alkene-to-thiol transformation via radical methods was unwieldy (Figure 
5.7).10  With compound 5.2 in hand, we opted instead to alkylate HO-PEG-OH with a 
trityl-protected alkyl halide to obtain the target linkers.  Development of such a route 
would constitute a new, flexible path to this useful class of tethering compounds.   
 
 
Figure 5.7.  Comparison of approaches to heterobifunctional diblock linkers. 
 
Scheme 5.3 shows the new synthetic strategy in which the initial steps to 5.1 and 
5.2 have not changed.  This approach gave the first quantifiable yields of non-
functionalized spacer and showed promise for further optimization.  In particular, this 
new route provides for control over linker length and functionalization.  Conversion of 
primary alcohols 5.2 to either the alkyl iodide or the alkyl bromide 5.9 proceeded with 
good yields (78-96%), but the low solubility of the products in non-polar solvents made 
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purification difficult.  Transformation of the alcohol into the alkyl iodide was performed 
using modified conditions developed by Skaanderup et al.11  Transformation into 
bromide was first attempted, with discouraging results, following a procedure by 
Harrison et al. that requires PBr3.12  Indeed, varying reaction conditions with PBr3 never 
afforded the brominated product (5.9a) in more that 30% yield.  The Appel reaction was 
then attempted using carbon tetrabromide and triphenylphosphine.13  Halogenation under 
optimized conditions generated the alkyl bromides 5.9a,b in excellent yields. 
 
 
Scheme 5.3.  Synthetic route to heterobifuntional diblock linkers. 
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Results of all bromination reactions are shown in Table 5.1, with the optimized 
alkyl iodide-forming reaction as reference.  As shown, the Appel reaction (entry 4) 
provided the best yields. 
 
 
Table 5.1.  Optimization of alkyl halide synthesis. 
Entry Reagents Solvent X Temp (°C) Yield (%) 
1 
I2 (1.5 eq), 
PPh3 (1.5 eq), 
Imidazole (2 eq) 
THF I r.t. 78 
2 PBr3 (1.1 eq) CH2Cl2 Br r.t. 30 
3 PBr3 (1.1 eq) CH2Cl2 Br 50 23 
4 
CBr4 (1.5 eq),  
PPh3 (1.5 eq) 
Imidazole (2 eq) 
CH2Cl2 Br r.t. 96 
 
Figure 5.8 shows the 1H NMR spectra of hydroxythiol 5.2a and bromothiol 5.9a 
in which can be observed the upfield shift from 5.59 ppm to 3.35 ppm of the CH2 signal 
(H1) adjacent to the hydroxyl group and the bromine groups, respectively.  
 
 
Figure 5.8.  1H NMR spectra (CDCl3) of hydroxythiol 5.2a and bromothiol 5.9a. 
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The coupling reaction of the protected halothiols 5.9 with PEG units required 
considerable optimization to once again avoid E2 reactions.  A variety of reaction 
temperatures, solvents, and reagent ratios were employed to optimize this low-yield step 
(Table 5.2).   
 
 
Table 5.2.  Optimization of SN2 coupling reaction. 
Entry X Solv eq. PEG4 eq. NaH Temp 
(°C) 
Time (hr) Yield (%) 
1 I DMF 3 15 50 12 21 
2 I DMSO 3 15 45→60 36 0 
3 I THF 3 15 45 12 <5 
4 I THF/HMPA 3 15 45 12 <5 
5 I DMF 6 30 35 72 24 
6 I DMF 6 12.2 50 12 33 
7 Br DMF 5 9.8 r.t. 24 10 
8 Br DMF 6 11.8 r.t. 72 41 
 
Although Williamson ether syntheses generally require heating to initiate the SN2 
displacement of the halogen, in our case such conditions led to greater decomposition of 
the reactant.  Yet, at low temperatures, the displacement reaction proceeded very slowly. 
The most promising yields were obtained when the reaction was performed at room 
temperature for a prolonged period (e.g., 48-72 hours).  Using a large excess of PEG 
reagent only improved yields slightly.  We postulated that any unreacted NaH might be 
exacerbating the E2 problem, so fewer equivalents NaH were used than actually required 
to fully deprotonate the alcohol groups of the PEG reactant.  It is important to highlight 
that the PEG compounds are very hydrophilic and hygroscopic which also affects the SN2 
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displacement yield.  Indeed, Doi et al. have recently shown that one or two equivalents of 
water will effectively inhibit an SN2 reaction.14  We examined whether better yields 
might be obtained using the alkyl bromide.  As shown in Table 5.3, the bromide reaction 
afforded the best yield of the desired adduct, although still only in a modest 41% yield. 
Imparting diblock linkers 5.10 with the aminooxy functionality (Scheme 5.3) was 
accomplished using a standard Mitsunobu reaction.15  Yields of 5.11 (Scheme 5.3) were 
encouragingly high (74-96%) after the difficulties of previous steps, and product 
purifications proceeded uneventfully.  Deprotection of the phthalimide group to unmask 
the aminooxy was performed with hydrazine monohydrate in dichloromethane at room 
temperature.  Flash column chromatography (SiO2) of the crude material afforded 
products 5.12 in high yields (ca. 59-98%).  Finally, deprotection of the trityl group to 
unmask the thiol functionality was performed using a 1:1 mixture of trifluoroacetic acid 
and CH2Cl2 under reducing conditions (5% triethylsilane). In this reaction, triethylsilane 
is used as a carbocation scavenger, which is known to increase yields and reduce reaction 
time.16  The reaction completed within one hour and afforded the final heterobifunctional 
diblock linker 5.13 in good yields (44-97%). 
The aminooxy linkers were very reactive towards aldehydes as well as ketones.  
Indeed, we found that upon exposure to acetone vapors present in standard laboratory 
atmosphere, oxime ether formation took place.  Also, over time, the thiol group forms 
disulfides on exposure to oxygen (Figure 5.9). 
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Figure 5.9.  Comparison of the 1H NMR spectra (CDCl3) for the representative thiol-
aminooxy diblock spacer 5.13a-PEG(4) (black), its corresponding acetone adduct (red), 
and its disulfide dimer (blue). 
 
We also explored synthesis of a primary amine-functionalized linker for use in 
solid phase synthesis.  Scheme 5.4 shows how replacing N-hydroxyphthalimide by 
phthalimide in the Mitsunobu step of the synthesis afforded the amine-based linker 5.14 
in 95% yield.  Deprotection of the phthalimide followed the same hydrazine procedure 
and gave the primary amine 5.15 in 72% yield.  We attempted to couple this product to 
cypate bis(carboxylic acid) using a solid phase synthesis procedure with little success as 
it will be shown in section 5.D of this chapter. 
 
 
Scheme 5.4.  Synthesis of an amine functionalized linker. 
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 Computational studies of the final thiol-aminooxy linkers 5.13 and the thiol-
amine linker 5.16 (never prepared) were conducted to estimate extended length of the 
synthesized diblock linker.  Theoretical extended spacer lengths were calculated after 
energy minimization using HyperChem® software.  The values are shown in Table 5.3. 
 
Table 5.3.  Theoretical linker length calculations. 
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5.B.3.  Conclusion 
We prepared a panel of heterobifunctional diblock (hydrophobic/hydrophilic) 
linkers to test the concept depicted in Figure 5.1.  Design features in our linkers include a 
thiol functionality at one end of the linker (hydrophobic region) to improve loading onto 
gold nanoparticles and an aminooxy group at the other end (poly(ethylene glycol) (PEG) 
region) to enable facile oximation with aldehyde substrates, such as an aldehyde-
modified cypate probe.  
 The present synthetic route to heterobifunctional thiol- and aminooxy-terminated 
diblock spacers proceeds with an improved overall yield as compared to previous diblock 
linker syntheses.  In section 5.D of this Chapter, we will show how our aminooxy linkers 
enable formation of cypate nano-entities through simple “click” mixing operations. 
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5.C. Synthesis of Peptide Linkers and Cypate Functionalization 
5.C.1.  Synthesis of Peptide Linkers 
 As discussed in the previous sections, our goal was also to prepare peptide linkers 
containing a thiol moiety for attachment to the surface of the AuNP as well as aminooxy 
functionality for chemoselective ligation to a cypate bis(aldehyde).  However, as 
presented in Figure 5.1, it is important that this short linker is of an appropriate length so 
that the AuNP quenches cypate fluorescence emission.  Finally, the peptide must be 
cleaved by the enzyme urokinase plasminogen activator (uPA).  In particular, uPA has 
been implicated in remodelling of the extracellular matrix, enhancing both cell 
proliferation and migration, and modulating cell adhesion.6  Consistent with its role in 
cancer progression, multiple groups have shown that high levels of uPA in primary breast 
cancers are independently associated with risks of recurrence.6  With these goals in mind, 
we selected 5.13 as our target peptide (Figure 5.10).   
 
 
Figure 5.10.  Aminooxy peptide spacer. 
 
The specific amino acid sequence in this prototype follows from the literature that 
the Gly-Gly-Arg motif is selectively cleaved by uPA.17  Also, the length of the peptide 
chain (6 amino acids plus cysteamine, approximately 2.5nm) was chosen based on initial 
observations by our collaborator Achilefu et al. who showed that cypate fluorescence 
emission was quenched when cypate was attached to a NGP via an 8 amino acid spacer.18 
uPA recognition sequence
5.19
HS
H
N Gly Gly Arg Gly Gly Gly ONH2
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 Scheme 5.5 shows the solid phase synthesis strategy for the aminooxy peptide. 
Methoxy-activated, cysteamine-loaded polystyrene resin (Novabiochem) was reacted 
with the N-Fmoc-protected Gly-Gly amino acids depicted in Scheme 5.5 following the 
standard protocol of DIC-mediated coupling to obtain the resin-bound Fmoc-protected 
peptide 5.17.   
 
 
Scheme 5.5.  Solid phase synthesis of aminooxy peptide. 
 
Piperidine-mediated cleavage of the Fmoc group to unmask the primary amine 
allows for further elongation of the peptide by iterating standard protocol of DIC-
mediated coupling with Fmoc-protected N-terminal arginine.  Successive 
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deprotection/coupling cycles with the desired amino acids led to the resin-bound peptide 
aminooxy 5.18.  Releasing the peptide from the resin was achieved using standard 
trifluoroacetic acid (TFA) procedures in presence of triethylsilane in dichloromethane.  
The peptide 5.19 was confirmed by HRMS analysis (Figure 5.11).  The help and 
knowledge of Dr. Archna Massey and Dr. Souvik Biswas was much appreciated in the 
initial synthetic efforts of these peptide linkers.    
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11.  HRMS (X-axis: m/z; Y-axis: intensity) of aminooxy peptide 5.19. 
 
 In particular, we were gratified to find that overacylation of the aminooxy moiety 
did not occur during the coupling of the Fmoc-protected aminooxy glycine.  Wahl19a and 
Brask19b were among the first to report this undesirable reaction in which mono-protected 
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aminooxy peptides do not satisfactorily prevent further reaction of the aminooxy with an 
activated amino acid, leading to N-overacylation (Scheme 5.6).  Decostaire et al.20 had 
shown that the α-effect of the oxygen affects the nucleophilic and the basic character of 
the amino-group by making it more acidic.  Therefore, coupling conditions in the 
presence of strong base increase overacylation.  To circumvent this side-reaction, Duléry 
et al.21 showed that ethoxyethylidene (Eei) could be used as a protecting group to prevent 
overacylation of aminooxy peptides.  Eei can be cleaved to unmask the aminooxy using 
mild acidic conditions (1% TFA in CH2Cl2).   
 
 
Scheme 5.6.  Coupling conditions leading to overacylation, and Eei protected aminooxy 
peptides. 
 
The aminooxy peptide 5.19 was provided to Kyung Kang and her graduate 
student Jianting Wang who confirmed cleavage of uPa sequence during uPa incubation 
studies.22  
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3.C.2.  Aldehyde Functionalization of Cypate 
To enable the direct chemoselective ligation, under neutral conditions, of both the 
peptide aminooxy and the heterobifunctional diblock linkers with the fluorescent probe 
cypate, we needed to functionalize cypate with two aldehyde moieties.  Shown in Figure 
5.12 is our target cypate bis(aldehyde).   
 
 
Figure 5.12.  Cypate bis(aldehyde) target to enable oximation ligation. 
 
Dr. Samuel Achilefu, one of our collaborators, provided the initial cypate 
bis(carboxylic) acid 5.14.  Cypate has excitation and emmission wavelengths of 780 nm 
and 830 nm respectively, which places them in the near infrared (NIR), and therefore 
could be applied for cancer detection and diagnosis.4,5  More importantly, cypate is FDA 
approved.23 
Our synthetic strategy (as outlined in Scheme 5.7) aimed at modifying the 
carboxylic acid via a bis-amide formation using a reagent that contains a masked 
aldehyde in the form of an acetal.  Reaction of 5.14 with 4-aminobutyraldehyde diethyl 
acetal via a carbodiimide mediated coupling reaction generated the desired bis(amide-
acetal) cypate adduct 5.15 in good yields (68%).  It is important to highlight that cypate 
and its analogs are extremely sensitive to light.  Therefore, isolation and purification of 
5.15 was performed in the dark using column chromatography.  Treatment of 5.15 with 
N N
NH HN
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OHC CHO
Cypate bis(aldehyde)
5.22
3 3
! 164!
acetic acid in water at room temperature effected hydrolysis of the acetal moieties within 
4 hours to give the corresponding bis-aldehyde analog 5.16 in 63% yield.  
 
 
Scheme 5.7.  Synthesis of cypate bis(aldehyde). 
 
Although standard coupling syntheses generally require mild basic conditions, in 
our case, the synthesis of 5.15 gave the best yields in absence of base.  Indeed, it is 
possible, as shown in Scheme 5.8, that base leads to decomposition of cypate via a β-
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elimination reaction.  This elimination process can occur either at the carboxylic state (R 
= OH), or after coupling, at the amide state (R = NHR’).  
  
 
Scheme 5.8.  Decomposition of cypate analogs via β-elimination. 
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5.D.  Nano-Entity Assembly  
5.D.1.  Solid Phase Assembly 
 Previous work by Dr. Biswas and Dr. Massey aimed to prepare the peptide-cypate 
conjugate via solid phase synthesis.  They first attempted the direct coupling of terminal 
amine peptide 5.17 with cypate (Schme 5.9).   
 
 
Scheme 5.9.  Solid phase coupling of cypate with terminal amine peptide. 
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The short spacer peptide was fitted with a terminal amine moiety by substituting 
the last glycine in Scheme 5.5 with Fmoc-protected amino-glycine, as shown in Scheme 
5.9. Following the standard coupling and Fmoc-deprotection procedures, 5.17 was 
reacted with cypate and then cleaved from the resin to obtain the peptide-cypate 
conjugate 5.18.  In general, based on the theoretical concentration of resin reactive sites, 
conjugate 5.18 was obtained in 8-12% yield.  This is due to the large excess of cypate 
(ca. 4-5 equiv.) required to prevent the reaction at both carboxylic acid groups of cypate 
and to insure that all the peptides have been coupled. 
 Following this work, we attempted to couple our trityl-protected amine spacer 
TrS-C16PEG8-NH2 (Scheme 5.4, compound 5.9) to the available –CO2H group of the 
peptide-bound cypate (Scheme 5.9, 5.17) using standard amide-forming coupling 
conditions.  Unfortunately, cleavage of the material from the resin using the established 
conditions (TFA, TES, CH2Cl2) gave a mixture of products.  The primary component, 
shown in Figure 5.13, was identified by HRMS as an elimination product (Scheme 5.8). 
 
 
Figure 5.13.  Major byproduct of the coupling of amine space 5.9 with peptide-cypate 
conjugate 5.17 using solid phase synthesis. 
 
 This preliminary work illustrates the difficulty associated with cypate 
functionalization and coupling, and hence the value of the neutral aminooxy ligation 
strategy.  
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5.C.2.  Click Chemistry Assembly 
 Facing major decomposition of cypate and low synthetic yields through the solid 
phase synthesis strategy, we examined the reactivity of cypate bis(aldehyde) 5.16 with 
our thiol-aminooxy diblock linkers for ligation of the two elements.  We anticipated that 
the neutral conditions required for the oximation reaction would minimize cypate 
decomposition.   
 
 
Scheme 5.10.   Ligation reaction between a diblock linker and cypate bis(aldehyde). 
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We tested the key oximation reaction independently of any gold nanoparticles. 
Cypate analog 5.16 was treated with spacer molecule HS-(CH2)12-PEG8-ONH2 (Scheme 
5.3, compound 5.7a-3) using an excess of cypate bis(aldehyde) to favor mono-oximation.  
Simple stirring of the solution resulted in oximation, and the mono-product 5.19 was 
isolated (52% yield unoptimized) after SiO2 chromatography.  Figure 5.14 shows the 
HRMS of the spacer-cypate conjugate 5.19. 
 
 
Figure 5.14.  HRMS (X-axis: m/z; Y-axis: intensity) of a spacer-cypate conjugate. 
 
Gratified by this result we attempted the ligation of our aminooxy peptide bound 
to the polymer resin (Scheme 5.5, compound 5.12) with cypate bis(aldehyde) 5.16 and 
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by ligating cypate bis(aldehyde) 5.16 to the aminooxy peptide 5.12 in DMF at room 
temperature for 12 hours.  Attachment of cypate in this manner was visually evident by 
the change in color of the resin after reaction with the bis(aldehyde) analog (beads 
changed from yellow to blue, analogous to the change in the amide-coupling approach). 
After washing the resin from unreacted cypate, we reacted the cypate-loaded resin with 
aminooxy spacer TrS-(CH2)12-PEG8-ONH2.  Cleavage from the resin was conducted 
using TFA and Et3SiH.  These same conditions would also unmask the thiol group by 
deprotecting the trityl group, affording the final target conjugate 5.26. 
 
 
Figure 5.15.  Structure of the target conjugate composed of a peptide short linker with a 
cancer specific enzyme recognition sequence, a fluorophore, and a diclock linker.  
 
Unfortunately, MS analysis revealed a mixture of different products.  First it 
seems that the N-O bond of the peptide chain was cleaved under these conditions (likely 
due to reduction by the Et3SiH reagent).  Indeed, the hydroxy peptide shown in Figure 
5.16 indicates that the RO-N=C linkage (oxime ether) does not survive the cleavage 
conditions.  
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Figure 5.16.  Residual hydroxy peptide generated by the reduction of N-O bond. 
 
 From these observations, we attempted the direct formation of the final target 
conjugate 5.26 by mixing ligated cypate 5.25 with unbound peptide aminooxy 5.19, 
under neutral and mild conditions, as shown in Scheme 5.11. 
 
 
Scheme 5.11.  Reaction for the formation of the final peptide-cypate-linker conjugate. 
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After reacting for 12 hours at room temperature, we used HRMS to identify the 
products formed.  As we expected, the desired dual-chain product 5.26 was formed.  
Figure 5.17 shows the HRMS mass distribution of our dual-chain probe 5.26 formed in 
Scheme 5.11, versus the theoretical HRMS mass distribution.  It can be seen that both 
figures match, confirming the formation of 5.26. 
 
 
Figure 5.17.  Our dual chain probe 5.26 (top) vs theoretical (bottom) HRMS (X-axis: 
m/z; Y-axis: intensity) of dual chain probe. 
  
Gratified by these results, we provided the Kang group with both our 
heterobifunctional diblock linkers and cypate bis(aldehyde) for loading onto gold 
nanoparticles and subsequent fluorescent studies.  Four batches of 10 nm citric-AuNP 
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and a shorter alcohol/thiol linker sPEG (HS-(CH2)11-PEG3-OH). After loading and 
purification by dialysis, the sizes of the nanoparticles were measured again using a 
90Plus/BI-MAS particle size analyzer.  Table 5.4 shows the different ratios by percentage 
of the sPEG to 5.13a-PEG(4) linkers, as well as the measured size of the AuNP. 
 
Table 5.4.  Particle size measurements before and after spacer conjugation to AuNP. 
 
 
IT can be clearly seen that the size of the AuNP increased from 7.26 nm for 
simple citric-AuNPs to as high as 13.27 nm after the reaction with the linkers.  This 
indicates that the citric AuNP did successfully bind to sPEG and 5.13a-PEG(4).  The 
analyzed size of the particles conjugated with 4a was larger than that of the particles with 
only sPEG, suggesting that 5.13a-PEG(4) successfully coupled with the AuNP.  
However, large concentrations of 5.13a-PEG(4) led to aggregation and precipitation of 
the gold nanoparticles.  It is possible that the increased concentration of aminooxy groups 
at the surface of the AuNPs led to reactions with other gold particles, forming undesired 
and unreactive aggregates.  Thus, the sPEG served as a stabilizer to keep the 
functionalized gold particles from aggregating and precipitating.   
After proving the loading of our aminooxy linkers, samples S1-S3 were reacted 
with cypate bis(aldehyde) 5.22 for 4 hrs.  After purification by dialysis the particles were 
suspended in DI water for fluorescence studies.  Figure 5.18 shows the absorption scan 
 sPEG  (% used  in reaction) 
5.13a-PEG(4) 
(% used in reaction) 
Analyzed Size  
(nm) 
Citric-AuNP 0 0 7.26 ± 2.90 
Sample 1 (S1) 100 0 10.16 ± 2.18 
Sample 2 (S2) 95 5 13.27 ± 3.46 
Sample 3 (S3) 80 20 12.34 ± 2.27 
Sample 4 (S4) 0 100 aggregated 
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for all three samples (S1-S3), as well as the absorption scan of the gold nanoparticles, and 
the cypate 5.20.  
 
 
Figure 5.18.  Absorption scan of AuNP-sPEG/AuNP-5.13a-PEG(4)-cypate samples. 
 
The scan showed that compared to bare AuNP and sample S1, which should not 
bind cypate bis(aldehyde) since it lacks aminooxy moieties, samples S2 and S3 have 
increased absorption at 780 nm indicating cypate bis(aldehyde) ligated via oximation 
reaction.  However, as can be seen in Figure 5.19, the levels of fluorescence emissions of 
samples S2 and S3 that had been coupled with cypate bis(aldehyde) were 90% lower than 
free cypate bis(aldehyde).  The conjugated cypate bis(aldehyde) emitted fluorescence at 
830 nm after the samples were excited with light of 780 nm and 794 nm wavelengths. 
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Figure 5.19.   Fluorescence of free cypate bis(aldehyde) (control) and samples S2 and S3 
after conjugation with cypate bis(aldehyde). 
 
Given the evidence shown previously for conjugation of the linker 5.13a-PEG(4) 
to both the AuNP and the cypate fluorophore, it was difficult to explain the fluorescence 
quenching observed in these experiments.  One possibility, as shown in Figure 5.20, was 
that the hydrophobic nature of the cypate fluorophore was causing it to migrate into the 
hydrophobic domain generated by the sPEG linkers, as well as the 5.13a-PEG(4) linkers, 
and surrounding the gold nanoparticle.  To verify this hypothesis, we provided the Kang 
group with aminooxy compound 5.27 (Figure 5.20), which contains an aminooxy group 
for chemoselective reaction with aldehydes, and an ammonium salt, which makes it very 
hydrophilic.  We surmised that, if conjugated cypate was migrating to the hydrophobic 
domain, then reaction with 5.27 should increase its hydrophilicity, pulling cypate away 
for the hydrophobic quenching environment, and restore the fluorescence.  As expected, 
making cypate bis(aldehyde) more hydrophilic by reaction with ammonium 5.27 restored 
the fluorescence of the nano-entity.22 
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Figure 5.20.  Fluorescence quenching and restoring experiments. 
 
 Figure 5.20A shows the loading of cypate bis(aldehyde) and 5.13a-PEG(4) 
linkers in the presence of sPEG linkers (to avoid aggregation).  However, as shown in 
Figure 5.20B, mono-conjugated cypate migrates to the hydrophobic domain surrounding 
the AuNP, and thus its fluorescence is quenched.  However, when adding hydrophilic 
compound 5.27 to the system, fluorescence was restored.  Indeed, aminooxy 5.27 reacts 
with the second available aldehyde in cypate and increases its hydrophilicity so that the 
fluorophore migrates out of the hydrophobic layer. 
AuNP
Cypate migration 
to hydrophobic domainAuNP
Loading 5.13a-PEG(4) linkers
with cypate bis(aldehyde)
Fluorescence quenched due
to cypate migration
AuNP
Reaction with 5.27 restores 
fluorescence of the nano-entity
Gold Nanoparticle
Zone 1: Quenched Fluorescence
Zone 2: Enhanced Fluorescence
Hydrophobic Domain of 5.13a-PEG(4)
Cy Cypate bis(aldehyde)
BA
C
Cy
Hydrophilic Domain of 5.13a-PEG(4)
Cy
Cy
Cy
Cy
sPEG Linker HS O
O
9 OH2sPEG
Hydrophilic aminooxy ONH2N
I
5.27
Cy
Cy
C
y
Cy
Cy
Cy
Cy
Cy
Cy
! 177!
5.D.3.  Conclusion 
 We demonstrated in this section the unquestionable advantages of aminooxy 
ligation for the assembly of the cypate dual-chain probe. Indeed, we showed that normal 
coupling conditions, which require the presence of base and multiple reagents, led to 
significant decomposition of the cypate bis(aldehyde).  Conversely, the use of an 
oximation reaction to ligate heterobifunctional diblock linkers, cypate bis(aldehyde), and 
the aminooxy peptide generated the desired cypate dual-chain probe 5.26.  
 Finally, the aminooxy reaction enabled by our heterobifunctional diblock linkers 
showed its versatility during the stepwise loading of cypate bis(aldehyde) onto the gold 
nanoparticles.  First, we showed that the 5.13a-PEG(4) linker could be loaded onto gold 
nanoparticles by mixing with gold citrate; then simple mixing of cypate bis(aldehyde) 
with the resulting 5.13a-PEG(4)-activated AuNPs led to ligation of cypate with the nano-
entity.  Fluorescence studies showed that although cypate was properly bound to the gold 
surface, its fluorescence was partially quenched due to an unexpected migration of cypate 
bis(aldehyde) into the hydrophobic domain surrounding the gold nano-entity.  To 
demonstrate this theory, we used again the oximation reaction to attach a highly 
hydrophilic aminooxy-ammonium salt 5.27 to cypate and restore its fluorescence within 
the nano-entity. 
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6.A.  General Statement 
 All solvents and reagents used in this thesis were reagent grade and were used as 
received unless otherwise indicated.  Dry THF and CH2Cl2 were obtained from SPBT-
101 Bench Top Solvent Purification System (LC Technology Solutions, Inc., USA).  
Anhydrous DMF was purchased from Sigma-Aldrich.  Unless otherwise noted, all 
reagents were purchased from commercial suppliers and were used without further 
purification.  The progress of reactions was monitored by thin-layer chromatography 
(TLC) using precoated silica plates (EMD Silica Gel 60 F254).  Visualization was 
accomplished by staining the plates with iodine, PMA (3% phosphomolybdic 
acid/ethanol solution), PAA stain (2.5% p-anisaldehyde acid/ethanol solution).  UV 
active compounds were visualized by UV light (254 nm).  Silica gel 60 (230-400 mesh) 
was used for flash column chromatography.  1H NMR spectra were recorded at 400, 500 
or 700 MHz, and 13C spectra were recorded at 100, 125 or 175 MHz, respectively, in the 
indicated solvents.  The chemical shifts are reported in ppm values relative to the solvent 
residual peak CDCl3 (7.26 ppm for 1H NMR and 77.23 ppm for 13C NMR). Coupling 
constants are reported in hertz (Hz). High resolution ESI-MS were obtained using a 
FTICR-MS system (LTQ FT, Thermo Electron Corp.) at the Center for Regulatory and 
Environmental Analytical Metabolomics (CREAM) Mass Spectrometry Facility, 
University of Louisville, Kentucky.  Solid phase peptide synthesis was performed using 
methoxy-activated, cysteamine-loaded polystyrene resin (Novabiochem, cat. no. 01-64-
0086). All amino acids (Novabiochem) and peptide coupling reagents (Aldrich Chemical 
Company) were used as received from vendors.  Cypate was provided by our collaborator 
Dr. Samuel Achilefu (Washington University, St. Louis). 
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6.B.  Experimental Procedures of Chapter 2 
Improved Preparation of O-(diphenylphosphinyl)hydroxylamine 
 
 
O-(Diphenylphosphinyl)hydroxylamine (DPPH) 
 To a stirred solution (mechanical stirring) of hydroxylamine hydrochloride (6.46 
g, 93.0 mmol) in water (20 mL) at -10 °C was added a solution of sodium hydroxide 
(3.55 g, 88.7 mmol) in water (20 mL). Diethyl ether (180 mL) was then added and the 
biphasic mixture was further cooled using an ice-methanol bath (ca. -15 °C). 
Diphenylphosphinic chloride (10.0 g, 42.3 mmol) was added rapidly via syringe, and the 
reaction mixture was stirred vigorously for 10 min, and then warmed to 0 °C and stirred 
an additional 15 min. The resultant white slurry was filtered and the retentate was washed 
successively with cold water (60 mL) and Et2O (70 mL). The resultant amorphous paste 
was dried under vacuum to afford a white powder that then was treated with aq. NaOH 
(0.25 M, 120 mL) at 0 °C for 30 min. The slurry was filtered and the resultant amorphous 
solid was washed with cold water (40 mL), and was dried under vacuum 10 h to afford 
the title compound (7.68 g, 78%) with >97% purity by 31P nmr. Recrystallization of an 
analytical sample from methanol delivered DPPH in crystalline form, mp. 140–141 °C, 
lit.1 (uncrystallized sample) 130 °C (dec); 1H NMR (400 MHz, CDCl3) δ 7.87–7.82 (4H, 
m), 7.57–7.53 (2H, m), 7.49–7.47 (4H, m), 5.84 (2H, br) ppm; 31P NMR (162 MHz, 
CDCl3) δ 37.5 ppm; HRMS calculated for [DPPH+Na]+: 256.04979, found: 256.04965. 
P
O
ONH2
DPPH
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Experimental Procedures for a Chemoselective, One-Pot Transformation of Aldehydes to 
Nitriles 
 
Method A:  Typical Procedures for One-Pot Aldehyde to Nitrile Transformation. 
Preparation of trans-cinnamonitrile (Table 2.5, Entry 8)  
 To trans-cinnamaldehyde (0.13 g, 1.0 mmol) in toluene (5 mL) at room 
temperature was added DPPH (0.267 g, 1.15 mmol) in one portion.  The resulting 
suspension was stirred at room temperature for 3 h and then gradually warmed over 45 
min to 85 °C.  The reaction mixture became clear as the temperature reached 80 °C.  
After being heated at 85 °C for 5 h, the reaction was allowed to cool to room temperature 
and then diluted by addition of Et2O (20 mL) and saturated aq. NaHCO3 to dissolve 
precipitated diphenylphosphinic acid.  The layers were separated, and the organic layer 
was washed successively with saturated aq. NaHCO3 and brine (2 x 10 mL).  The 
aqueous layer was extracted with EtOAc (2x).  All of the organic layers were combined 
and then dried (Na2SO4).  The solvents were removed by rotary evaporation, and the 
crude residue was purified by column chromatography (SiO2, hexane/ethyl acetate, 2:1 
v/v, Rf = 0.62) to afford trans-cinnamonitrile (105 mg, 81%) as a light yellow oil with 
spectroscopic data in agreement with published values.2  1H NMR (400 MHz, CDCl3) δ 
7.46-7.38 (m, 6H), 5.90 (d, J = 16.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 150.5, 
133.5, 131.2, 129.1, 127.33, 118.11, 96.3. 
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Method B:  Typical Procedures for One-Pot Aldehyde to Nitrile Transformation. 
Preparation of 4-hydroxybenzonitrile (Table 2.5, Entry 3) 
 To 4-hydroxybenzaldehyde (0.09 g, 0.78 mmol) in toluene (5 mL) at room 
temperature was added DPPH (0.366 g, 1.57 mmol) in one portion.  The resulting 
suspension was stirred at room temperature for 3 h and then gradually warmed over 45 
min to 95 °C.  After heating at 95 °C for 12 h, the reaction was allowed to cool to room 
temperature and then diluted by addition of EtOAc (20 mL) and saturated aq. NaHCO3 to 
dissolve the precipitated diphenylphosphinic acid.  The layers were separated, and the 
organic layer was washed successively with saturated aq. NaHCO3 and brine (2 x 10 
mL).  The aqueous layer was extracted with EtOAc (2x).  The combined organic layer 
was dried (Na2SO4).  The solvents were removed by rotary evaporation, and the crude 
residue was purified by column chromatography (SiO2), eluting with hexane/ethyl acetate 
(2:1, v/v; Rf = 0.33) to afford 4-hydroxybenzonitrile (72 mg, 78% yield) as a yellow 
solid: mp 111-113 °C, having spectral characteristics in agreement with published data.3 
1H NMR (CDCl3, 700 MHz) δ 7.55 (d, J = 8.4 Hz, 2H), 6.91 (d, J = 8.4 Hz, 2H), 5.78 (s, 
1H); 13CNMR (CDCl3, 100 MHz) δ 159.9, 134.3, 119.2, 116.4, 103.3. 
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Method C:  Typical Procedures for One-Pot Aldehyde to Nitrile Transformation. 
Preparation of 3-pyridinecarbonitrile (Table 2.5, Entry 11) 
 To 3-pyridinecarboxaldehyde (0.10 g, 0.93 mmol) in toluene (5 mL) at room 
temperature was added trifluoroacetic acid (72 µL, 1 mmol).  After the mixture was 
stirred for 5 min, DPPH (0.250 g, 1.07 mmol) was added in one portion.  The resulting 
suspension was stirred at room temperature for 3 h and then gradually warmed over 45 
min to 95 °C.  After heating at 95 °C for 12 h, the reaction was allowed to cool to room 
temperature and then diluted by addition of EtOAc (15 mL) and saturated aq. NaHCO3 to 
dissolve the precipitated diphenylphosphinic acid. The layers were separated, and the 
organic layer was washed successively with saturated aq. NaHCO3 and brine (2 x 10 
mL). The aqueous layer was extracted with EtOAc (2x) and DCM (2x).  The combined 
organic layer was dried (Na2SO4). The solvents were removed by rotary evaporation, and 
the crude residue was purified by column chromatography (SiO2), eluting with 
CH2Cl2/hexane/ethyl acetate (7:2:1, v/v; Rf = 0.34) to afford 3-pyridinecarbonitrile (60 
mg, 64% yield) as a white solid, mp 49.1-50.2 °C, having spectral characteristics in 
agreement with published data.4  1H NMR (CDCl3, 400MHz) δ 8.90 (s, 1H), 8.83 (d, J = 
4.8 Hz, 1H), 7.98 (d, J = 8 Hz, 1H), 7.45 (dd, J = 4.8, 8.0 Hz, 1H); 13C NMR (CDCl3, 100 
MHz) δ 153.2, 152.7, 139.4, 123.7, 116.7, 110.3. 
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Polar Solvent Procedure: One-Pot Aldehyde to Nitrile Transformation.  
Preparation of 3-phenylpropionitrile (Table 2.5, Entry 6) 
 To 3-phenylpropionaldehyde (0.70 g, 0.52 mmol) in water (8 mL) at room 
temperature was added DPPH (0.14 g, 0.60 mmol) in one portion. The resulting 
suspension was stirred at room temperature for 3 h and then gradually warmed over 45 
min to 95 °C. After heating at 95 °C for 12 h, the reaction was cooled to room 
temperature and extracted with EtOAc (2 x 10 mL) and Et2O (10 mL). The combined 
organic layer was washed with brine (10 mL) and then dried (Na2SO4). The solvents were 
removed by rotary evaporation, and the crude residue was purified by column 
chromatography (SiO2), eluting with hexane/ethyl acetate (2:1, v/v; Rf = 0.55) to afford 
3-phenylpropionitrile (50 mg, 73% yield) as a yellow oil, having spectral characteristics 
in agreement with published data.5  1H NMR (CDCl3, 400 MHz) δ 7.34 (t, J = 7.2 Hz, 
2H), 7.27 (t, J = 7.2 Hz, 1H), 7.22 (d, J = 7.2 Hz, 3H), 2.96 (t, J = 7.6 Hz, 2H), 2.61 (t, J 
= 7.6 Hz, 2H); 13C NMR (CDCl3, 100 MHz) δ 138.2, 129.0, 128.5, 127.4, 119.3, 31.7, 
19.5. 
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Tabulation of spectroscopic data of all the nitrile products (entry numbers refer to 
position in Table 2.5) 
 
Benzonitrile (entry 1) 
1H NMR (400 MHz): δ 7.67 (d, J = 7.6 Hz, 2H), 7.60 (m, 1H), 7.47 (m, 2H) 
13C NMR (100 MHz): δ 132.7, 132.1, 129.0, 118.8, 112. 4 
 
1-Naphthonitrile (entry 2) 
1H NMR (400 MHz): δ 8.26 (d, J = 8.4 Hz, 1H), 8.10 (d, J = 8.0 Hz, 1H), 7.93-7.91 (m, 
2H), 7.71 (t, J = 7.6 Hz, 1H), 7.63 (t, J = 8.0 Hz, 1H), 7.53 (t, J = 7.6 Hz, 1H) 
13C NMR (100 MHz): δ 133.2, 132.9, 132.6, 132.3, 128.6, 128.5, 127.5, 125.1, 124.9, 
117.7, 110.2 
 
4-Hydroxybenzonitrile (entry 3) 
1H NMR (700 MHz): δ 7.55 (d, J = 8.4 Hz, 2H), 6.91 (d, J = 8.4 Hz, 2H), 5.78 (s, 1H) 
13C NMR (100 MHz): δ 159.9, 134.3, 119.2, 116.4, 103.3 
 
p-Methoxybenzonitrile (entry 4) 
1H NMR (400 MHz): δ 7.55 (d, J = 8.4 Hz, 2H), 6.92 (d, J = 8.4 Hz, 2H), 3.82 (s, 3H) 
13C NMR (100 MHz): δ 162.8, 133.9, 119.2, 114.7, 103.8, 55.5 
 
4-(Methylthio)benzonitrile (entry 5) 
Spectral characteristics in agreement with published data.6 
1H NMR (400 MHz): δ 7.54 (d, J = 8.4 Hz, 2H), 7.27 (d, J = 8.4 Hz, 2H), 2.51 (s, 3H) 
13C NMR (100 MHz): δ 146.0, 132.1, 125.4, 118.9, 107.6, 14.6 
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3-Phenylpropionitrile (entry 6) 
1H NMR (400 MHz): δ 7.34 (t, J = 7.2 Hz, 2H), 7.27 (t, J = 7.2 Hz, 1H), 7.22 (d, J = 7.2 
Hz, 3H), 2.96 (t, J = 7.6 Hz, 2H), 2.61 (t, J = 7.6 Hz, 2H) 
13C NMR (100 MHz): δ = 138.2, 129.0, 128.5, 127.4, 119.3, 31.7, 19.5 
 
Myristonitrile (entry 7)  
1H NMR (400 MHz): δ 2.31 (t, J = 7.6 Hz, 2H), 1.64 (q, J = 7.6 Hz, 2H), 1.44-1.41 (m, 
2H), 1.39-1.24 (m, 18H), 0.86 (t, J = 7.2 Hz, 3H) 
13C NMR (100 MHz): δ 119.8, 31.8, 29.6, 29.5, 29.4, 29.3, 29.2, 28.7, 28.6, 25.3, 22.6, 
17.0, 14.0 
 
trans-Cinnamonitrile (entry 8) 
1H NMR (400 MHz): δ 7.46–7.38 (m, 6H), 5.9 (d, J = 16.8 Hz, 1H) 
13C NMR (100 MHz): δ 150.5, 133.5, 131.2, 129.1, 127.3, 118.1, 96.3 
 
3-Acetylbenzonitrile (entry 9) 
Spectral characteristics in agreement with published data.7 
1H NMR (400 MHz): δ 8.23 (app. s, 1H), 8.18 (app. d, J = 8.0 Hz, 1H), 7.85 (app. d, J = 
8.0 Hz, 1H), 7.61 (app. t, J = 8.0 Hz, 1H) 2.64 (s, 3H) 
13C NMR (100 MHz): δ 195.7, 137.7, 135.9, 132.1, 132.0, 129.6, 117.8, 113.1, 26.5 
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4-(Acetyloxy)butanenitrile (entry 10) 
Spectral characteristics in agreement with published data.8 
1H NMR (700 MHz): δ 4.17 (t, J = 6.2 Hz, 2H), 2.44 (t, J = 7.2 Hz, 2H), 2.05 (s, 3H), 
2.03-1.96 (m, 2H) 
13C NMR (175 MHz): δ 170.9, 119.0, 62.3, 30.9, 24.9, 22.8, 20.9, 14.4 
 
3-Pyridinecarbonitrile (entry 11) 
Spectral characteristics in agreement with published data.9 
1H NMR (400 MHz): δ 8.90 (s, 1H), 8.83 (d, J = 4.8 Hz, 1H), 7.98 (d, J = 8 Hz, 1H), 7.45 
(dd, J = 4.8 Hz, J = 8 Hz, 1H) 
13C NMR (100 MHz): δ 153.2, 152.7, 139.4, 123.7, 116.7, 110.3 
 
N-Boc-4-(cyanomethyl)piperidine (entry 12) 
Spectral characteristics in agreement with published data.10 
1H NMR (400 MHz): δ 4.15 (app. d, J = 12.8 Hz, 2H), 2.69 (app. t, J = 12.8 Hz, 2H), 
2.30 (d, J = 6.4 Hz, 2H), 1.82-1.76 (m, 3 H), 1.44 (s, 9H), 1.27-1.23 (m, 2H) 
13C NMR (100 MHz): δ 154.8, 118.3, 79.8, 43.5, 33.5, 31.4, 28.6, 24.2 
 
N-Boc-4-cyanopiperidine (entry 13) 
Spectral characteristics in agreement with published data.11 
1H NMR (500 MHz): δ 3.68-3.63 (m, 2H), 3.36-3.31 (m, 2H), 2.80-2.78 (m, 1H), 1.89-
1.86 (m, 2H), 1.85-1.77 (m, 2H), 1.45 (s, 9H) 
13C NMR (100 MHz): δ 154.5, 121.1, 80.1, 41.8, 28.5, 26.4 
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Ethyl 2-(3-cyano-1H-indol-1-yl)acetate (entry 14) 
1H NMR (400 MHz): δ 7.78 (d, J = 7.6 Hz, 1H), 7.62 (s, 1H), 7.34-7.30 (m, 3H), 4.87 (s, 
1H), 4.25 (q, J = 7.2 Hz, 2H), 4.25 (q, J = 7.2 Hz, 3H) 
13C NMR (100 MHz): δ 167.2, 135.9, 135.6, 127.8, 124.5, 122.7, 120.3, 115.6, 110.2, 
87.5, 62.5, 48.3, 14.2 
IR (cm-1): 2223, 1740 
HRMS (ESI+, m/z) calcd for C13H12N2O2, [M + Na]+ 251.0791, found 251.0791 
Light yellow solid; Melting point: 96.5-98 ºC 
 
4-((tert-Butyldimethylsilyl)oxy)butanenitrile (entry 15) 
Spectral characteristics in agreement with published data.12 
1H NMR (500 MHz): δ 3.70 (t, J = 5.5 Hz, 2 H), 2.44 (t, J = 7 Hz, 2 H), 1.83 (m, 2 H), 
0.88 (s, 9 H), 0.05 (s, 6 H) 
13C NMR (175 MHz): δ 119.8, 60.6, 28.5, 25.9, 18.3, 13.8, -5.3 
 
Phthalonitrile (entry 16) 
1H NMR (400 MHz): δ 7.85-7.82 (m, 2 H), 7.78-7.73 (m, 2H) 
13C NMR (175 MHz): δ 133.8, 133.4, 116.1, 115.5 
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Synthesis 
 
1-Naphthaldehyde O-diphenylphosphoryl oxime (2.2) 
 To 1-naphthaldehyde (0.15 g, 1.0 mmol) in tetrahydrofuran (10 mL) at room 
temperature was added DPPH (0.267 g, 1.15 mmol) in one portion.  The resulting 
suspension was stirred at room temperature for 30 h.  Then, the reaction was concentrated 
by rotary evaporation, and the crude residue was purified by column chromatography 
(SiO2), eluting with CH2Cl2/MeOH (95:5, v/v; Rf = 0.52) to afford 1-naphthaldehyde O-
diphenylphosphoryl oxime (2.2) (50 mg, 79% yield) as a gum.  1H NMR (CDCl3, 
400MHz) δ 9.04 (s, 1H), 8.34 (d, J = 8.8Hz, 1H), 8.00-7.95 (m, 4H), 7.91 (d, J = 8.0Hz, 
1H), 7.84 (d, J = 7.6Hz, 1H), 7.71 (d, J = 7.2 Hz, 1 H), 7.59-7.43 (m, 9H); 13C NMR 
(CDCl3, 100 MHz) δ 158.1, 158.0, 133.8, 132.6, 132.4, 132.3, 131.1, 130.6, 129.9, 129.8, 
128.8, 128.7, 228.6, 127.8, 126.5, 126.3, 125.2, 125.0; 31P NMR (CDCl3, 162 MHz) δ 
35.60; FT-ICR-MS (ESI+, m/z) calcd for C23H18NO2P, [M + Na]+ 394.0967, found 
394.0976. 
 
 
 
 
 
 
H
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6.C.  Experimental Procedures of Chapter 3 
Synthesis 
 
 
Hexanal oxime (3.5) 
 To hexanal (3.1) (1.5 g, 15 mmol) in methanol (5 mL) was added saturated aq 
sodium bicarbonate (2.5 mL) and hydroxylamine hydrochloride (1.14 g, 16.5 mmol).  
After stirring 16 h at room temperature, the reaction mixture was extracted with Et2O 
(3x).  The combined organic extract was washed with brine (3x) and then dried (Na2SO4).  
The ether was removed by rotary evaporation and the crude residue was purified by SiO2 
column chromatography (hexane:EtOAc, 1:1 v/v; Rf  = 0.73) to afford 3.5 (0.48 g, 89% 
yield) as a 1.5:1 mixture of E:Z isomers.  The spectral characterization of 3.5 was in 
agreement with published values.13  1H NMR (400 MHZ, CDCl3) (E)-isomer δ 7.42 (t, J 
= 6.0 Hz, 1H), 2.20 (dt, J = 7.6, 6.4 Hz, 2H), 1.48 (m, 2H), 1.31 (m, 4H), 0.93 (s, 9H), 
0.90 (t, J = 2.4 Hz, 3H). 
 
 
 
 
 
 
 
N
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Hexanal O-(tert-butyldimethylsilyl) oxime (3.9)  
 To a solution of aldoxime 3.5 (0.20 g, 1.74 mmol) in dry CH2Cl2 (1.5 mL) at 0 °C 
was added TBS-Cl (0.314 g, 2.08 mmol), imidazole (0.238 g, 3.50 mmol), and 4-(N,N-
dimethylamino)pyridine (ca. 5 mg).  The reaction was warmed to room temperature and 
stirred 72 hours whereupon the solvent was removed by rotary evaporation.  The residue 
was purified by SiO2 column chromatography (hexane:EtOAc, 2:1, v/v; Rf = 0.69) to 
afford 3.9 (0.26 g, 65% yield) as a 1:1 mixture of E:Z isomers; 1H NMR (400 MHz, 
CDCl3) (E)-isomer δ 7.49 (t, J = 6.0 Hz, 1H), 2.19 (dt, J = 7.6, 6.8 Hz, 2H), 1.47 (m, 2H), 
1.31 (m, 4H), 0.93 (s, 9H), 0.89 (t, J = 6.8 Hz, 3H), 0.16 (s, 6H); 13C NMR (100 MHz, 
CDCl3) isomer mixture δ 156.8, 155.9, 31.7, 31.4, 29.6, 26.4, 26.3, 26.2, 26.0, 25.5, 22.5, 
18.4, 18.3, 14.1, –5.05, –5.09.  
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1-(2,2-Dimethoxyethoxy)propane (3.13) 
  To a solution of sodium hydroxide (2.98 g, 74.4 mmol) in n-propanol (9.84 g, 
163.7 mmol) at room temperature was added commercial α-bromo-acetaldehyde 
dimethylacetal (5 g, 29.8 mmol).  The reaction mixture was heated to reflux for 45 h.  
The reaction then was cooled to room temperature and extracted with ether (75 mL).  The 
ether layer was washed successively with saturated aq. NaHCO3 (2x15 mL), brine (2x15 
mL) and then dried (Na2SO4).  The solvents were removed by rotary evaporation and the 
residue was purified by SiO2 column chromatography (hexane:EtOAc, 6:1, v/v; Rf = 
0.45) to give the corresponding α-(n-propoxy)-acetaldehyde dimethylacetal (3.13) (1.51 
g, 25% yield); 1H NMR (400 MHz, CDCl3) δ 4.50 (t, J = 5.2 Hz, 1H), 3.47 (d, J = 5.2 Hz, 
2H), 3.43 (t, J = 7.2 Hz, 2H), 3.39 (s, 6H), 1.61 (m, 2H), 0.91 (t, J = 7.6 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 102.7, 73.3, 70.4, 53.8, 22.7, 10.3. 
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n-Propoxyaldehyde (3.3) 
 To the propoxyacetal 3.13 (0.642 g, 4.33 mmol) in water (20 mL) was added p-
toluene sulfonic acid (PTSA) (3.296 g, 17.32 mmol).  The reaction was stirred 20 h at 
room temperature.  The reaction mixture then was extracted with ether (4x70 mL) and the 
combined organic extract was washed with brine (2x) and dried (Na2SO4).  The solvent 
was removed by rotary evaporation and the residue was purified by short path distillation 
(35 mbar, collect bp 42-45 °C), using an acetone - dry ice bath to cool the collection 
vessel, to give aldehyde 3 (0.36 g, 81% yield). !The spectral characterization of 3 was in 
agreement with published values.14  1H NMR (400 MHz, CDCl3) δ 9.73 (s, 1H), 4.05 (s, 
2H), 3.50 (t, J = 6.8 Hz, 2H), 1.62 (m, 2H), 0.93 (t, J = 6.8 Hz, 3H). 
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2-Propoxyacetaldehyde oxime (3.7)  
 Using the procedure outlined for synthesis of aldoxime 3.5, n-propoxyethanal 3.3 
(0.300 g, 2.89 mmol) was transformed to aldoxime 3.7 (0.191 g, 56% yield).  Purification 
by SiO2 column chromatography (hexane:EtOAc, 6:1, v/v; Rf = 0.20) gave aldoxime 3.7 
as a 1.2:1 mixture of E:Z isomers; 1H NMR (400 MHz, CDCl3) (E)-isomer: δ 7.50 (bs, 
1H), 4.08 (d, J = 5.6 Hz, 2H), 3.42 (t, J = 6.8 Hz, 2H), 1.61 (m, 2H), 0.92 (t, J = 6.8 Hz, 
3H); 13C NMR (100 MHz, CDCl3) (E)-isomer δ 148.4, 72.5, 67.3, 22.7, 10.4. 
 
 
 
2-Propoxyacetaldehyde O-(tert-butyldimethylsilyl) oxime (3.11)  
 Using the procedure outlined for synthesis of silyl aldoxime 3.9, n-
propoxyethanaldoxime 3.7 (0.034 g, 0.29 mmol) was transformed to silyl aldoxime 3.11 
(0.062 g, 62% yield).  Purification by SiO2 column chromatography (hexane:ether, 3:1, 
v/v; Rf = 0.75) gave silyl aldoxime 11 as a 1:1 mixture of E:Z isomers;  1H NMR (400 
MHz, CDCl3) (E)-isomer δ 7.56 (t, J = 5.6 Hz, 1H), 4.08 (d, J = 5.6 Hz, 2H), 3.40 (t, J = 
6.8 Hz, 2H), 1.60 (m, 2H), 0.93 (t, J = 9.2 Hz, 3H), 0.92 (s, 9H), 0.16 (s, 6H); 13C NMR 
(100 MHz, CDCl3) isomer mixture δ 155.6, 152.4, 73.3, 72.5, 67.7, 65.4, 26.2, 26.1, 23.0, 
23.0, 18.3, 18.3, 10.72, 10.71, –5.0, –5.1. 
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2-Heptanone oxime (3.6)  
 Using the procedure outlined for synthesis of aldoxime 3.5, 2-heptanone (3.2) (1.5 
g, 13.1 mmol) was transformed to 2-heptaketoxime 3.6 (1.25g, 74%).  Purification by 
SiO2 column chromatography (hexane:EtOAc, 2:1, v/v; Rf = 0.42) gave ketoxime 3.6 as a 
1:0.3 mixture of E:Z isomers.  The spectral characterization of 6 was in agreement with 
published values.15  1H NMR (400 MHz, CDCl3) (E)-isomer δ 2.17 (t, J = 8 Hz, 2H), 1.87 
(s, 3H), 1.50 (quin, J = 7.6, 7.2 Hz, 2H), 1.30 (m, 4H), 0.90 (t, J = 6.4 Hz, 3H).  
 
 
 
Heptan-2-one O-(tert-butyldimethylsilyl) oxime (3.10)  
 Using the procedure outlined for synthesis of silyl aldoxime 3.9, ketoxime 3.6 
(0.100 g, 0.77 mmol) was transformed to silyl ketoxime 3.10 (0.124 g, 66% yield).  
Purification by SiO2 column chromatography (hexane:EtOAc, 2:1, v/v; Rf = 0.76) gave 
silyl ketoxime 3.10 as a 1:0.3 mixture of E:Z isomers.  1H NMR (400 MHz, CDCl3) (E)-
isomer δ 2.17 (t, J = 7.6 Hz, 2H), 1.83 (s, 3H), 1.49 (m, 2H), 1.29 (m, 4H), 0.92 (s, 9H), 
0.87 (t, J = 6.8 Hz, 3H), 0.14 (s, 6H); 13C NMR (100 MHz, CDCl3) isomer mixture δ 
162.9, 162.3, 35.8, 32.0, 31.5, 29.2, 26.3, 26.3, 26.1, 25.5, 22.6, 20.1, 18.3, 14.1, 14.1, 
14.0, –5.0. 
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2-Propoxyacetic acid (3.14) 
 To a solution of a-bromoacetic acid (3.0 g, 21.6 mmol) in n-propanol (7.14 g, 119 
mmol) at 0 °C was added sodium hydroxide (1.29 g, 46.5 mmol).  The reaction mixture 
was heated to reflux for 12 h.  The reaction then was cooled to room temperature and 
basified using a small portion of aq. sodium hydroxide (1N) prior to removing the n-
propanol by rotary evaporation.  Water was added to the residue and the resultant mixture 
was washed with ether (3x), cooled to 0 °C and acidified with aq. HCl, and then extracted 
with EtOAc (3x).  The combined EtOAc layer was dried (Na2SO4).  Removal of the 
solvents by rotary evaporation gave the corresponding α-(n-propoxy)acetic acid (1.3 g, 
51% yield); 1H NMR (400 MHz, CDCl3) δ 4.11 (s, 2H), 3.50 (t, J = 6.8 Hz, 2H), 1.64 (m, 
2H), 0.93 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 175.4, 73.6, 67.6, 22.6, 
10.2.  
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1-Propoxypropan-2-one (3.4) 
 To a solution of α-(n-propoxy)acetic acid (0.234 g, 1.98 mmol) in dry diethyl 
ether (2 mL) at –78 °C was added dropwise a solution of methyl lithium (1.6M in Et2O, 
3.1 mL, 4.94 mmol).  The reaction mixture was stirred at –78 °C for 30 min and then 
warmed to room temperature.  After 4 h, the reaction mixture was cooled to 0 °C and 
quenched by addition of cold (0 °C) saturated aq. NH4Cl (3 mL).  The quenched mixture 
was extracted with ether (3x) and the combined organic extract was dried (Na2SO4).  The 
solvent was removed by rotary evaporation and the crude product was purified by short 
path distillation (35 mbar, collect bp 45-50 °C) to afford 3.4 (0.086 g, 37% yield).  The 
spectral characterization of 3.4 was in agreement with published values.16  1H NMR (400 
MHz, CDCl3) δ 4.00 (s, 2H), 3.42 (t, J = 6.8 Hz, 2H), 2.15 (s, 3H), 1.64 (m, 2H), 0.93 (t, 
J = 7.2 Hz, 3H). 
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1-Propoxypropan-2-one oxime (3.8)  
 Using the procedure outlined for synthesis of aldoxime 3.5, n-propoxyacetone 
(3.4) (0.086 g, 0.74 mmol) was transformed to ketoxime 3.8 (0.043 g, 44% yield).  
Purification by SiO2 column chromatography (hexane:ether, 2:1, v/v; Rf = 0.37) gave 
ketoxime 3.8 as a 1:0.17 mixture of E:Z isomers.  1H NMR (400 MHz, CDCl3) (E)-
isomer δ 3.98 (s, 2H), 3.35 (t, J = 6.8 Hz, 2H), 1.93 (s, 3H), 1.60 (m, 2H), 0.91 (t, J = 7.2 
Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 156.4, 73.1, 72.0, 71.8, 65.6, 22.7, 11.2, 10.5.  
 
 
 
 
1-Propoxypropan-2-one O-(tert-butyldimethylsilyl) oxime (3.12)  
 Using the procedure outlined for synthesis of silyl aldoxime 3.9, ketoxime 3.8 
(0.051 g, 0.39 mmol) was transformed to silyl ketoxime 3.12 (0.065 g, 68% yield).  
Purification by SiO2 column chromatography (hexane:ether, 2:1, v/v; Rf = 0.9) gave silyl 
ketoxime 3.12 as a 1:0.2 mixture of E:Z isomers.  1H NMR (400 MHz, CDCl3) (E)-
isomer δ 3.99 (s, 2H), 3.33 (t, J = 6.4 Hz, 2H), 1.91 (s, 3H), 1.57 (m, 2H), 0.93 (s, 9H), 
0.91 (t, J = 7.2 Hz, 3H), 0.15 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 159.9, 73.2, 72.2, 
72.0, 66.5, 26.2, 26.2, 25.9, 23.0, 23.0, 18.3, 18.2, 16.7, 12.0, 10.7, –2.7, –5.03, –5.07. 
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Gas Chromatography-Mass Spectrometry Procedures 
 The GC/TOF-MS analyses were performed on a LECO Pegasus® 4D time-of-
flight mass spectrometer (LECO Corporation, St. Joseph, MI) equipped with a Gerstel 
MPS2 auto-sampler (GERSTEL Inc, Linthicum, MD).  The Pegasus 4D GC GC/TOF-
MS instrument was equipped with an Agilent 6890 gas chromatograph featuring a LECO 
two-stage cryogenic modulator and a secondary oven.  A 30 m x 0.25 mm 1dc x 0.25 µm 
1df, DB-225 GC capillary column [(50%-phenyl)-dimethylpolysiloxane] (Agilent 
Technologies J&W, Santa Clara, CA) was used as the primary column for the 
GCxGC/TOF-MS analysis.  A second column of 2 m x 0.18 µm 2dc x 0.25 µm 2df, DB-
5MS [(5%-cyanopropylphenyl)dimethylpolysiloxane] (Agilent Technologies J&W, Santa 
Clara, CA) was placed inside the secondary oven after the thermal modulator.  The 
helium carrier gas flow rate was set to 1.0 mL/min at a corrected constant flow via 
pressure ramps.  A 2.0 µL liquid sample was injected into the liner using the split mode 
(25 : 1), with the injection port temperature set at 250 °C.  The primary column 
temperature was programmed with an initial temperature of 60 °C for 0.5 min and then 
increased at a rate of 10 °C/ min to 210 °C. The secondary column temperature program 
was set to an initial temperature of 65 °C for 0.5min and then increased at the same 
temperature gradient employed in the first column up to a temperature of 215 °C 
accordingly.  The thermal modulator was set to +20 °C relative to the primary oven, and 
a modulation time of 0s was used, which allowed the instrument to be operated in the 
GC/TOF-MS mode.  The MS mass range was m/z = 25–500 with an acquisition rate of 10 
spectra per second.  The ion source chamber was set at 230 °C with the MS transfer line 
temperature set to 225 °C, the detector voltage was set at 1600 V, and the electron energy 
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for ionization was set at 70 eV.  The ion acceleration voltage was turned on after a 
solvent delay of 168s. LECO’s ChromaTOF software package (version 4.21) equipped 
with the National Institute of Standards and Technology (NIST) MS database (NIST MS 
Search 2.0, NIST/EPA/NIH Mass Spectral Library; NIST 2002) was used for instrument 
control, spectrum deconvolution and metabolite identification in all experiments.  These 
parameters are baseline offset = 0.5; smoothing = auto; peak width = 1s; signal-to-noise 
ratio (S/N) = 4; mass threshold = 100; minimum forward similarity match before name is 
assigned = 600.  The peak true spectrum was also exported as part of the information for 
each peak in absolute format of intensity values. 
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Quantum Chemical Calculations 
 Dean Tantillo and his graduate students Osvaldo Gutierrez and Jason Harrison 
performed all theoretical calculations.   
 All structures were optimized at the UB3LYP/6-31 G(d) level of theory17 with the 
guess = (mix,always) keyword as implemented in the GAUSSIAN03 suite of programs,18 
unless otherwise noted.  Some selected structures were also optimized at the UB3LYP/6-
311++G(2d,2p) level of theory to investigate the effect of a larger basis set.  Although 
B3LYP has been used previously, with success, for studies of neutral and radical cation 
pericyclic reactions,19 selected structures were also optimized using UM06-2X/6-31 
G(d),20 UMP2/6-31 G(d),21 and SCS-UMP2/6-31G(d)22 as implemented in 
GAUSSIAN09.23  All stationary points were characterized as minima or transition state 
structures by vibrational analysis, and intrinsic reaction coordinate calculations24 were 
performed for selected transition state structures to confirm their connections to 
surrounding minima.  Structural drawings were produced using Ball & Stick.25 
In order for the McLafferty rearrangement to take place, another structural 
feature, beside the characteristics described in Chapter 3, must be fulfilled: the γ-
hydrogen must be properly aligned for the initial H-transfer.  In other words, the 
conformation of the alkyl side-chain must be favorable.  For all compounds two 
conformations are important: R1-trans and R2-gauche (see Scheme 6.1).  !
!
Scheme 6.1. The R1-trans and R2-gauche equilibrium. 
X
R Y
X
R Y
R1-trans R2-gauche
R = H, CH3;  X = O, NOH, NOSi(CH3)3;  Y = CH2, O
! 205!
It is clear that only the R2-gauche conformation can undergo the McLafferty 
rearrangement.  The results of calculations to determine the relative energies of the 
twelve compounds investigated are shown in Table 6.1. 
 
Table 6.1. Relative energies (R&UB3LYP/6-31G(d); 298.15 K; kcal/mol) for the species 
involved in the R1-trans and R2-gauche equilibrium. !
     Neutral Odd-electron 
positive ion 
  
Class Entry R X Y R1 R2 R1 R2 EI 
(eV) 
EI 
(kcal/mol) 
Aldehyde/Ketone 1 H O CH2 0.0 0.4 4.4 0.0 9.1 209.1 
 2 CH3 O CH2 0.0 0.9 3.0 0.0 8.7 201.5 
 3 H O O 0.9 0.0 N/A 0.0 8.7 201.6 
 4 CH3 O O 1.3 0.0 N/A 0.0 8.4 193.0 
Oxime 5 H NOH CH2 0.0 0.9 2.0 0.0 8.8 201.9 
 6 CH3 NOH CH2 0.0 1.0 0.0 0.0 8.4 194.2 
 7 H NOH O 0.6 0.0 0.0 0.6 8.6 198.9 
 8 CH3 NOH O 0.6 0.0 0.0 0.6 8.3 191.6 
Silyl oxime 9 H NOSiH3 CH2 0.0 0.9 0.0 0.0 8.5 197.1 
 10 CH3 NOSiH3 CH2 0.0 1.0 0.0 0.4 8.3 190.3 
 11 H NOSiH3 O 0.5 0.0 0.0 1.0 8.5 195.4 
 12 CH3 NOSiH3 O 0.6 0.0 0.0 1.5 8.2 188.5 
 
It can be seen that except for compounds 3.1 and 3.2 in the odd-electron positive 
ions state, the relative energy differences are quite small and that there tends to be a 
preference for the R1-trans conformations in the neutral state and for the R2-gauche 
conformation in the ionized state.  For the oxime and silyl oxime ether compounds the 
preference disappears or even reverses.  The reversed R1-trans preference when Y = CH2 
can be understood if one takes into account the donation of the lone pair on oxygen to the 
σ*C–C bond.  If the barrier height between the R1-trans and R2-gauche conformations is 
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not too high then at the calculated relative energies conversion between the 
conformations might take place.  However, it is not clear if this will positively, or 
negatively, influence the extent to which the McLafferty rearrangement is taking place in 
the odd-electron positive ions of compounds. !!
!
 
Figure 6.1. Overview of the McLafferty reverse charge rearrangement thermochemistry 
for the twelve model compounds 3.1-3.12. 
! 207!
6.D.  Experimental Procedures of Chapter 4 
Synthesis 
 
(Dimethylsilanediyl)bis(methylene) dipropionate (4.1) 
 To a solution of bis(chloromethyl)dimethylsilane 4.0 (1.04 g, 6.63 mmol) in 
propionic acid (2 mL, 26.7 mmol) at 0 °C was added dropwise triethylamine (5.6 mL, 
39.8 mmol).  The reaction mixture was stirred at 0 °C for 5 min and then heated to reflux.  
After 12 h, the reaction mixture was allowed to cool to room temperature.  The solution 
was then diluted by addition of Et2O (40 mL) and filtered to remove triethylamine salt.  
The filtrate was washed successively with saturated aq NaHCO3 and brine (2 x 10 mL) 
and the organic layer was dried (Na2SO4).  The solvent was removed by rotary 
evaporation, and the crude residue was purified by column chromatography (SiO2, 
hexane/ethyl acetate, 6:2, v/v; Rf = 0.49) to afford 4.1 (1.39 g, 90%) as a colorless oil.  1H 
NMR (400 MHz, CDCl3) δ 3.84 (s, 2H), 2.33 (q, J = 7.2 Hz, 2H), 1.14 (t, J = 7.2 Hz, 
3H), 0.14 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 175.2, 55.4, 27.6, 9.5, -5.8. 
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(Benzyloxy)(chloromethyl)dimethylsilane (4.3) 
 To a solution of benzyl alcohol (1.96 g, 18.2 mmol) and imidazole (1.23 g, 18.21 
mmol) in dry CH2Cl2 (10 mL) at 0 °C, was added dropwise via syringe 
chloromethyl(dimethylsilylchloride) 4.2 (2.17 g, 15.2 mmol).  The reaction was stirred 
and allowed to come to room temperature.  After 2 h stirring at room temperature, the 
solution was concentrated by rotary evaporation.  The residue was diluted in Et2O (10 
mL) and filtered.  The filtrate was concentrated by rotary evaporation and the resulting 
crude was purified by column chromatography (SiO2, hexane/ethyl acetate/Et2O, 8:1:2, 
v/v) to afford the desired product 4.3 as clear oil (1.65 g, 51%).  1H NMR (400 MHz, 
CDCl3) δ 7.27-7.18 (m, 5H), 4.71 (s, 2H), 2.72 (s, 2H), 0.21 (s, 6H); 13C NMR (100 
MHz, CDCl3) δ 140.4, 128.5, 127.5, 126.7, 65.6, 29.7, -3.3. 
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((Benzyloxy)dimethylsilyl)methyl propionate (POMS-OBn) 
 To a solution of CsF (0.3g, 1.97 mmol) in anhydrous DMF (5 mL) under N2 
atmosphere was added via syringe O-trimethylsilylpropionic acid (0.315g, 2.15 mmol).  
The solution was stirred 20 min at room temperature and then chloromethylbenzyl silane 
4.3 (0.366 g, 1.7 mmol) was added dropwise via syringe.  The resulting solution was 
heated to 45 °C for 4h and then was allowed to cool to room temperature.  The solvents 
were removed by rotary evaporation and the resulting crude was analyzed by GC-MS and 
1H NMR (400 MHz, CDCl3) δ 7.35-7.23 (m, 5H), 4.73 (s, 2H), 3.79 (s, 2H), 2.30 (q, J = 
8 Hz, 2H), 1.11 (t, J = 8 Hz, 3H), 0.18 (s, 6H). 
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(1,1,3,3-Tetramethyldisiloxane-1,3-diyl)bis(methylene) dipropionate (4.5) 
 To a solution of chloromethyldimethylsiloxane (4.4) (5.0 g, 21.6 mmol) in 
propionic acid (4.85 mL, 64.8 mmol) at 0 °C was added dropwise triethylamine (8.8 mL, 
62.7 mmol).  The reaction mixture was stirred at 0 °C for 5 min and then heated to 100 
°C.  After 20 h, the reaction mixture was allowed to cool to room temperature.  The 
solution was then diluted by addition of Et2O (20 mL) and filtered to remove 
triethylamine salt.  The filtrate was washed successively with saturated aq NaHCO3 and 
brine (2 x 15 mL) and the organic layer was dried (Na2SO4).  The solvent was removed 
by rotary evaporation, and the crude residue was purified by column chromatography 
(SiO2, hexane/ethyl acetate, 6:2, v/v) to afford 4.5 (6.16 g, 93% yield) as a clear liquid.  
1H NMR (400 MHz, CDCl3) δ 3.71 (s, 2H), 2.34 (q, J = 7.6 Hz, 2H), 1.14 (t, J = 7.6 Hz, 
3H), 0.15 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 175.1, 57.5, 27.5, 9.3, -1.0. 
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(Dimethylsilanediyl)bis(methylene) diacetate (4.12) 
 To a solution of bis(chloromethyl)dimethylsilane 4.0 (1.02 g, 6.5 mmol) in acetic 
acid (2.24 mL, 37.2 mmol) at 0 °C was added dropwise triethylamine (8.24 mL, 58.7 
mmol).  The reaction mixture was stirred at 0 °C for 5 min and then heated to reflux.  
After 19 h, the reaction mixture was allowed to cool to room temperature.  The solution 
was then diluted by addition of Et2O (40 mL) and filtered to remove triethylamine salt.  
The filtrate was washed successively with saturated aq NaHCO3 and brine (2 x 10 mL) 
and the organic layer was dried (Na2SO4).  The solvent was removed by rotary 
evaporation, and the crude residue was purified by column chromatography (SiO2, 
hexane/ethyl acetate, 6:2, v/v; Rf = 0.47) to afford 4.12 (1.33 g, 100%) as a colorless oil, 
having spectral characteristics in agreement with published data.26 1H NMR (400 MHz, 
CDCl3) δ 3.84 (s, 2H), 2.04 (s, 3H), 0.144 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 171.9, 
55.7, 20.9, -5.7.  
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(Dimethylsilanediyl)dimethanol (3.13) 
 To a solution of lithium hydroxide (0.66 g, 15.8 mmol) in MeOH/H2O (8:3, v/v, 
11 mL) at 0 °C was slowly added a solution of the bisacetate 4.12 (0.54 g, 2.6 mmol) in 
tetrahydrofuran (2 mL).  The reaction mixture was stirred at 0 °C for 30 min and then 
warmed to room temperature.  After 4 h, the reaction mixture was extracted with Et2O 
(3x) and the combined organic extract was washed with brine (2x) and then dried 
(Na2SO4).  The solvents were removed by rotary evaporation and the crude product was 
purified by column chromatography (SiO2, CH2Cl2/MeOH, 9:1, v/v; Rf = 0.35) to afford 
4.13 (0.28 g, 89%) as a colorless oil having spectral characteristics in agreement with 
published data.26    1H NMR (400 MHz, CDCl3) δ 3.58 (s, 2H), 1.80 (bb, 2H), 0.121 (s, 
3H); 13C NMR (100 MHz, CDCl3) δ 55.4, -6.5. 
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2-(((Hydroxymethyl)dimethylsilyl)methoxy)isoindoline-1,3-dione (4.14) 
 To a solution of silanediol 4.13 (0.28 g, 2.33 mmol), N-hydroxyphthalimide (0.34 
g, 2.1 mmol), and triphenylphosphine (0.55 g, 2.1 mmol) in dry THF (15 mL) under N2 at 
0°C was added dropwise diisopropyl azodicarboxylate (0.5 mL, 2.5 mmol) by syringe.  
The solution quickly turned a dark yellow-orange.  The reaction flask was then allowed 
to return to room temperature.  After 12h, the mixture then was concentrated by rotary 
evaporation, diluted with EtOAc (60 mL), transferred to a separatory funnel, and washed 
successively with saturated aq NaHCO3 and brine (2 x 15 mL).  The organic layer was 
then dried over Na2SO4, concentrated by rotary evaporation, and the crude residue was 
purified by column chromatography (SiO2, CH2Cl2 /ethyl acetate/Et2O/hexane, 3:3:3:1, 
v/v; Rf = 0.48) to afford 4.14 (0.49 g, 79%).  1H NMR (400 MHz, CDCl3) δ 7.60 (m, 2H), 
5.52 (m, 2H), 4.00 (s, 2H), 3.41 (s, 2H), 1.90 (bb, 1H), 0.00 (s, 6H); 13C NMR (100 MHz, 
CDCl3) δ 163.6, 134.7, 129.17, 123.8, 73.06, 53.9, −6.3. 
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((((1,3-Dioxoisoindolin-2-yl)oxy)methyl)dimethylsilyl)methyl propionate (4.9) 
 To mono-phthalimide alcohol 4.14 (0.19 g, 0.72 mmol) in dry dichloromethane (5 
mL) at room temperature was added propionic acid (0.08 g, 1.1 mmol).  After cooling the 
resulting solution at 0 °C were added N,N’-diisopropylcarbodiimide (0.54 mL, 3.5 mmol) 
and a pinch of DMAP.  The reaction was stirred at 0 °C for 10 min, and then allowed to 
come to room temperature.  After being stirred at room temperature for 1h the solution 
was filtered, and the filtrate was concentrated by rotary evaporation.  The crude residue 
was purified by column chromatography (SiO2, dichloromethane/hexane/ethyl acetate, 
2:2:1, v/v; Rf = 0.66) to 4.9 (0.2 g, 90% yield).  1H NMR (500 MHz, CDCl3) δ 7.82 (m, 
2H), 7.73 (m, 2H), 4.16 (s, 2H), 3.95 (s, 2H), 2.35 (q, J = 8 Hz, 2H), 1.15 (t, J = 8 Hz, 
3H), 0.28 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 175.4, 163.3, 134.5, 129.3, 123.6, 72.4, 
55.2, 27.6, 9.5, -5.9. 
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(((Aminooxy)methyl)dimethylsilyl)methyl propionate (POMS-ONH2) 
 To the propionyloxymethylphthalimide silane 4.9 (0.03 g, 0.1 mmol) in 
dichloromethane  (5 mL) at 0 °C was added hydrazine (23 µL, 0.5 mmol).  After being 
was stirred at 0 °C for 5 min.  The reaction flask was then allowed to return to room 
temperature.  After 1h at room temperature, the mixture was filtered and the filtrate was 
concentrated by rotary evaporation.  The crude residue was purified by column 
chromatography (SiO2, dichloromethane/methanol, 95:5, v/v to afford POMS-ONH2 (17 
mg, 92%) as a clear liquid.  1H NMR (400 MHz, CDCl3) δ 5.48 (bb, 2H), 3.84 (s, 2H), 
3.58 (s, 2H), 2.33 (q, J = 8 Hz, 2H), 1.14 (t, J = 8 Hz, 3H), 0.11 (s, 6H); 13C NMR (100 
MHz, CDCl3) δ = 175.4, 69.3, 55.8, 27.7, 9.6, -5.7. 
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((((1,3-Dioxoisoindolin-2-yl)oxy)methyl)dimethylsilyl)methyl 2,2-2H2-propionate  
(d2-4.9) 
 Using the same procedure outlined for the synthesis of 4.9, mono-phthalimide 
alcohol 4.14 (0.17 g, 0.64 mmol) was reacted with 2,2-2H3-propionic acid (0.076 g, 1.0 
mmol), N,N’-diisopropylcarbodiimide (490 µL, 0.63 mmol) and DMAP (cat.) to afford 
d2-4.9 (0.19g, 93% yield); 1H NMR (400 MHz, CDCl3) δ 7.82 (m, 2H), 7.73 (m, 2H), 
4.16 (s, 2H), 3.95 (s, 2H), 1.13 (s, 3H), 0.28 (s, 6H); 13C NMR (100 MHz, CDCl3) 
δ 175.5, 163.3, 134.6, 129.3, 123.6, 72.4, 55.2, 9.4, −5.9. 
 
 
 
(((Aminooxy)methyl)dimethylsilyl)methyl 2,2-2H2-propionate (d2-POMS-ONH2) 
 Using the same procedure for the synthesis of POMS-ONH2, ester phthalimide 
d2-4.9 (0.03 g, 0.09 mmol) was reacted with hydrazine (19 µL, 0.39 mmol) to afford d2-
POMS-ONH2 (13 mg, 91% yield); 1H NMR (400 MHz, CDCl3) δ 5.48 (bb, 2H), 3.84 (s, 
2H), 3.58 (s, 2H), 1.13 (s, 3H), 0.12 (s, 6H); 13C NMR (100 MHz, CDCl3) 
δ 175.4, 69.3, 55.7, 9.4, −5.7. 
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((((1,3-Dioxoisoindolin-2-yl)oxy)methyl)dimethylsilyl)methyl 2,2,3,3,3-2H2-
propionate (d5-4.9) 
 Using the same procedure outlined for the synthesis of 4.9, mono-phthalimide 
alcohol 4.14 (0.18 g, 0.68 mmol) was reacted with 2,2,3,3,3-2H3-propionic acid (85 mg, 
1.07 mmol), N,N’-diisopropylcarbodiimide (516 µL, 3.33 mmol) and DMAP (cat.) to 
afford d5-4.9 (0.19g, 89% yield); 1H NMR (400 MHz, CDCl3) δ 7.82 (m, 2H), 7.73 (m, 
2H), 4.16 (s, 4H), 3.95 (s, 2H), 0.28 (s, 6H); 13C NMR (100 MHz, CDCl3) 
δ 175.5, 163.3, 134.6, 129.3, 123.6, 72.4, 55.2, −5.9. 
 
 
 
 
(((aminooxy)methyl)dimethylsilyl)methyl 2,2,3,3,3-2H2-propionate (d5-POMS-ONH2) 
 Using the same procedure for the synthesis of POMS-ONH2, ester phthalimide 
d5-4.9 (0.03 g, 0.09 mmol) was reacted with hydrazine (20 µL, 0.41 mmol) to afford d5-
POMS-ONH2 (13 mg, 81% yield); 1H NMR (400 MHz, CDCl3) δ 5.47 (bb, 2H), 3.84 (s, 
2H), 3.58 (s, 2H), 0.12 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 175.4, 69.3, 55.7, −5.7. 
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1,3-Dioxoisoindolin-2-yl propionate (4.15) 
 To a solution of N-hydroxyphthalimide (0.363 g, 2.22mmol) in CH2Cl2 (7 mL), 
was added propionic acid (0.15 g, 2.0mmol), N,N'-Dicyclohexylcarbodiimide (1.25 g, 6.0 
mmol) and a pintch of DMAP.  After being stirred at room temperature for 1.5 h, the 
solution was diluted in Et2O and filtered.  The filtrate was concentrated by rotary 
evaporation and the resulting crude was purified by column chromatography (SiO2, 
hexane/ethyl acetate, 6:4, v/v) to afford the desired phthalimide ester 4.15 (0.27 g, 61%).  
1H NMR (500 MHz, CDCl3) δ 7.88 (m, 2H), 7.79 (m, 2H), 2.70 (q, J = 8 Hz, 2H), 1.31 (t, 
J = 8 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 170.6, 162.2, 134.9, 129.2, 124.2, 24.7, 8.9. 
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Naphthalen-1-ylmethyl acetate (4.19a) 
 To a solution of 1-naphthalenemethanol (2g, 12.64 mmol) in dry CH2Cl2 (10 mL) 
at 0 °C, was added glacial acetic acid (0.91 g, 15.17 mmol), diisopropylcarbodiimide (2.9 
mL, 18.96 mmol) and DMAP (cat.).  After stirring for 10 min at 0 °C, the reaction was 
allowed to come to room temperature.  After stirring at room temperature for 1.5h, the 
reaction was diluted in Et2O and filtered. The filtrate was concentrated by rotary 
evaporation and the resulting crude was purified by column chromatography (SiO2, 
hexane:ethyl acetate, 7:2, v/v; Rf = 0.48) to afford ester 4.19a (2.5 g, 82% yield) as a thick 
oil.  1H NMR (400 MHz, CDCl3) δ 8.02 (d, J = 8.4 Hz, 1H), 7.90-7.85 (m, 2H), 7.58-7.46 
(m, 4H), 5.59 (s, 2H), 2.12 (s, 3H); 13C NMR (100 MHz, CDCl3) 
δ 171.6, 133.9, 131.8, 131.6, 129.5, 128.9, 127.7, 126.7, 126.2, 125.5, 123.7, 64.8, 21.2. 
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naphthalen-1-ylmethyl 2-13C-acetate (4.19b) 
 Using the same procedure outlined for the synthesis of naphthalene acetate 4.19a, 
13C-labeled acetic acid (1 g, 16.38 mmol), 1-naphthalenemethanol (3.1 g, 19.65 mmol), 
diisopropylcarbodiimide (3.8 mL, 24.57 mmol), and DMAP (cat.) were reacted to afford 
4.19-b (3.33 g, 100%).  1H NMR (700 MHz, CDCl3) δ 8.02 (d, J = 8.4 Hz, 1H), 7.89 (d, J 
= 7.7 Hz, 1H), 7.85 (d, J = 7.7 Hz, 1H), 7.58-7.52 (m, 3H), 7.44 (t, J = 7.0 Hz, 1H), 5.58 
(s, 2H), 2.33 (d, 129.5 Hz, 2H); 13C NMR (175 MHz, CDCl3) 
δ  133.9, 131.8, 131.6, 129.5, 128.9, 127.7, 126.7, 126.2, 125.5, 123.8, 64.8, 21.3. 
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Naphthalen-1-ylmethyl 3-13C-3,3,3-2H-propionate (4.20a) 
 To a solution of naphthalene acetate 4.19a (2.88 g, 14.38 mmol) in dry THF (15 
mL) under N2 atmosphere at -78 °C, was added dropwise a 1M solution of lithium 
bis(trimethylsilyl)amide in THF (13.7 mL, 13.7 mmol).  After stirring at -78 °C for 15 
minutes, 13CD3-labeled iodomethane was added to the reaction via syringe.  The reaction 
was left at -78 °C for 3h and then was allowed to come to room temperature. After 
stirring for 3h at room temperature, the reaction was cooled to 0 °C and the reaction was 
quenched by adding dropwise cold saturated aq. solution of NH4Cl (15 mL).  The 
resulting solution was then extracted with Et2O (3 x 20 mL) and the combined organic 
layers were washed with brine (2 x 10 mL) and dried over Na2SO4.  The solvents were 
removed by rotary evaporation and the resulting crude was purified by column 
chromatography (SiO2, hexane:ethyl acetate, 9:1, v/v; Rf = 0.36) to afford naphthalene 
propionate ester 4.20-a (1.4 g, 47%).  1H NMR (400 MHz, CDCl3) δ 8.02 (d, J = 8.4 Hz, 
1H), 7.89 (d, J = 7.6 Hz, 1H), 7.85 (d, J = 7.6 Hz, 1H), 7.58-7.52 (m, 3H), 7.44 (t, J = 7.2 
Hz, 1H), 5.58 (s, 2H), 2.36 (bs, 2H); 13C NMR (175 MHz, CDCl3) δ  174.3, 
133.9, 131.84, 131.81, 129.4, 128.9, 127.6, 126.7, 126.6, 126.1, 125.5, 123.8, 64.7, 27.7-
27.5 (m), 8.9-8.3 (m). 
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Naphthalen-1-ylmethyl 2,3-13C2-3,3,3-2H-propionate (4.20b) 
 Using the same procedure outlined for the synthesis of labeled naphthalene 
propionate 4.20a, 13C-labeled naphthalene acetate 4.19b (2.9 g, 14.41 mmol), lithium 
bis(trimethylsilyl)amide (13.7 mL, 13.7 mmol), and 13CD3-labeled iodomethane were 
reacted to give the desired labeled naphthalene propionate ester 4.20b (1.245g, 41%).  1H 
NMR (400 MHz, CDCl3) δ 8.02 (d, J = 8.4 Hz, 1H), 7.89 (d, J = 7.6 Hz, 1H), 7.85 (d, J = 
7.6 Hz, 1H), 7.58-7.52 (m, 3H), 7.44 (t, J = 7.2 Hz, 1H), 5.58 (s, 2H), 2.36 (dd, J = 4.2, 
128.4 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 133.9, 131.8, 129.4, 128.9, 127.6, 126.7, 
126.1, 125.5, 123.78, 64.7, 27.7-27.4 (m), 9.1-7.9 (m). 
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3-13C-3,3,3-2H-propionic acid (Propionic acid-33) 
 To propionate naphthalene ester 4.20a (1.4 g, 6.45 mmol) in THF (4 mL), was 
added a solution of NaOH (1.03 g, 25 mmol) in water/MeOH (2:1, 12 mL).  After stirring 
the reaction for 4h at room temperature, the resulting solution was extracted with Et2O (4 
x 15 mL).  The aqueous layer was the concentrated by rotary evaporation to remove all 
traces of MeOH.  The resulting solution was the acidified using concentrated HCl until 
pH 2, and NaCl was added until saturation.  The resulting aqueous solution was then 
extracted with Et2O (4 x 15 mL), the organic layers were combined and dried over 
Na2SO4, and the solvent was carefully removed by rotary evaporation.  The resulting 
concentrate containing Propionic acid-33 was directly used for the synthesis of 4.18-c. 
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2,3-13C2-3,3,3-2H-propionic acid (Propionic acid-34) 
 Using the same procedure outlined for the synthesis of Propionic acid-33, labeled 
naphthalene propionate 4.20b (1.24 g, 5.67 mmol) in THF (4 mL) and NaOH (0.9 g, 22.7 
mmol) in water/MeOH (2:1, 12 mL) were reacted to give labeled Propionic acid-44.  
The product was directly used for the the synthesis of 4.18-d. 
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N-(2-hydroxyethoxy)phthalimide (4.17).  
 To 2-bromoethanol (3.00 g, 24.00 mmol) in DMF (15 mL) at room temperature 
were added N-hydroxyphthalimide (4.30 g, 26.35 mmol) and triethylamine (3.71 mL, 
26.40 mmol).  The reaction mixture then was stirred at 75 °C for 24 h whereupon the 
reaction was allowed to cool to room temperature and then diluted by addition of Et2O 
(20 mL).  The resulting solution was filtered to remove the precipitated triethylamine salt, 
and the filtrate was concentrated by rotary evaporation.  The resulting paste was 
dissolved in EtOAc (70 mL) and washed successively with saturated aq. NaHCO3 until 
the aqueous layer remained clear, and then brine (2 X 10 mL).  The organic layer was 
dried (Na2SO4) and the solvent was removed by rotary evaporation to afford phthalimide 
4.17 (3.65 g, 73%) as a pale yellow solid, mp. 74-76 ºC, (lit. 82-84 ºC) having spectral 
characteristics in agreement with published data.27  1H NMR (400 MHz, CDCl3) δ 7.84 
(m, 2H), 7.76 (m, 2H), 4.28 (t, J = 4.4 Hz, 2H), 3.79 (t, J = 4.4 Hz, 2H), 3.51 (br s, 1H); 
13C NMR (100 MHz) δ 164.6, 135.0, 128.9, 124.0, 80.1, 59.7. 
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2-((1,3-Dioxoisoindolin-2-yl)oxy)ethyl 3,3,3-2H3-propionate (4.18-b).   
 To phthalimide 4.17 (1.48 g, 7.13 mmol) in dichloromethane (8 mL) at room 
temperature was added 3,3,3-2H3-propionic acid (0.5 g, 6.48 mmol).  After cooling the 
resulting solution to 0 °C, N,N’-diisopropylcarbodiimide (1.5 mL, 9.72 mmol) and 
DMAP (cat.) were added.  The reaction mixture was stirred at 0 °C for 5 min, and then 
allowed to warm to room temperature.  After stirring at room temperature for 1h the 
reaction mixture was filtered and the filtrate was concentrated by rotary evaporation.  The 
crude residue was purified by column chromatography (SiO2, 
dichloromethane:hexane:ethyl acetate, 3:1:1, v/v; Rf = 0.62) to afford ester 4.18-b (1.30 g, 
76% yield) as a white solid, mp. 56.5-58.5 ºC; 1H NMR (400 MHz, CDCl3) δ 7.84 (m, 
2H), 7.75 (m, 2H), 4.42 (s, 4H), 2.33 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 174.5, 
163.5, 134.8, 129.0, 123.8, 76.0, 61.9, 27.3; FT-ICR-MS (ESI+, m/z) calcd for 
C13H11D3NO5, [M + H]+ 267.1055, found 267.1058.  
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2-(Aminooxy)ethyl 3,3,3-2H3-propionate (AEP-32).   
 To ester 4.18-b (1.30 g, 4.90 mmol) in dichloromethane  (10 mL) at 0 °C was 
added methylhydrazine (284 mL, 5.38 mmol).  After stirring at 0 °C for 45 min, the 
reaction mixture was filtered and the filtrate was concentrated by rotary evaporation.  The 
crude residue was passed through a short column of SiO2, eluting with 
dichloromethane:methanol, 95:5, v/v (Rf = 0.47), to afford a light yellow liquid.  
Kugelrohr distillation of the product (5 mmHg, collect at 80 °C) afforded AEP-32 (0.56 
g, 84% yield) as a clear liquid; 1H NMR (400 MHz, CDCl3) δ 5.29 (br. s, 2H), 4.28 (t, J = 
4.4 Hz, 2H), 3.83 (t, J = 4.4 Hz, 2H), 2.33 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 174.8, 
73.7, 62.1, 27.4; IR (neat) 3324, 1729, 1590, 1461, 1180, 1080, 1046 cm-1; FT-ICR-MS 
(ESI+, m/z) calcd for C5H9D3NO3, [M + H]+ 137.1000, found 137.1000. 
 
 
 
 
 
 
AEP-32
O O NH2
O
D3C
! 228!
 
2-((1,3-Dioxoisoindolin-2-yl)oxy)ethyl 3-13C1-3,3,3-2H3-propionate (5b).   
 Using the general procedure outlined for the synthesis of ester 4.18-b, 
phthalimide 4.17 (1.07 g, 5.16 mmol) was reacted with 3-13C1-3,3,3-2H3-propionic acid 
(0.366 g, 4.69 mmol), N,N’-diisopropylcarbodiimide (1.09 mL, 7.03 mmol) and DMAP 
(cat.) to afford ester 4.18-c (1.13g, 90% yield); 1H NMR (400 MHz, CDCl3) δ 7.83 (m, 
2H), 7.75 (m, 2H), 4.42 (s, 4H), 2.33 (d, J = 3.6 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 
174.5, 163.5, 134.8, 129.0, 123.8, 76.9, 76.1, 61.9, 27.5, 27.1, 9.0-7.8 (m); FT-ICR-MS 
(ESI+, m/z) calcd for C1213CH11D3NO5, [M + H]+ 268.1088, found 268.1095. 
 
 
 
2-(Aminooxy)ethyl 3-13C1-3,3,3-2H3-propionate (AEP-33).   
 Using the general procedure for the synthesis of AEP-32, ester 4.18-c (1.29 g, 
4.84 mmol) was reacted with methylhydrazine (280 mL, 5.33 mmol) to afford AEP-33 
(0.514 g, 77% yield); 1H NMR (400 MHz, CDCl3) δ 5.52 (br. s, 2H), 4.30 (t, J = 4.4 Hz, 
2H), 3.84 (t, J = 4.4 Hz, 2H), 2.35 (d, J = 3.6 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 
174.8, 73.7, 62.1, 27.6, 27.3, 9.1-7.9 (m); FT-ICR-MS (ESI+, m/z) calcd for 
C413CH9D3NO3, [M + H]+ 138.1034, found 138.1033. 
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2-((1,3-Dioxoisoindolin-2-yl)oxy)ethyl 2,3-13C2-3,3,3-2H3-propionate (5c).   
 Using the general procedure outlined for the synthesis of ester 4.18-b, 
phthalimide 4.17 (1.03 g, 4.99 mmol) was reacted with 2,3-13C2-3,3,3-2H3-propionic acid 
(0.33 g, 4.15 mmol), N,N’-diisopropylcarbodiimide (0.96 mL, 6.23 mmol) and DMAP 
(cat.) to afford ester 4.18-d (0.96 g, 87% yield); 1H NMR (400 MHz, CDCl3) δ 7.83 (m, 
2H), 7.75 (m, 2H), 4.42 (s, 4H), 2.33 (dd, J = 4.2, 128.4 Hz, 2H); 13C NMR (100 MHz, 
CDCl3) δ 163.5, 134.8, 129.0, 123.8, 76.1, 61.9, 27.8-27.1 (m), 9.1-7.6 (m); FT-ICR-MS 
(ESI+, m/z) calcd for C1113C2H10D3NNaO5, [M + Na]+ 291.0941, found 291.0959. 
 
 
 
2-(Aminooxy)ethyl 2,3-13C2-3,3,3-2H3-propionate (AEP-34).   
 Using the general procedure for the synthesis of AEP-32, ester 4.18-d (0.95 g, 
3.55 mmol) was reacted with methylhydrazine (205 mL, 3.90 mmol) to afford AEP-34 
(0.404 g, 83% yield); 1H NMR (400 MHz, CDCl3) δ 5.52 (br. s, 2H), 4.29 (t, J = 4.4 Hz, 
2H), 3.83 (t, J = 4.4 Hz, 2H), 2.35 (dd, J = 3.6, 128.4 Hz, 2H); 13C NMR (100 MHz, 
CDCl3) δ 73.7, 62.1, 27.6- 27.3 (m), 9.1-7.9 (m); FT-ICR-MS (ESI+, m/z) calcd for 
C313C2H9D3NO3, [M + H]+ 139.1067, found 139.1069. 
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2,5-Dioxopyrrolidin-1-yl 3,3,3-2H3-propionate (NHS-32) 
 To N-hydroxysuccinimide (0.360 g, 3.12 mmol) in dry dichloromethane (8 mL) at 
room temperature was added 3,3,3-2H3-propionic acid (0.2 g, 2.26 mmol).  After cooling 
the resulting solution to 0 °C, N,N’-diisopropylcarbodiimide (0.490 mL, 3.12 mmol) and 
DMAP (cat.) were added.  The reaction mixture was stirred at 0 °C for 5 min, and then 
allowed to warm to room temperature.  After stirring at room temperature for 1h the 
reaction mixture was filtered and the filtrate was concentrated by rotary evaporation.  The 
crude residue was purified by column chromatography (SiO2, 
dichloromethane:hexane:ethyl acetate, 5:3:2, v/v; Rf = 0.47) to afford NHS-32 (0.408 g, 
90% yield) as a white solid, mp. 47.0-47.6 ºC; 1H NMR (400 MHz, CDCl3) δ 2.83 (bs, 
4H), 2.63 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 169.6, 169.4, 25.8, 24.5; IR (neat) 
2951, 1817, 1781, 1718, 1381, 1210, 1066, 917, 805, 652 cm-1 FT-ICR-MS (ESI+, m/z) 
calcd for C8H10D3NNaO5, [M + MeOH + Na]+ 229.0874, found 229.0874. 
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2,5-Dioxopyrrolidin-1-yl 3-13C-3,3,3-2H3-propionate (NHS-33) 
Using the general procedure for the synthesis of NHS-32, N-hydroxysuccinimide 
(0.234 g, 2.04 mmol) was reacted with 3-13C1-3,3,3-2H3-propionic acid (0.1 g, 1.36 
mmol) to afford NHS-33 (0.156 g, 70% yield over 2 steps; saponification of ester 4.20a 
followed by coupling of corresponding propionic acid with N-hydroxysuccinimide); 1H 
NMR (400 MHz, CDCl3) δ 2.83 (bs, 4H), 2.63 (d, J = 4.4 Hz, 2H); 13C NMR (100 MHz, 
CDCl3) δ 169.6, 169.4, 25.8, 24.6, 24.3, 8.7-7.5 (m); FT-ICR-MS (ESI+, m/z) calcd for 
C713CH10D3NNaO5, [M + MeOH + Na]+ 230.0908, found 230.0908. 
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2,5-Dioxopyrrolidin-1-yl 2,3-13C2-3,3,3-2H3-propionate (NHS-34) 
Using the general procedure for the synthesis of NHS-32, N-hydroxysuccinimide 
(0.234 g, 2.04 mmol) was reacted with 2,3-13C1-3,3,3-2H3-propionic acid (0.1 g, 1.36 
mmol) to afford NHS-34 (0.137 g, 61% yield over 2 steps; saponification of ester 4.20b 
followed by coupling of corresponding propionic acid with N-hydroxysuccinimide); 1H 
NMR (400 MHz, CDCl3) δ 2.83 (bs, 4H), 2.63 (dd, J = 130 Hz, J = 4.4 Hz, 2H); 13C 
NMR (100 MHz, CDCl3) δ 169.6, 169.4, 25.8, 24.6-24.0 (m) , 8.7-7.5 (m); FT-ICR-MS 
(ESI+, m/z) calcd for C613C2H10D3NNaO, [M + MeOH + Na]+ 231.0941, found 231.0941. 
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Gas Chromatography-Mass Spectrometry Procedures 
A.  Multiplex Experiment: Proof of Concept 
A.1.  General Procedure for Sample Mixture Derivatization.   
 The sample mixtures A, B and C were prepared (see below) and derivatized by 
treatment with an excess (~4 equiv) of reagents AEP-32, AEP-33, and AEP-34, 
respectively, to afford the derivatized mixtures A32, B33, and C34.  The resultant mixtures 
A32, B33 and C34 were combined and an aliquot (50 µL) from the combined mixture was 
directly injected into the GC-MS instrument for analysis.  All GC-MS analyses were 
performed using an Agilent Technologies GC-MS instrument (Agilent Technologies, 
Palo Alto, CA); GC component: Agilent 7820A gas chromatograph, MS component: 
Agilent 5975 Series MSD.  The GC-MS instrument was fitted with a HP-5MS 
chromatographic column 30 m long with an internal diameter of 250 µm and a stationary-
phase film thickness of 0.25 µm.  High-purity helium was used as the carrier gas at a flow 
rate of 1.0 mL/min.  The starting column oven temperature was 60 °C with a ramp of 20 
°C/min to a maximum temperature of 315 °C and then held at this temperature for 2 min.  
The combined mixture of derivatized carbonyl substrates was examined using a 120-s 
solvent delay. The 1 µL of sample solution was injected in the split mode of injection at a 
ratio of 10:1.  The inlet temperature was set at 275 °C and the transfer line at 250°C.  The 
ion MS source was held at 230 °C and the MS Quad at 150 °C.  The detector voltage was 
set at 1200 V, and the electron energy for ionization was set at 70 eV.  Mass spectra were 
collected from 25 to 400 m/z.  The A-C sample mixtures were prepared, derivatizated and 
then analyzed by GC-MS a total of three times.     
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A.2.  Sample Mixture Preparation 
Sample Mixture A.  To a solution mixture consisting of hexanal (100 µL of a 0.66 M 
solution), 1-naphthaldehyde (300 µL of a 0.60 M solution), 2-heptanone (100 µL of a 
0.84 M solution), 1-methyl-4-piperidone (500 µL of a 0.60 M solution), tetrahydro-4H-
pyran-4-one (200 µL of a 0.58 M solution), and 2-indanone (500 µL of a 0.40 M 
solution), total volume 1.7 mL, was added dichloromethane (300 µL) to generate a 
sample mixture A (2.0 mL). 
 
Derivatized Mixture A32.  To a 100 µL aliquot of sample mixture A at room temperature 
was added AEP-32 (23 µL).  After incubation at room temperature 48h, the 
dichloromethane was removed by rotary evaporation and the resultant mixture of oxime 
ethers was redissolved in dichloromethane (1.0 mL) to generate derivatized mixture A32. 
 
Sample Mixture B.  To a solution mixture consisting of hexanal (100 µL of a 0.66 M 
solution), 1-naphthaldehyde (100 µL of a 0.60 M solution), 2-heptanone (300 µL of a 
0.84 M solution), 1-methyl-4-piperidone (500 µL of a 0.60 M solution), tetrahydro-4H-
pyran-4-one (100 µL of a 0.58 M solution), and 2-indanone (300 µL of a 0.40 M 
solution), total volume 1.4 mL, was added dichloromethane (600 µL) to generate a 
sample mixture B (2.0 mL). 
 
Derivatized Mixture B33.  To a 100 µL aliquot of sample mixture B at room temperature 
was added AEP-33 (21 µL).  After incubation at room temperature 48h, the 
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dichloromethane was removed by rotary evaporation and the resultant mixture of oxime 
ethers was redissolved in dichloromethane (1.0 mL) to generate derivatized mixture B33. 
 
Sample Mixture C.  To a solution mixture consisting of hexanal (100 µL of a 0.66 M 
solution), 1-naphthaldehyde (100 µL of a 0.60 M solution), 2-heptanone (100 µL of a 
0.84 M solution), 1-methyl-4-piperidone (100 µL of a 0.60 M solution), tetrahydro-4H-
pyran-4-one (200 µL of a 0.58 M solution), and 2-indanone (100 µL of a 0.40 M 
solution), total volume 0.7 mL, was added dichloromethane (1.3 mL) to generate a 
sample mixture C (2.0 mL). 
 
Derivatized Mixture C34.  To a 100 µL aliquot of sample mixture C at room temperature 
was added AEP-34 (11 µL).  After incubation at room temperature 48h, the 
dichloromethane was removed by rotary evaporation and the resultant mixture of oxime 
ethers was redissolved in dichloromethane (1.0 mL) to generate derivatized mixture C34. 
 
 
 
 
 
 
 
 
 
! 236!
A.3.  Ion Count Averages and Accuracy Determination 
Table 6.2 summarizes the averages, calculated from three separate experiments, for the 
MST ion counts, accuracy (% error) and the standard deviation.  Total average error was 
calculated at 4.9% ± 0.3%. 
 
Table 6.2.  Summary of the calculated accuracy (% error) and the standard deviation for 
the MSTs. 
 
Carbonyl 
Substrate 
  
MST 
Actual 
A,B,C 
Ratio 
Accuracy  
(% error) 
Normalized 
average ion 
count 
Standard 
deviation 
(m/z)   Z E Z E Z E 
hexanal 
32 1 4.16 2.47 10.85 9.34 0.55 0.45 
33 1 3.52 5.23 10.05 8.65 0.14 0.13 
34 1 1.18 2.96 10.35 9.4 0.35 0.31 
1-naphth-
aldehyde 
32 3 3.82 4.46 10.74 8.16 0.47 0.26 
33 1 4.42 4 3.83 2.95 0.25 0.11 
34 1 8.54 9.72 4.04 3.12 0.21 0.15 
2-heptanone 
32 1 6.24 4.82 3.05 2.44 0.45 0.43 
33 3 4.05 3.7 8.24 6.69 0.65 0.74 
34 1 5.9 6.29 3.04 2.47 0.39 0.41 
tetrahydro-4H-
pyran-4-one 
32 2 3 13.09 0.98 
33 1 4.3 6.87 0.18 
34 2 3.45 12.96 0.15 
1-methyl-4-
piperidone 
32 5 3.16 11.91 0.28 
33 5 5.21 10.98 0.34 
34 1 11.95 2.59 0.1 
2-indanone 
32 5 2.34 5.47 0.21 
33 3 2.89 3.26 0.1 
34 1 9.67 1.21 0.05 
 
A.4.  Representative calculation of accuracy for 2-indanone, run 1.   
The ratio of AEP–2-indanone in the combined mixture A32:B33:C34 (run 1) was 5:3:1.  
Thus, the expected MST ratio at m/z 32, 33, and 34 is 5:3:1, respectively.  The 32-34 
MST intensities were measured from the mass spectrum generated by the integration of 
the GC signal for the AEP–2-indanone adduct and found to be 5.66, 3.17, and 1.17 ion 
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counts (parent fragment ion normalized to 100), respectively.  Summing the total ion 
counts for the three MSTs gives 10.00, and dividing this value by 9 (sum of the total 2-
indanone adduct ratio, 5:3:1) gives 1.11, which represents the unit ion count of one MST 
for 2-indanone.  From this we can calculate the full, expected intensities for each MST:  5 
= 5.55: 3 = 3.33: 1 = 1.11.  Comparing the measured intensities to the expected intensities 
gives the error (#measured – expected #/ expected):  MST m/z 32 gave 5.66 ion counts = 
1.98% error; MST m/z 33 gave 3.17 ion counts = 4.80% error; MST m/z 34 gave 1.17 ion 
counts = 5.40% error.  This procedure was repeated for the second and third runs, and the 
three values obtained for each MST then were averaged to provide the value given in the 
table above. 
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B.  Turmeric Extract Profiling and Absolute Quantification 
B.1.  Derivatization Procedure 
 Dr. Xiang Zhang and his graduate student Xue Shi performed the sample 
preparation and the GCxGC-MS injections in this section. 
 Turmeric extract (steam distilled curcuma essential oil) from the roots of 
Curcuma Longa (India) was purchased from New Directions Aromatics Inc. (San Ramon, 
CA).  Curcuma oil (10 µL) was dissolved in acetonitrile (90 µL).  Equimolar quantities of 
AEP-33 reagent and AEP-34 reagent (2 mgs each) were dissolved in acetonitrile (100 
µL), and the mixture then was added to the curcuma oil solution.  The resultant AEP 
reagent – curcuma oil mixture was stirred at 40 °C for 1 hour.   
 Analyses of the derivatized mixture were performed using a Pegasus 4D 
GC×GC/TOF-MS instrument (LECO Corporation, St. Joseph, MI) equipped with an 
Agilent 6890 gas chromatograph featuring a two-stage cryogenic modulator and 
secondary oven.  A 60 m × 0.25 mm i.d. × 0.25 µm (film thicknesses) DB-5ms GC 
capillary column ((5%-phenyl)-dimethylpolysiloxane, Agilent Technologies J&W) was 
used as the primary column for the GC×GC/TOF-MS analysis.  A second GC column of 
1 m × 0.25 mm i.d. × 0.25 µm film thickness, DB-17ms ((50%-Phenyl)-
methylpolysiloxane, Agilent Technologies J&W) was placed inside the secondary GC 
oven after the thermal modulator.  The helium carrier gas flow rate was set to 2 mL/min 
at a corrected constant flow via pressure ramps.  The inlet temperature was set at 280 °C.  
The primary column temperature was programmed with an initial temperature of 60 °C 
for 0.5 min and then ramped at 5 °C/min to 270 °C to keep 12 min.  The secondary 
column temperature program was set to an initial temperature of 80 °C for 0.5 min and 
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then also ramped at the same temperature gradient employed in the first column to 290 
°C accordingly.  The thermal modulator was set to +20 °C relative to the primary oven, 
and a modulation time of 2 s was used.  The hot pulse time is 0.4 s.  The mass range was 
25−800 m/z with an acquisition rate of 200 spectra per second. The ion source chamber 
was set at 230 °C with the MS transfer line temperature set to 280 °C, and the detector 
voltage was 1450 V with electron energy of 70 eV.  The acceleration voltage was turned 
on after a solvent delay of 325 s. 2 µL samples were injected into the system with a split 
ratio of 50:1.  The GC×GC–TOF MS data were processed using LECO’s instrument 
control software ChromaTOF for peak picking. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
! 240!
B.2.  Absolute Quantification 
 Turmeric extract (steam distilled curcuma essential oil) from the roots of 
Curcuma Longa (India) was purchased from New Directions Aromatics Inc. (San Ramon, 
CA).  Curcuma oil (10 µL) was dissolved in acetonitrile (90 µL).  2 mg of AEP-33 
reagent were dissolved in 100 µL of acetonitrile and added to the dissolved curcuma oil.  
Derivatization was carried out at 40 °C for 1 hour and followed by storing at 5 °C for 72 
hours.  
 AEP-34 adduct of 2-nonanone (Z-isomer) and AEP-34 adduct of 2-undecanone 
(Z-isomer) were used as standards for the quantification experiments.   Solutions of these 
two standards were formulated in acetonitrile at 40.6 µg/mL (155 nmol/mL) and 16 
µg/mL (55 nmol/mL), respectively.  The derivatized curcuma oil (30 µL) was mixed with 
the AEP-34 adduct of 2-nonanone (Z-isomer, 7.5 µL of a 40.6 µg/mL (155 nmol/mL) 
solution) and the AEP-34 adduct of 2-undecanone (Z-isomer, 7.5 µL of a 16 µg/mL (55 
nmol/mL) solution).  Three separate ‘spike-in’ experiments were performed, and then 
each was analyzed by GCxGC-TOF-MS. 
 Table 6.3 summarizes the averages, calculated from three separate experiments, 
for the ratios of the reporter MSTs, the average concentration for each isomer of the 
carbonyl substrates and the total concentration of the carbonyl substrates in the sample.  
The table shows the chromatogram peak area ratio of the Z- and E-isomers in the 
turmeric extract derivatized with AEP-33 before spike-in with the AEP-34 modified Z-
isomers.  
  
 
! 241!
 The total concentration of the AEP-33 adducts in the extract were found to be 
436.0 ±26 µg/mL (1.67 ±0.1 µmol/mL) and 536 ±54 µg/mL (1.85 ±0.2 µmol/mL) 
respectively.  These values correspond to 237 ± 14 µg/mL of 2-nonanone in the extract 
and 315 ± 32 µg/mL, respectively. 
 
Table 6.3.  Summary of the calculated concentrations of the AEP-adducts of 2-nonanone 
and 2-undecanone in the turmeric extract. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Carbonyl 
substrate 
AEP-adduct 
 
Chromatogram 
isomer ratio 
before spike-in 
Average MST 
ratio in  
spike-in 
Normalized 
average ion 
counts 
Standard 
deviation 
Determined 
injection 
concentration  
Determined 
injection 
concentration 
(µg/mL) 
Total 
concentration  
in the extract 
(µg/mL) (Z-isomer) (µg/mL) 
Z E 33 34 33 34 33 34 Z E   
 2-nonanone 1 2.07 1.05 1 18.4 17.5 1.3 0.9 7.1 (±0.4) 
14.7 
(±0.9) 21.8 (±1.3) 436.0 (±26) 
  2-undecanone 1 1.63 3.55 1 13.5 3.8 0.5 1.3  10.2      (±1) 
16.6 
(±1.7) 26.8 (±2.7) 536.0 (±54) 
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6.E.  Experimental Procedures of Chapter 5 
Synthesis 
 
 
14-Bromo-tetradecan-1-ol (5.1b)   
 To a solution of 14-bromotetradecanoic acid (1 g, 2.98 mmol) in dry THF (20 
mL) at -15 °C under N2, a 1M solution of BH3 in THF (7.75 mL) was added via syringe.  
The reaction was stirred at 0 °C for 2 hours, and then at room temperature for 4 hours.  
The crude was slowly poured in a cooled (0 °C) saturated aq NaHCO3 solution (10 mL) 
and stirred for 15 min.  The resulting solution was then extracted with Et2O (5 x 20 mL).  
The organic layers were combined and washed with brine (2 x 10 mL) and then dried 
over Na2SO4 and concentrated by rotary evaporation.  The crude residue was purified by 
column chromatography (SiO2, CH2Cl2) to afford the desired product as a clear oil (0.9 g, 
95% yield) having spectral characteristics in agreement with published data.28  1H NMR 
(500 MHZ, CDCl3) δ 3.63 (q, J = 6.5 Hz, 2H), 3.40 (t, J = 7 Hz, 2H), 1.86 (qn, J = 7.5 
Hz, 2H), 1.55 (qn, J = 7 Hz, 2H), 1.44-1.20 (m, 24H). 
 
 
 
 
 
 
Br OH14
5.1b
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12-Tritylsulfanyl-dodecan-1-ol (5.2a)   
 To a solution of 12-bromo-dodecan-1-ol (5.1a) (1.0 g, 3.78 mmol) in MeOH (40 
mL) at room temperature was added potassium carbonate (1.04 g, 7.56 mmol).  After 
stirring 5 minutes, triphenylmethanethiol (1.36 g, 4.90 mmol) was added, and the reaction 
was stirred at room temperature for 16 hours.  The reaction solution was then diluted with 
diethyl ether (100 mL), transferred to a separatory funnel, and neutralized with a 
Na2HPO4/NaH2PO4 buffer (10 mL).  The buffer was removed, and the organic layer was 
then washed with NaCl brine (3 × 75 mL).  The aqueous layers were combined and 
extracted with diethyl ether (25 mL), and the organic layers were combined, dried over 
Na2SO4 and concentrated by rotary evaporation.  The crude residue was purified by flash 
chromatography (12 g SiO2; CH2Cl2:MeOH (v:v) 100:0 → 95:5) to afford the desired 
product 5.2a (1.71 g, 99% yield) as a white solid having spectral characteristics in 
agreement with published data.29  1H NMR (500 MHZ, CDCl3) δ 7.34 (d, J = 7.5 Hz, 
6H), 7.20 (t, J = 7.5 Hz, 6H), 7.13 (t, J = 7.4 Hz, 3H), 3.56 (t, J = 4.5 Hz, 2H), 2.06 (t, J = 
7.5 Hz, 2H), 1.49 (qn, J = 7 Hz, 2H), 1.02-1.35 (m, 18H). 
 
 
 
 
 
 
 
TrS OH10
5.2a
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1-Bromo-12-tritylsulfanyl-dodecane (5.9a)   
 To an evacuated and N2 purged flask containing 5.2a (0.900 g, 1.95 mmol), 
sodium bicarbonate (0.164 g, 1.95 mmol), and a stir bar, dry CH2Cl2 (30 mL) was added 
by syringe.  In separate flasks, carbon tetrabromide (1.618 g, 4.88 mmol) and 
triphenylphosphine (1.330 g, 5.07 mmol) were each purged with N2, and minimal dry 
CH2Cl2 was added by syringe to dissolve each solid.  Both the carbon tetrabromide and 
triphenylphospine were cannulated into the reaction flask, and the solution was stirred for 
12 hours.  The resulting dark red solution was diluted with Et2O and washed with NaCl 
brine (3 x 50 mL).  The aqueous washes were combined and extracted with Et2O (50 
mL), and all organic extracts were combined and washed once more with NaCl brine 
(100 mL).  The organic solution was dried over Na2SO4, concentrated by rotary 
evaporation, and purified by flash column chromatography (12 g SiO2; CH2Cl2, 100 mL) 
to give the desired product 5.9a (0.989 g, 96% yield) as a white solid having spectral 
characteristics in agreement with published data.30  1H NMR (500 MHZ, CDCl3) δ 7.34 
(d, J = 7.5 Hz, 6H), 7.20 (t, J = 7.5 Hz, 6H), 7.13 (t, J = 7.4 Hz, 3H), 3.33 (t, J = 7 Hz, 
2H), 2.06 (t, J = 7 Hz, 2H), 1.78 (qn, J = 7.5 Hz, 2H), 1.27-1.38 (m, 4H), 1.02-1.26 (m, 
14H). 
 
 
 
 
 
TrS Br10
5.9a
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14-Tritylsulfanyl-tetradecan-1-ol (5.2b). 
 Using the same procedure outlined for the synthesis of 5.2a, 14-bromo-dodecan-
1-ol (5.1b) (0.9 g, 2.82 mmol), potassium carbonate (1.17 g, 8.45 mmol), and 
triphenylmethanethiol (1.32 g, 4.79 mmol) were reacted to afford the desired product 
5.2b as a clear oil (1.3 g, 89.7% yield) having spectral characteristics in agreement with 
published data.31  1H NMR (500 MHZ, CDCl3) δ 7.41 (d, J = 7.5 Hz, 6H), 7.25 (t, J = 7.5 
Hz, 6H), 7.20 (t, J = 7.4 Hz, 3H), 3.62 (q, J = 6.5 Hz, 2H), 2.12 (t, J = 7 Hz, 2H), 1.54 
(qn, J = 7 Hz, 2H), 1.41-1.14 (m, 26H). 
 
 
 
 
 
 
 
 
 
 
 
 
 
TrS OH14
5.2b
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1-iodo-12-tritylsulfanyl-tetradecane (5.9b’) 
 To an evacuated and N2 purged flask containing triphenylphosphine (0.22 g, 0.84 
mmol), I2 (0.213 g, 0.84 mmol), and a stir bar, dry tetrahydrofuran (20 mL) was added by 
syringe.  To the resulting solution was added imidazole (0.076 g, 1.12 mmol) in dry 
tetrahydrofuran (3 mL) and stirred for 5 min.  A solution of alcohol 5.2b (0.29 g, 0.56 
mmol) in minimal tetrahydrofunare was finally added via cannula.  After 12 h at room 
temperature, the solution was diluted with Et2O (100 mL) and washed with saturated aq. 
NaHCO3 and brine (3 x 10 mL).  The organic solution was dried over Na2SO4, 
concentrated by rotary evaporation, and purified by flash column chromatography (12 g 
SiO2; CH2Cl2, 100 mL) to give the desired product 5.9b’ (0.31 g, 88% yield) as a white 
solid.  1H NMR (500 MHZ, CDCl3) δ 7.35 (d, J = 7.5 Hz, 6H), 7.22 (t, J = 7.5 Hz, 6H), 
7.14 (t, J = 7.4 Hz, 3H), 3.13 (t, J = 7.5 Hz, 2H), 2.07 (t, J = 7.5 Hz, 2H), 1.77 (qn, J = 
7.5 Hz, 2H), 1.33-1.28 (m, 4H), 1.28-1.0 (m, 24); 13C NMR (125 MHZ, CDCl3) 
δ 145.4, 129.9, 128.2, 128.1, 126.8, 66.6, 33.9, 32.3, 30.8, 29.95, 29.9, 29.8, 29.7, 29.5, 2
9.3, 28.9, 28.8, 7.6. 
 
 
 
 
 
 
TrS I14
5.9b'
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1,1,1-triphenyl-15,18,21,24-tetraoxa-2-thiahexacosan-26-ol (5.10a-PEG(4))   
 To a suspension of sodium hydride (0.292 g, 12.17 mmol) in DMF (10 mL) at 
0°C under N2, a solution of vacuum-dried tetra(ethylene glycol) (1.201 g, 6.18 mmol) in 
anhydrous DMF (20 mL) under N2 was transferred by cannula, and the reaction flask was 
purged with N2.  After 5 minutes, the solution turned a pale yellow color.  Then 5.9a 
(0.54 g, 1.03 mmol) in anhydrous DMF (25 mL) under N2 was transferred to the reaction 
flask in the same manner.  The reaction was allowed to come to room temperature, kept 
under N2 atmosphere, and stirred for 72 hours.  The resulting dark yellow solution was 
then dissolved in Et2O (75 mL), transferred to a separatory funnel, and washed with NaCl 
brine (75 mL) mixed with RO water (5 mL).  Aqueous layers were combined and 
extracted with Et2O (50 mL), and then organic layers were combined and washed once 
more with NaCl brine (50 mL).  The final organic extract was then dried over Na2SO4 
and concentrated by rotary evaporation.  The crude residue was purified by flash column 
chromatography (12 g SiO2; CH2Cl2:MeOH (v:v) 100:0 → 90:10) to give the desired 
product as a yellow oil (0.268g, 41% yield).  1H NMR (500 MHZ, CDCl3) δ 7.40 (d, J = 
7.5 Hz, 6H), 7.27 (t, J = 7.5 Hz, 6H), 7.19 (t, J = 7.4 Hz, 3H), 3.72 (t, J = 3 Hz, 2H), 
3.56-3.69 (m, 12H), 3.44 (t, J = 7 Hz, 2H), 2.13 (t, J = 7.5 Hz, 2H), 1.57 (qn, J = 7 Hz, 
2H), 1.38 (qn, J = 7.5 Hz, 2H), 1.10-1.33 (m, 18H); 13C NMR (125 MHz, CDCl3) δ 
145.33, 129.85, 128.02, 126.72, 72.73, 71.780, 70.88, 70.85, 70.631, 70.30, 62.03, 32.28, 
29.87, 29.83, 29.81, 29.78, 29.73, 29.65, 29.43, 29.26, 28.84, 26.33, 21.37, 21.32; FTMS 
calcd for C39H56O5S [M + Na] 659.3746, found 659.3744. 
5.10a-PEG(4)
TrS O10
O OH3
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1,1,1-triphenyl-15,18,21,24,27,30-hexaoxa-2-thiadotriacontan-32-ol (5.10a-PEG(6))   
 Using the same procedure outlined for the synthesis of 5.10a-PEG(4), sodium 
hydride (0.178 g, 7.43 mmol), hexa(ethylene glycol) (1.07 g, 3.81 mmol), and 5.9a 
(0.330 g, 0.632 mmol) were reacted in to give the desired product 5.10a as a yellow oil 
(0.184g, 46% yield).  1H NMR (500 MHZ, CDCl3) δ 7.34 (d, J = 7.5 Hz, 6H), 7.20 (t, J = 
7.5 Hz, 6H), 7.13 (t, J = 7.4 Hz, 3H), 3.72 (t, J = 4 Hz, 2H), 3.56-3.69 (m, 18H), 3.44 (t, J 
= 7 Hz, 2H), 2.13 (t, J = 7.5 Hz, 2H), 1.57 (qn, J = 7 Hz, 2H), 1.38 (qn, J = 7.5 Hz, 2H), 
1.11-1.34 (m, 18H); 13C NMR (125 MHz, CDCl3) δ 145.34, 129.85, 128.02, 126.72, 
72.73, 71.80, 70.88, 70.84, 70.63, 70.30, 62.02, 32.27, 29.89, 29.82, 29.81, 29.78, 29.74, 
29.66, 29.43, 29.26, 28.84, 26.34, 21.43; FTMS calcd for C43H64O7S [M + Na] 747.4271, 
found 747.4263. 
 
 
 
 
 
 
 
 
 
5.10a-PEG(6)
TrS O10
O OH5
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1,1,1-triphenyl-15,18,21,24,27,30,33,36-octaoxa-2-thiaoctatriacontan-38-ol  
(5.10a-PEG(8)) 
 Using the same procedure outlined for the synthesis of 5.10a-PEG(4), sodium 
hydride (0.14 g, 5.88 mmol), octa(ethylene glycol) (1.12 g, 3.02 mmol), and 5.9a (0.42 g, 
0.8 mmol) were reacted in to give the desired product 5.10a-PEG(8) as a yellow oil 
(0.31g, 48% yield).  1H NMR (500 MHZ, CDCl3) δ 7.43 (d, J = 7.5 Hz, 6H), 7.30 (t, J = 
7.5 Hz, 6H), 7.23 (t, J = 7.4 Hz, 3H), 3.73 (t, 2H), 3.64-3.58 (m, 30H), 3.47 (t, 2H), 2.16 
(t, 2H), 1.58 (qn, 2H), 1.41 (qn, 2H), 1.27-1.22 (m, 16H); 13C NMR (125 MHz, CDCl3) δ 
145.1, 129.6, 127.8, 126.5, 72.5, 71.5, 70.65, 70.6, 70.3, 70.0, 66.3, 61.7, 32.0, 29.65, 
29.6, 29.5, 29.4, 29.2, 29.0, 28.6, 26.1; FTMS calculated for C47H72NaO9S [M + Na+] 
835.4789, found 835.4774. 
 
 
 
 
 
 
 
 
 
 
5.10a-PEG(8)
TrS O10
O OH7
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1,1,1-triphenyl-19,22,25,28-tetraoxa-2-thiatriacontan-30-ol (5.10b-PEG(4)) 
 Using the same procedure outlined for the synthesis of 5.10a-PEG(4), sodium 
hydride (0.38 g, 15.7 mmol), tetra(ethylene glycol) (1.6 g, 8.22 mmol), and 5.9b’ (0.330 
g, 0.632 mmol) were reacted in to give the desired product 5.10b-PEG(4) as a yellow oil 
(0.212 g, 24%).  1H NMR (500 MHZ, CDCl3) δ 7.43 (d, J = 7.5 Hz, 6H), 7.30 (t, J = 7.5 
Hz, 6H), 7.23 (t, J = 7.4 Hz, 3H), 3.75 (t, 2H), 3.68-3.59 (m, 14H), 3.47 (t, J = 6.5 Hz, 
2H), 2.16 (t, J = 7.5 Hz, 2H), 1.59 (qn, J = 7 Hz, 2H), 1.41 (qn, 2H), 1.38-1.10 (m, 26H). 
 
 
 
 
 
 
 
 
 
 
 
 
 
TrS O14
O OH3
5.10b-PEG(4)
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1,1,1-triphenyl-19,22,25,28,31,34-hexaoxa-2-thiahexatriacontan-36-ol  
(5.10b-PEG(6)) 
 Using the same procedure outlined for the synthesis of 5.10a-PEG(4), sodium 
hydride (78 mg, 3.27 mmol), hexa(ethylene glycol) (0.52 g, 1.8 mmol), and 5.9b (0.2 g, 
0.35 mmol) were reacted in to give the desired product 5.10b-PEG(6) as a yellow oil 
(0.123 g, 38%).  1H NMR (500 MHZ, CDCl3) δ 7.41 (d, J = 7.5 Hz, 6H), 7.28 (t, J = 7.5 
Hz, 6H), 7.21 (t, J = 7.4 Hz, 3H), 3.71 (t, J = 4 Hz, 2H), 3.65-3.57 (m, 22H), 3.45 (t, J = 
7 Hz, 2H), 2.14 (t, J = 7.5 Hz, 2H), 1.56 (qn, J = 7 Hz, 2H), 1.37 (m, 2H), 1.37-1.10 (m, 
26H); 13C NMR (125 MHz, CDCl3): 145.1, 129.6, 127.8, 126.5, 72.5, 71.5, 70.6, 70.5, 
70.0, 61.7, 32.0, 29.65, 29.6, 29.55, 29.5, 29.4, 29.2, 29.0, 28.6, 26.1. 
 
 
 
 
 
 
 
 
 
 
5.10b-PEG(6)
TrS O14
O OH5
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1,1,1-triphenyl-19,22,25,28,31,34,37,40-octaoxa-2-thiadotetracontan-42-ol  
(5.10b-PEG(8)) 
 Using the same procedure outlined for the synthesis of 5.10a-PEG(4), sodium 
hydride (0.13 g, 5.52 mmol), octa(ethylene glycol) (1.02 g, 2.76 mmol), and 5.9b (0.4 g, 
0.69 mmol) were reacted in to give the desired product 5.10b-PEG(8) as a yellow oil 
(0.29 g, 48%).  1H NMR (400 MHZ, CDCl3) δ 7.40 (d, J = 8.0 Hz, 5H), 7.28-7.24 (m, 
7H), 7.13 (t, J = 7.4 Hz, 3H), 3.72 (t, J = 4 Hz, 2H), 3.64-3.54 (m, 30H), 3.44 (t, J = 7 
Hz, 2H), 2.13 (t, J = 7.5 Hz, 2H), 1.57 (qn, J = 7 Hz, 2H), 1.39 (qn, J = 7.5 Hz, 2H), 
1.33-1.10 (m, 24H); 13C NMR (100 MHz, CDCl3): 145.1, 129.6, 127.8, 127.5, 72.55, 
71.5, 70.65, 70.6, 70.3, 70.0, 66.3, 61.7, 32.0, 29.7, 29.6, 29.55, 29.5, 29.4, 29.2, 29.0, 
28.6, 26.1; FTMS calculated for C51H80NaO9S [M + Na+] 891.5415, found 891.5447. 
 
 
 
 
 
 
 
 
 
5.10b-PEG(8)
TrS O14
O OH7
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2-[2-(2-{2-[2-(12-Tritylsulfanyl-dodecyloxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-
isoindole-1,3-dione (5.11a-PEG(4)).   
 To a solution of product 5.10a-PEG(4) (0.220 g, 0.345 mmol) in dry THF (5 mL) 
under N2 at 0°C were added N-hydroxyphthalimide (0.068 g, 0.414 mmol) and 
triphenylphosphine (0.109 g, 0.414 mmol).  Over the next 5-10 minutes, diisopropyl 
azodicarboxylate (0.082 mL, 0.414 mmol) was added dropwise by syringe.  The solution 
quickly turned a dark yellow-orange.  The reaction flask was then allowed to return to 
room temperature and stirred overnight to yield an opaque golden solution.  The mixture 
then was concentrated by rotary evaporation, diluted with EtOAc (100 mL), transferred to 
a separatory funnel, and washed with NaCl brine (3 × 75 mL).  The organic layer was 
then dried over Na2SO4, concentrated by rotary evaporation, then concentrated further by 
vacuum pump.  The crude residue was purified by flash column chromatography (12 g 
SiO2; Hexane:EtOAc (v:v) 90:10 → 0:100) to give the desired product 5.11a-PEG(4) as 
a bright yellow oil (0.241g, 74% yield).  1H NMR (500 MHZ, CDCl3) δ 7.84 (dd, J = 5.5, 
3 Hz, 2H), 7.74 (dd, J = 5.5, 3 Hz, 2H), 7.40 (d, J = 7.5 Hz, 6H), 7.27 (t, J = 7.5 Hz, 6H), 
7.20 (t, J = 7.4 Hz, 3H), 4.38 (t, J = 4.5 Hz, 2H), 3.87 (t, J = 4.5 Hz, 2H), 3.67 (t, J = 4.5 
Hz, 2H), 3.55-3.65 (m, 10H), 3.43 (t, J = 7 Hz, 2H), 2.13 (t, J = 7.5 Hz, 2H), 1.56 (qn, J = 
7 Hz, 2H), 1.38 (qn, J = 7 Hz, 2H), 1.10-1.35 (m, 16H); 13C NMR (125 MHz, CDCl3) δ 
171.10, 134.64, 129.84, 128.01, 126.72, 123.72, 109.99, 71.79, 71.02, 70.837, 70.79, 
70.76, 70.73, 70.27, 69.54, 65.48, 29.77, 29.65, 29.25, 28.83, 23.14, 23.11, 23.09. 
5.11a-PEG(4)
TrS O10
O ONPhth3
! 254!
 
2-((1,1,1-triphenyl-15,18,21,24,27,30-hexaoxa-2-thiadotriacontan-32-
yl)oxy)isoindoline-1,3-dione (5.11a-PEG(6)).   
 Using the same procedure outlined for the synthesis of 5.11a-PEG(4), thiol-PEG 
diblock chain 5.10a-PEG(6) (0.100 g, 0.138 mmol), N-hydroxyphthalimide (0.027 g, 
0.166 mmol) and triphenylphosphine (0.044 g, 0.166 mmol) were reacted in presence of 
diisopropyl azodicarboxylate (0.032 mL, 0.166 mmol) to give the desired product 5.11a-
PEG(6) as a bright yellow oil (0.091g, 75% yield).  1H NMR (500 MHZ, CDCl3) δ 7.84 
(dd, J = 5.5, 3 Hz, 2H), 7.75 (dd, J = 5.5, 3 Hz, 2H), 7.40 (d, J = 7.5 Hz, 6H), 7.27 (t, J = 
7.5 Hz, 6H), 7.20 (t, J = 7.4 Hz, 3H), 4.38 (t, J = 4.5 Hz, 2H), 3.86 (t, J = 4.5 Hz, 2H), 
3.55-3.68 (m, 20H (plus H2O impurities)), 3.44 (t, J = 7 Hz, 2H), 2.38 (t, J = 7.5 Hz, 2H), 
2.13 (t, J = 7.5 Hz, 2H), 1.56 (qn, J = 7 Hz, 2H), 1.38 (qn, J = 7 Hz, 2H), 1.10-1.35 (m, 
14H); 13C NMR (125 MHz, CDCl3) δ 154.49, 134.68, 129.95, 129.92, 129.84, 128.23, 
128.213, 128.18, 128.11, 128.02, 126.72, 71.17, 70.93, 70.86, 70.83, 64.76, 64.68, 29.89, 
29.837, 29.81, 29.65, 22.39, 22.31. 
 
 
 
 
 
 
 
TrS O10
O ONphth5
5.11a-PEG(6)
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2-((1,1,1-triphenyl-15,18,21,24,27,30,33,36-octaoxa-2-thiaoctatriacontan-38-
yl)oxy)isoindoline-1,3-dione (5.11a-PEG(8)) 
 Using the same procedure outlined for the synthesis of 5.11a-PEG(4), thiol-
PEG diblock chain 5.10a-PEG(8) (0.29 g, 0.36 mmol), N-hydroxyphthalimide (0.077 g, 
0.47 mmol) and triphenylphosphine (0.116 g, 0.44 mmol) were reacted in presence of 
diisopropyl azodicarboxylate (0.1 mL, 0.5 mmol) to give the desired product 5.11a-
PEG(8) as a bright yellow oil (0.33g, 96% yield).  1H NMR (400 MHZ, CDCl3) δ 7.79 
(dd, 2H), 7.72 (dd, 2H), 7.38 (d, J = 7.5 Hz, 5H), 7.26 (t, J = 7.5 Hz, 7H), 7.18 (t, 3H), 
3.84 (t, J = 4.5 Hz, 2H), 3.64-3.52 (m, 30H), 3.42 (t, J = 7 Hz, 2H), 2.11 (t, J = 7.2 Hz, 
2H) 1.55 (m, 2H), 1.36 (m, 2H), 1.33-1.12 (m, 18H); 13C NMR (125 MHz, CDCl3) δ 
163.4, 145.1, 134.4, 129.6, 129.0, 127.8, 126.5, 123.5, 71.5, 70.8, 70.6, 70.0, 69.3, 32.0 
29.6, 29.55, 29.5, 29.4, 29.2, 29.0, 28.6, 26.1; FTMS calculated for C55H75KNO11S [M + 
K+] 996.4692, found 996.4712. 
 
 
 
 
 
 
 
TrS O12
O ONphth7
5.11a-PEG(8)
! 256!
 
2-((1,1,1-triphenyl-19,22,25,28-tetraoxa-2-thiatriacontan-30-yl)oxy)isoindoline-1,3-
dione (5.11b-PEG(4)) 
 Using the same procedure outlined for the synthesis of 5.11a-PEG(4), thiol-PEG 
diblock chain 5.10b-PEG(4) (54 mg, 0.078 mmol), N-hydroxyphthalimide (15 mg, 0.093 
mmol) and triphenylphosphine (24 mg, 0.093 mmol) were reacted in presence of 
diisopropyl azodicarboxylate (20 µL, 0.1 mmol) to give the desired product 5.11b-
PEG(4) as a bright yellow oil (52 mg, 80% yield).  1H NMR (500 MHZ, CDCl3) δ 7.86 
(dd, J = 5.5, 3 Hz, 2H), 7.77 (dd, J = 5.5, 3 Hz, 2H), 7.43 (d, J = 7.5 Hz, 6H), 7.30 (t, J = 
7.5 Hz, 6H), 7.23 (t, J = 7.4 Hz, 3H), 4.40 (t, J = 4.5 Hz, 2H), 3.89 (t, J = 4.5 Hz, 2H), 3.6 
(t, 2H), 3.64-3.57 (m, 10H), 3.46 (t, J = 7 Hz, 2H), 2.16 (t, J = 7.5 Hz, 2H), 1.59 (m, 4H), 
1.41 (m, 2H), 1.38-1.10 (m, 24H). 
 
 
 
 
 
 
 
 
 
TrS O14
O ONphth3
5.11b-PEG(4)
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2-((1,1,1-triphenyl-19,22,25,28,31,34-hexaoxa-2-thiahexatriacontan-36-
yl)oxy)isoindoline-1,3-dione (5.11b-PEG(6)) 
 Using the same procedure outlined for the synthesis of 5.11a-PEG(4), thiol-PEG 
diblock chain 5.10b-PEG(6) (0.1 g, 0.13 mmol), N-hydroxyphthalimide (30 mg, 0.18 
mmol) and triphenylphosphine (48 mg, 0.18 mmol) were reacted in presence of 
diisopropyl azodicarboxylate (47 µL, 0.23 mmol) to give the desired product 5.11b-
PEG(6) as a bright yellow oil (96 mg, 80% yield).  1H NMR (500 MHZ, CDCl3) δ 7.84 
(m, 2H), 7.60 (m, 2H), 7.43 (m, 6H), 7.28 (t, J = 7.5 Hz, 6H), 7.22 (t, J = 7.4 Hz, 3H), 
4.39 (t, J = 4.5 Hz, 2H), 3.88 (t, J = 4.5 Hz, 2H), 3.66-3.59 (m, 20H), 3.45 (t, J = 7 Hz, 
2H), 2.14 (t, J = 7.5 Hz, 2H), 1.59 (m, 2H), 1.39 (m, 2H), 1.38-1.10 (m, 24H). 
 
 
 
 
 
 
 
 
 
 
TrS O14
O ONphth5
5.11b-PEG(6)
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2-(1,1,1-triphenyl-19,22,25,28,31,34,37,40-octaoxa-2-thiadotetracontan-42-
yl)isoindoline-1,3-dione (5.14) 
 Using the same procedure outlined for the synthesis of 5.11a-PEG(4), thiol-PEG 
diblock chain 5.10b-PEG(8) (0.125 g, 0.14 mmol), phthalimide (25 mg, 0.17 mmol) and 
triphenylphosphine (44 mg, 0.17 mmol) were reacted in presence of diisopropyl 
azodicarboxylate (50 µL, 0.25 mmol) to give the desired product 5.14 as a bright yellow 
oil (134 mg, 95% yield).  1H NMR (400 MHZ, CDCl3) δ 7.84 (dd, 2H), 7.70 (dd, 2H), 
7.40 (d, 6H), 7.27 (t, 6H), 7.20 (t, 3H), 3.90 (t, 2H), 3.73 (t, 2H), 3.55-3.64 (m, 28H), 
3.44 (t, 2H), 2.13 (t, 2H), 1.56 (qn, 2H), 1.37 (qn, 2H), 1.10-1.35 (m, 24H); 13C NMR 
(100 MHZ, CDCl3) δ 168.21, 145.069, 133.88, 132.13, 129.58, 127.75, 126.45, 123.20, 
70.57, 70.55, 70.52, 70.06, 70.02, 67.95, 67.88, 37.23, 32.23, 30.29, 29.65, 29.61, 29.54, 
29.48, 29.40, 29.16, 28.99, 28.56, 26.07, 25.58; HRMS: C59H83NO10S [M+Na+], 
calculated 1020.5635, found 1020.5651. 
 
 
 
 
 
 
 
TrS O14
O Nphth7
5.14
! 259!
 
O-(1,1,1-triphenyl-15,18,21,24-tetraoxa-2-thiahexacosan-26-yl)hydroxylamine 
(5.12a-PEG(4)).   
 To a solution of 5.11a-PEG(4) (0.131 g, 0.168 mmol) in CH2Cl2 (5 mL), 
hydrazine monohydrate (0.163 mL, 3.35 mmol) was added at room temperature.  Within 
10 seconds, the solution changed from transparent to dark red, and back to transparent.  
The reaction was stirred for 3 hours, and the solution changed color once again to an 
opaque white.  The CH2Cl2 was then removed by rotary evaporation, and the resulting 
white solid was purified by flash chromatography (8 g SiO2; CH2Cl2:MeOH (v:v) 99:1 → 
90:10) to afford the desired product as a pale yellow oil (0.106 g, 98% yield).  1H NMR 
(500 MHZ, CDCl3) δ 7.41 (d, J = 7.5 Hz, 6H), 7.27 (t, J = 7.5 Hz, 6H), 7.20 (t, J = 7.4 
Hz, 3H), 5.52 (s, br), 3.84 (t, J = 4.5 Hz, 2H), 3.62-3.70 (m, 12H), 3.57 (t, J = 3 Hz, 2H), 
3.44 (t, J = 6.5 Hz, 2H), 2.13 (t, J = 7.5 Hz, 2H), 1.57 (qn, J = 7 Hz, 2H), 1.38 (qn, J = 
7.5 Hz, 2H), 1.10-1.32 (m, 16H); 13C NMR (125 MHz, CDCl3) δ 145.33, 129.84, 128.01, 
126.72, 75.03, 71.79, 70.85, 70.29, 69.85, 32.26, 29.77, 29.72, 29.64, 29.42, 29.25, 26.32, 
23.69, 23.65; FTMS calcd for C39H57NO5S [M + Na] 674.3855, found 674.3857. 
 
 
 
 
 
TrS O12
O ONH23
5.12a-PEG(4)
! 260!
 
O-(1,1,1-triphenyl-15,18,21,24,27,30-hexaoxa-2-thiadotriacontan-32-
yl)hydroxylamine (5.12a-PEG(6)).   
 Using the same procedure outlined for the synthesis of 5.12a-PEG(4), a solution 
of 5.11a-PEG(6) (0.080 g, 0.090 mmol) in CH2Cl2 (5 mL) and hydrazine monohydrate 
(0.069 mL, 1.31 mmol), afforded the desired aminooxy product 5.12-PEG(6) as a pale 
yellow oil (0.066 g, 98% yield).  1H NMR (500 MHZ, CDCl3) δ 7.34 (d, J = 7.5 Hz, 6H), 
7.20 (t, J = 7.5 Hz, 6H), 7.13 (t, J = 7.4 Hz, 3H), 5.54 (s, br), 3.84 (t, J = 4.5 Hz, 2H), 
3.62-3.70 (m, 20H), 3.57 (t, J = 3 Hz, 2H), 3.44 (t, J = 6.5 Hz, 2H), 2.13 (t, J = 7.5 Hz, 
2H), 1.57 (qn, J = 7 Hz, 2H), 1.38 (qn, J = 7.5 Hz, 2H), 1.12-1.30 (m, 16H); 13C NMR 
(125 MHz, CDCl3) δ 145.33, 129.84, 128.01, 126.71, 75.03, 71.79, 70.84, 70.29, 69.86, 
64.61, 32.27, 29.88, 29.78, 29.73, 29.65, 29.42, 29.26, 28.84, 26.33, 26.31, 22.28, 21.84; 
FTMS calcd for C43H65NO7S [M + Na] 762.4380, found 762.4381. 
 
 
 
 
 
 
 
 
TrS O12
O ONH25
5.12a-PEG(6)
! 261!
 
O-(1,1,1-triphenyl-15,18,21,24,27,30,33,36-octaoxa-2-thiaoctatriacontan-38-
yl)hydroxylamine (5.12a-PEG(8)) 
 Using the same procedure outlined for the synthesis of 5.12a-PEG(4), a solution 
of 5.11a-PEG(8) (0.13 g, 0.135 mmol) in CH2Cl2 (5 mL) and hydrazine monohydrate 
(0.040 mL, 0.82 mmol), afforded the desired aminooxy product 5.12a-PEG(8) as a pale 
yellow oil (0.065 g, 59% yield).  1H NMR (500 MHZ, CDCl3) δ 7.40 (m, 6H), 7.28 (m, 
6H), 7.2 (m, 3H), 5.52 (bb, 2H), 3.83 (t, J = 4.5 Hz, 2H), 3.67-3.61 (m, 28H), 3.56 (t, J = 
3 Hz, 2H), 3.44 (t, J = 6.5 Hz, 2H), 2.13 (t, J = 7.5 Hz, 2H), 1.58 (m, 2H), 1.38 (m, 2H), 
1.38-1.13 (m, 16H); 13C NMR (125 MHz, CDCl3) δ 145.1, 129.6, 127.8, 126.5, 74.8, 
71.5, 70.6, 70.0, 69.6, 32.0, 29.65, 29.6, 29.55, 29.5, 29.5, 29.4, 29.2, 29.0, 28.6, 26.1; 
FTMS calculated for C47H73NNaO9S [M + Na+] 850.4898, found 850.4880. 
 
 
 
 
 
 
 
 
 
 
TrS O12
O ONH27
5.12a-PEG(8)
! 262!
 
O-(1,1,1-triphenyl-19,22,25,28-tetraoxa-2-thiatriacontan-30-yl)hydroxylamine 
(5.12b-PEG(4)) 
 Using the same procedure outlined for the synthesis of 5.12a-PEG(4), a solution 
of 5.11b-PEG(4) (57 mg, 0.068 mmol) in CH2Cl2 (5 mL) and hydrazine monohydrate 
(66 µL, 1.36 mmol), afforded the desired aminooxy product 5.12b-PEG(4) as a pale 
yellow oil (38 mg, 79% yield).  1H NMR (500 MHZ, CDCl3) δ 7.43 (m 5H), 7.30 (t, 7H), 
7.23 (m, 3H), 5.54 (bb, 2H), 3.86 (t, J = 4.5 Hz, 2H), 3.71-3.64 (m, 12H), 3.60 (t, J = 3 
Hz, 2H), 3.47 (t, J = 6.5 Hz, 2H), 2.16 (t, J = 7.5 Hz, 2H), 1.59 (m, 4H), 1.41 (qn, J = 7.5 
Hz, 2H), 1.38-1.15 (m, 24H); 13C NMR (125 MHz, CDCl3) δ 145.3, 129.9, 128.0, 126.7, 
75.0, 71.8, 70.9, 70.3, 69.9, 32.3, 29.9, 29.75, 29.7, 29.4, 29.3, 28.8, 26.3, 22.2, 22.15, 
22.1. 
 
 
 
 
 
 
 
 
 
TrS O14
O ONH23
5.12b-PEG(4)
! 263!
 
O-(1,1,1-triphenyl-19,22,25,28,31,34-hexaoxa-2-thiahexatriacontan-36-
yl)hydroxylamine (5.12bPEG(6)) 
 Using the same procedure outlined for the synthesis of 5.12a-PEG(4), a solution 
of 5.11b-PEG(6) (62 mg, 0.067 mmol) in CH2Cl2 (5 mL) and hydrazine monohydrate 
(64 µL, 1.33 mmol), afforded the desired aminooxy product 5.12b-PEG(6) as a pale 
yellow oil (37 mg, 70% yield). 1H NMR (500 MHZ, CDCl3) δ 7.43 (m 5H), 7.28 (t, 7H), 
7.27 (m 3H), 5.54 (s, br), 5.58 (bb, 2H), 3.85 (t, J = 4.5 Hz, 2H), 3.62-3.70 (m, 12H), 
3.57 (t, J = 3 Hz, 2H), 3.44 (t, J = 6.5 Hz, 2H), 2.15 (t, J = 7.5 Hz, 2H), 1.58 (qn, J = 7 
Hz, 2H), 1.38 (qn, J = 7.5 Hz, 2H), 1.12-1.30 (m, 24H); 13C NMR (125 MHz, CDCl3) δ 
145.1, 129.6, 127.8, 126.4, 71.5, 70.6, 70.5, 70.0, 61.7, 29.7, 29.6, 29.55, 29.5, 29.4, 29.0, 
26.1. 
 
 
 
 
 
 
 
 
 
TrS O14
O ONH25
5.12b-PEG(6)
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1,1,1-triphenyl-19,22,25,28,31,34,37,40-octaoxa-2-thiadotetracontan-42-amine (5.15) 
 Using the same procedure outlined for the synthesis of 5.12a-PEG(4), a solution 
of 5.14 (70 mg, 0.07 mmol) in CH2Cl2 (5 mL) and hydrazine monohydrate (30 µL, 0.62 
mmol), afforded the desired aminooxy product 5.15 as a pale yellow oil (44 mg, 72% 
yield).  1H NMR (500 MHz, CDCl3) δ  7.40 (d, 6H), 7.27 (t, 6H), 7.20 (t, 3H), 3.92 (t, 
2H), 3.75 (t, 2H), 3.55-3.67 (m, 24H), 3.57 (t, 2H), 3.44 (t, 2H), 3.17(t, 2H), 2.13 (t, 2H), 
1.56 (qn, 2H), 1.37 (qn, 2H), 1.10-1.35 (m, 24H); HRMS: C51H82NO8S, [M+H+] 
calculated 868.5761, found 868.5773. 
  
 
 
 
 
 
 
 
 
 
 
 
TrS O14
O NH27
5.15
! 265!
 
1-(aminooxy)-3,6,9,12-tetraoxatetracosane-24-thiol (5.13a-PEG(4))   
 To a N2 purged solution of 5.12a-PEG(4) (0.080 g, 0.123 mmol) in CH2Cl2 (0.5 
mL), trifluoroacetic acid (0.5 mL, excess), and triethylsilane (0.085 mL, 0.073 mmol) 
were added at room temperature.  The solution immediately turned dark yellow, then 
clear.  The reaction was kept under N2 atmosphere and stirred for 3 hours.  The volatiles 
were then removed by rotary evaporation and subsequent vacuum pumping, and the 
resulting white solid was purified by flash chromatography (5 g SiO2; CH2Cl2:MeOH, 
9:1, v/v) to afford the desired aminooxy-thiol 5.12a-PEG(4) as a pale yellow oil (0.035 g, 
70% yield).  1H NMR (500 MHZ, CDCl3) δ 5.56 (s, br), 3.84 (t, J = 4.5 Hz, 2H), 3.62-
3.70 (m, 12H (plus H2O impurities)), 3.58 (t, J = 3 Hz, 2H), 3.44 (t, J = 6.5 Hz, 2H), 2.52 
(q, J = 7.5 Hz, 2H), 1.57 (m, J = 7 Hz, 2H), 1.23-1.41 (m, 18H); 13C NMR (125 MHz, 
CDCl3) δ 71.79, 70.85, 70.81, 70.78, 70.30, 69.86, 29.79, 29.72, 29.30, 28.61, 23.14, 
23.08; FTMS calcd for C20H43NO5S [M + Na] 432.2760, found 432.2760. 
 
 
 
 
 
 
 
 
HS O10
O ONH23
5.13a-PEG(4)
! 266!
 
1-(aminooxy)-3,6,9,12,15,18-hexaoxatriacontane-30-thiol (5.13a-PEG(6)).   
 Using the same procedure outlined for the synthesis of 5.13a-PEG(4), trityl 
deprotection of 5.12a-PEG(6) (0.045 g, 0.061 mmol) was performed using a solution of 
CH2Cl2/trifluoroacetic acid (1:1 ratio), and triethylsilane (5% by volume) to afford the 
desired aminooxy-thiol 5.13a-PEG(6) as a pale yellow oil (0.024 g, 79% yield).  1H 
NMR (500 MHZ, CDCl3) δ 5.55 (s, br), 3.84 (t, J = 4.5 Hz, 2H), 3.62-3.70 (m, 18H (plus 
H2O impurities)), 3.58 (t, J = 3 Hz, 2H), 3.44 (t, J = 6.5 Hz, 2H), 2.52 (q, J = 7.5 Hz, 2H), 
1.67 (qn, J = 7 Hz, 2H), 1.59 (m, J = 7 Hz, 2H), 1.23-1.41 (m, 16H); 13C NMR (125 
MHz, CDCl3) δ 71.55, 71.25, 70.61, 70.56, 70.54, 70.05, 69.61, 34.04, 29.55, 29.48, 
29.06, 28.37, 22.90, 22.84; FTMS calcd for C24H51NO7S [M + Na] 520.3284, found 
520.3280. 
 
 
 
 
 
 
 
 
 
 
HS O10
O ONH25
5.13a-PEG(6)
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1-(Aminooxy)-3,6,9,12,15,18,21,24-octaoxahexatriacontane-36-thiol (5.13a-PEG(8)) 
Using the same procedure outlined for the synthesis of 5.13a-PEG(4), trityl 
deprotection of 5.12a-PEG(8) (32 mg, 0.038 mmol) was performed using a solution of 
CH2Cl2/trifluoroacetic acid (1:1 ratio), and triethylsilane (5% by volume) to afford the 
desired aminooxy-thiol 5.13a-PEG(8) as a pale yellow oil (22 mg, 97% yield).  1H NMR 
(400 MHZ, CDCl3) δ 5.55 (bb, 2H), 3.85 (t, J = 4.8 Hz, 2H), 3.69-3.63 (m, 26H), 3.58 (t, 
2H), 3.46 (t, J = 7.2 Hz, 2H), 2.55 (q, J = 7.6 Hz, 2H), 1.64-1.55 (m, 2H), 1.37-1.26 (m, 
16H); 13C NMR (125 MHz, CDCl3) δ 74.8, 71.53, 70.6, 70.5, 70.0, 69.6, 34.0, 29.6, 
29.55, 29.5, 29.1, 28.4, 26.1, 24.6; FTMS calculated for C28H59NNaO9S [M + Na+] 
608.3803, found 608.3798. 
 
 
 
 
 
 
 
 
 
 
HS O10
O ONH27
5.13a-PEG(8)
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1-(Aminooxy)-3,6,9,12-tetraoxaoctacosane-28-thiol (5.13b-PEG(4)) 
Using the same procedure outlined for the synthesis of 5.13a-PEG(4), trityl 
deprotection of 5.12b-PEG(4) (28 mg, 0.039 mmol) was performed using a solution of 
CH2Cl2/trifluoroacetic acid (1:1 ratio), and triethylsilane (5% by volume) to afford the 
desired aminooxy-thiol 5.13b-PEG(4) as a pale yellow oil (8 mg, 44% yield).  1H NMR 
(500 MHZ, CDCl3) δ 5.55 (bb, 2H), 3.86 (t, J = 5 Hz, 2H), 3.70-3.64 (m, 12H), 3.59 (t, J 
= 3 Hz, 2H), 3.47 (t, J = 6.5 Hz, 2H), 2.54 (q, J = 7.5 Hz, 2H), 1.63-1.57 (m 4H), 1.40-
1.21 (m, 26H); 13C NMR (125 MHz, CDCl3) δ 75.0, 71.8, 70.9, 70.85, 70.8, 70.3, 69.9, 
64.5, 34.3, 29.9, 29.8, 29.7, 29.3, 28.6, 26.3, 24.9, 22.15, 22.1. 
 
 
 
 
 
 
 
 
 
 
 
HS O14
O ONH23
5.13b-PEG(4)
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1-(Aminooxy)-3,6,9,12,15,18-hexaoxatetratriacontane-34-thiol (5.13b-PEG(6)) 
Using the same procedure outlined for the synthesis of 5.13a-PEG(4), trityl 
deprotection of 5.12b-PEG(6) (27 mg, 0.034 mmol) was performed using a solution of 
CH2Cl2/trifluoroacetic acid (1:1 ratio), and triethylsilane (5% by volume) to afford the 
desired aminooxy-thiol 5.13b-PEG(6) as a pale yellow oil (17 mg, 90% yield).  1H NMR 
(400 MHZ, CDCl3) δ 5.46 (bb, 2H), 3.78 (t, J = 4.5 Hz, 2H), 3.62-3.58 (m, 20H), 3.51 (t, 
J = 3 Hz, 2H), 3.39 (t, J = 6.5 Hz, 2H), 2.48 (q, J = 7.5 Hz, 2H), 1.55-148 (m, 4H), 1.59 
1.30-1.18 (m, 28H); 13C NMR (125 MHz, CDCl3) δ 74.7, 71.5, 70.6, 70.5, 70.05, 69.6, 
34.0, 29.65, 29.63, 29.60, 29.57, 29.5 29.1, 28.4, 26.6 24.6.  
 
 
 
 
 
 
 
 
 
HS O14
O ONH25
5.13b-PEG(6)
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Scheme 6.2.  Synthesis of aminooxy-peptide 5.19. 
Solid Phase Synthesis: Aminooxy-peptide 5.19 
Steps 1&2.  Cysteamine-loaded polystyrene resin (200 mg, 0.14 mmol active 
amine) was treated with Fmoc-protected diglycine (Novabiochem, 150 mg, 0.42 mmol) 
in the presence of diisopropylcarbodiimide (DIC, 0.064 mL, 0.42 mmol), N-
hydroxybenzotriazole (HOBt, 56 mg, 0.42 mmol) and N,N-diisopropylethylamine 
(DIPEA, 0.12 mL, 0.84 mmol) in DMF (3 mL).  After shaking overnight, the resin was 
filtered and thoroughly washed with CH2Cl2 (7x). The resin then was dried under 
vacuum, swelled using DMF, filtered, and treated with 20% piperidine in DMF (3 mL) at 
room temperature for 40 mins. The piperidine washing process was repeated once. The 
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resin was filtered and washed successively with DMF (3x) and CH2Cl2 (5x), and then 
dried under vacuum. 
Steps 3&4.  The diglycine loaded resin (®-G-G-NH2) was swelled using DMF 
over 30 mins, filtered, and then treated with Fmoc-protected arginine-Boc2 
(Novabiochem, 250 mg, 0.42 mmol), DIC (0.064 mL, 0.42 mmol), HOBt (56 mg, 0.42 
mmol) and DIPEA (0.12 mL, 0.84 mmol) in DMF (3 mL). After shaking overnight, the 
resin was filtered and thoroughly washed with CH2Cl2 (7x). The resin was dried under 
vacuum, swelled using DMF, filtered, and then treated with 20% piperidine in DMF (3 
mL) at room temperature for 40 mins. The piperidine washing process was repeated once. 
The resin was filtered and washed successively with DMF (3x) and CH2Cl2 (5x), and 
then dried under vacuum. 
Steps 5&6.  The ®-G-G-R-NH2 resin was swelled using DMF over 30 mins, 
filtered, and then treated with Fmoc-protected diglycine (Novabiochem, 250 mg, 0.70 
mmol), DIC (0.108 mL, 0.70 mmol), HOBt (90 mg, 0.70 mmol) and DIPEA (0.25 mL, 
1.4 mmol) in DMF (3 mL). After shaking overnight, the resin was filtered and thoroughly 
washed with CH2Cl2 (7x). The resin was dried under vacuum, swelled using DMF, 
filtered, and then treated with 20% piperidine in DMF (3 mL) at room temperature for 40 
mins. The piperidine washing process was repeated once. The resin was filtered and 
washed successively with DMF (3X) and CH2Cl2 (5X), and then dried under vacuum. 
Steps 7&8.  The ®-G-G-R-G-G-NH2 resin (100 mg) was swelled using DMF 
over 30 mins, filtered, and then treated with Fmoc-protected aminooxyglycine 
(Polypeptide, 75 mg, 0.21 mmol), DIC (0.033 mL, 0.21 mmol), HOBt (28 mg, 0.21 
mmol) and DIPEA (0.075 mL, 0.42 mmol) in DMF (2 mL). After shaking overnight, the 
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resin was filtered and thoroughly washed with CH2Cl2 (7x). The resin was dried under 
vacuum, swelled using DMF, filtered, and then treated with 20% piperidine in DMF (3 
mL) at room temperature for 40 mins. The piperidine washing process was repeated once. 
The resin was filtered and washed successively with DMF (3x) and CH2Cl2 (5x), and 
then dried under vacuum. 
To confirm the integrity of the aminooxy peptide linker, a sample of the resin was 
treated with TFA (50%), triethylsilane (5%) in CH2Cl2 at room temperature to cleave the 
peptide from the resin as well as to deprotect the arginine. Analysis by HRMS confirmed 
the title compound; HRMS, C18H35N10O7S, [M+H+], calculated 535.2405, found 
535.2411. 
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Cypate bis(acetal) 5.21 
 To a solution of cypate (5.20) (75 mg, 0.12 mmol) in dimethylformamide (5 mL) 
at 0 °C, were added consecutively hydroxybenzotriazole (64 mg, 0.48 mmol) and 1-ethyl-
3-(3-dimethylaminopropyl)carbodiimide) (92 mg, 0.48 mmol).  After stirring for 15 min, 
4,4-diethoxybutan-1-amine (85 µL, 0.48 mmol) was added in one portion.  The resulting 
solution was allowed to come to room temperature and was stirred in the dark.  After 12 
h, the solution was concentrated by rotary evaporation, and the resulting crude was 
dissolved in CH2Cl2 (40 mL) and washed with brine (3x 10 mL).  The organic layer was 
dried over Na2SO4 and the solvents were removed by rotary evaporation.  The resulting 
dark green paste was purified by chromatography (SiO2; CH2Cl2/MeOH, 9:1, v/v; Rf = 
0.3) to afford the desired cypate bis(acetal) (74 mg, 64%). HRMS, C57H75N4O6+, [M+], 
calculated 911.5681, found 911.5665. 
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Cypate bis(aldehyde) 5.22 
 A solution of cypate bis(acetal) 2.21 (42 mg, 0.046 mmol) in water (4 mL) and 
acetic acid (2 mL) was stirred at room temperature for 4h.  Then the solvents were 
removed by rotary evaporation and the resulting crude was further dried in a vacuum 
pump in the dark for 8h.  The dark green solid was purified by column chromatography 
(5 g SiO2; CH2Cl2:MeOH, 9:1, v/v, Rf = 0.25) to afford the desired cypate bis(aldehyde) 
(22mg, 63%).  HRMS, C49H55N4O4+ [M+], calculated 763.4218, found 763.4223. 
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Cypate mono-aldehyde linker 5.25 
 To a solution of cypate bis(aldehyde) 5.22 (10 mg, 0.013 mmol) in 
CH2Cl2/MeOH (9:1, 2 mL) was added dropwise a first portion of  linker 5.13a-PEG(8) (3 
mg, 0.005 mmol) dissolved in CH2Cl2/MeOH (1 mL).  After 2 h, a second porting of 
linker 5.13a-PEG(8) (3 mg, 0.005 mmol) dissolved in CH2Cl2/MeOH (1 mL) was added.  
The solution was left at room temperature in the dark for 12h.  The solution was then 
concentrate by rotary evaporation and the resulting crude was purified by column 
chromatography (SiO2; CH2Cl2:MeOH, 9:1, v/v, Rf = 0.37) to obtain the desired cypate 
mono-aldehyde linker 5.25 (7 mg, 52%).  HRMS, C77H112N5O12S+, [M+] calculated 
1330.8023, found 1330.8015. 
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Cypate linker/peptide 5.26 
 To a solution of cypate monoaldehyde spacer 5.25 (7 mg, 0.0052 mmol) in 
CH2Cl2 (3 mL) was added peptide aminooxy 5.19 (3 mg, 0.006 mmol) dissolved in 
MeOH (1 mL).  The solution was left at room temperature in the dark for 12h.  The 
solution was then concentrate by rotary evaporation to afford the desired product 5.26.  
HRMS, C95H145N15O18S2+ [M+ + H+]/2 calcd 924.0161, found 924.0185 (m/z where z = 
2). 
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An Improved Preparation
of O-(Diphenylphosphinyl)hydroxylamine
Se´bastien Laulhe´ and Michael H. Nantz
Department of Chemistry, University of Louisville, Louisville, KY 40208, USA
O-(Diphenylphosphinyl)hydroxylamine (DPPH) is a versatile electrophilic amination
reagent that has been used widely for the amination of stable carbanions, Grignard reagents
and pi -electron-rich nitrogen heterocycles.1–4 More recently, Armstrong et al. have used
DPPH for the aziridination of enones.5 Compared to other hydroxylamine derivatives that
typically are stored as hydrochloride salts, this activated phosphinyl reagent exhibits good
stability and can be stored indefinitely at 0◦C.
DPPH is prepared in a single step from hydroxylamine hydrochloride and
diphenylphosphinic chloride (1).6 However, the general and most used procedure, de-
veloped by Colvin et al.,1 is not reliable. Yields ranging from 42% to a maximum of 70%
have been reported using this method.7,8 In our hands, we found Colvin’s method to be sen-
sitive to reaction scale, with multigram attempts generally delivering DPPH in ca. 30–60%
yield. Our interest in aminooxy chemistry9 led us to develop a reproducible, higher yield
synthesis of DPPH. We report herein a convenient procedure for the preparation of DPPH
on multigram scale.
Adaptation of Schotten-Baumann conditions10 using a two-phase solvent system helped
minimize hydrolysis of starting chloride 1 prior to its reaction with hydroxylamine and
afforded DPPH in 78% yield on a 10-gram scale. The yield of DPPH formed using these
conditions did not vary significantly when the reaction scale was decreased (e. g., 4-gram
scale gave an 84% yield of DPPH). Product purity, generally compromised by the presence
of Ph2P(O)OH prior to base treatment, was readily assessed using 31P NMR (CDCl3):
DPPH, δ 37.5; Ph2P(O)OH δ 28.3.
Experimental Section
To a stirred solution (mechanical stirring) of hydroxylamine hydrochloride (6.46 g, 93.0
mmol) in water (20 mL) at −10◦C was added a solution of sodium hydroxide (3.55 g,
Submitted May 20, 2011.
Address correspondence to Michael H. Nantz, Department of Chemistry, University of Louisville,
Louisville, KY 40208, USA. E-mail: michael.nantz@louisville.edu
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A Chemoselective, One-Pot Transformation of Aldehydes to Nitriles
Seb́astien Laulhe,́ Sadakatali S. Gori, and Michael H. Nantz*
Department of Chemistry, University of Louisville, Louisville, Kentucky 40292, United States
*S Supporting Information
ABSTRACT: This paper describes a procedure for direct conversion of aldehydes to
nitriles using O-(diphenylphosphinyl)hydroxylamine (DPPH). Aldehydes are smoothly
transformed to their corresponding nitriles by heating with DPPH in toluene. The
reaction can be accomplished in the presence of alcohol, ketone, ester, or amine
functionality.
The preparation of nitriles by transformation of carbon-equivalent functional groups is an important synthetic
route to these versatile intermediates and valued target
pharmacophores.1 Among the most popular approaches is the
oxidation-state neutral conversion of carboxylic acids to nitriles
via dehydration of intermediate primary amides (Figure 1) either
using traditional dehydrating reagents2 or recently developed
metal-mediated procedures.3 An efficient complement to amide
dehydration is the oxidative transformation of aldehydes to
nitriles. Isolation of aldoxime intermediates (Figure 1) generally
is followed by activation of the oxime hydroxyl group (e.g., as a
sulfonate ester derivative) and then its elimination to afford the
nitrile.4 The appeal of this approach has led to several one-pot
methods for direct synthesis of nitriles from aldehydes using
either hydroxylamine or ammonia in combination with a variety
of activating reagents.5
Unfortunately, the accompanying reagents for these one-pot
approaches, such as CuCl2/NaOMe/O2,
5a Pb(OAc)4,
5b Ox-
one,5e H2O2,
5h I2,
5i NBS,5j IBX,5k and NaICl2,
5l often are not
tolerant of other functional groups or require somewhat harsh
conditions to effect the transformation. Ideally, an aldehyde-
selective reagent that would facilitate the conversion to the nitrile
under neutral conditions would greatly expand the utility of this
direct approach. We report here the use of O -
(diphenylphosphinyl)hydroxylamine (DPPH) as such a reagent.
Our interest in aminooxy chemistry6 led us to consider the use
of DPPH (Ph2P(O)ONH2) as a possible chemoselective
alternative to hydroxylamine or ammonia for introduction of
nitrogen onto the carbonyl carbon of aldehydes. Since the
reaction of this reagent with an aldehyde would directly form an
activated oxime ester as an intermediate (e.g., 1, Scheme 1), we
reasoned that it should be possible to thermally induce an
electrocyclic rearrangement resulting in the elimination of
diphenylphosphinic acid. A similar mechanism involving
elimination of methanesulfonic acid has been proposed for
formation of nitriles from intermediate sulfonylated aldoximes.7
Although DPPH is well appreciated as an electrophilic reagent
for the amination of a variety of nucleophiles,8 including
Grignard reagents,9 enols,10 or for amination of tertiary amines
in syntheses of aziridines from α,β-unsaturated carbonyl
substrates,11 its use as a nucleophilic counterpart, especially in
chemoselective “click” transformations, has received limited
attention.12 To test the action of DPPH as a suitable reagent for
oxime ester formation as well as the subsequent elimination to
the nitrile, we examined the reaction between DPPH and α-
naphthaldehyde (Scheme 1).
While presently not commercially available, DPPH can be
readily prepared in good yield in one step from commercially
available diphenylphosphinic chloride and hydroxylamine hydro-
chloride.13 Reaction of DPPHwith naphthaldehyde in THF gave
oxime ester 1 in 79% yield. Subsequent heating in toluene
revealed that the elimination of diphenylphosphinic acid from 1
required warming to above 80 °C to achieve a significant rate of
formation of naphthonitrile (2). Of particular note is that no
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Figure 1. Common functional group interconversions to prepare
nitriles.
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Fragmentation of oxime and silyl oxime ether
odd-electron positive ions by the McLafferty
rearrangement: new insights on structural
factors that promote a,b fragmentation
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Osvaldo Gutierrez,c Jason G. Harrison,c Dean J. Tantillo,c Xiang Zhanga
and Michael H. Nantza*
The McLafferty rearrangement is an extensively studied fragmentation reaction for the odd-electron positive ions from a diverse
range of functional groups and molecules. Here, we present experimental and theoretical results of 12 model compounds that
were synthesized and investigated by GC-TOFMS and density functional theory calculations. These compounds consisted of three
main groups: carbonyls, oximes and silyl oxime ethers. In all electron ionization mass spectra, the fragment ions that could be at-
tributed to the occurrence of a McLafferty rearrangement were observed. For t-butyldimethylsilyl oxime ethers with oxygen in a
b-position, the McLafferty rearrangement was accompanied by loss of the t-butyl radical. The various mass spectra showed that
the McLafferty rearrangement is relatively enhanced compared with other primary fragmentation reactions by the following fac-
tors: oxime versus carbonyl, oxygen versusmethylene at the b-position and ketone versus aldehyde. Calculations predict that the
stepwise mechanism is favored over the concerted mechanism for all but one compound. For carbonyl compounds, C–C bond
breaking was the rate-determining step. However, for both the oximes and t-butyldimethylsilyl oxime ethers with oxygen at
the b-position, the hydrogen transfer step was rate limiting, whereas with a CH2 group at the b-position, the C–C bond breaking
was again rate determining. n-Propoxy-acetaldehyde, bearing an oxygen atom at the b-position, is the only case that was pre-
dicted to proceed through a concerted mechanism. The synthesized oximes exist as both the (E)- and (Z)-isomers, and these were
separable by GC. In the mass spectra of the two isomers, fragment ions that were generated by the McLafferty rearrangement
were observed. Finally, fragment ions corresponding to the McLafferty reverse charge rearrangement were observed for all com-
pounds at varying relative ion intensities compared with the conventional McLafferty rearrangement. Copyright © 2012 John
Wiley & Sons, Ltd.
Supporting information may be found in the online version of this article.
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INTRODUCTION
The analysis of cellular aldehyde and ketone species is of
considerable importance for the field of metabolomics. [1–3]
Aldehydes and ketones can be formed endogenously by
various biochemical pathways. For example, aldehydes can be
formed by lipid peroxidation, carbohydrate metabolism and
ascorbate autoxidation as well as by various enzymatic
processes, such as those involving amine oxidase, cytochrome
P-450 or myeloperoxidase. [4] Endogenous ketones, such as
acetone and acetoacetic acid, are molecules produced as by-
products when fatty acids are broken down for energy in the
liver and kidney. [5] Other ketones, such as b-ketopentanoate,
may be created as a result of the metabolism of synthetic
triglycerides. [6] Furthermore, ketone bodies, such as acetone,
are produced from acetyl-CoA mainly in the mitochondrial
matrix of hepatocytes when carbohydrates are so scarce that
energy must be obtained from breaking down fatty acids. [7]
Acetone is responsible for the characteristic “fruity” odor of
the breath of persons with ketoacidosis. [8]
To isolate these carbonyl metabolites for analysis by mass
spectrometry, their selective conversion into labeled oximes
or oxime ether analogs by water-based “click chemistry” (i.e.
oximation) has become an elegant and highly chemo-specific
approach. [9,10] Oxime chemistry and subsequent silylations to
form silyl oxime ethers have been used to detect and analyze
natural and synthetic steroids, [11] trisaccharides [12–15] and
other classes of compounds [16,17] by gas chromatography–
mass spectrometry (GC-MS). Oximation proceeds rapidly under
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 1  Introduction 
 Indocyanine green (ICG) is one of a few, if not the only, near infrared (NIR) contrast 
agents that can be used for humans. The quantum yield of this fl uorophore is only 
0.0028 and 0.012, in water and plasma  [ 1 ] , respectively, and, therefore, artifi cially 
enhancing its quantum yield is highly desired. Since fl uorescence of a fl uorophore 
is initiated by optically exciting its electrons, one way of changing the fl uorescence 
level is by placing it near an electric fi eld. Gold nanoparticles (GNPs) generate a 
strong electric (plasmon) fi eld on and around them upon receiving light  [ 2,  3 ] . 
Therefore, they can be good candidates for infl uencing the electron status of a 
fl uorophore  [ 3 ] . Gold has been used extensively in bio-applications because of its 
chemical inertness. 
 The strength of the plasmon fi eld generated by a GNP is the highest on its surface 
and decays rapidly with the distance from the GNP surface  [ 4,  5 ] . If the fi eld strength 
that increases the fl uorescence of a fl uorophore is known, then one can achieve a 
higher fl uorescence by placing the fl uorophore at the distance from a GNP with this 
particular fi eld strength. 
 Here, we present the relationship between the plasmon fi eld strength on/around 
a GNP and fl uorescence of Cypate  [ 6 ] (an ICG-based NIR fl uorophore), which may 
be helpful for developing more effective and safe NIR optical contrast agents. 
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Abstract
Fluorophores have been extensively used as the signal mediator in biosensing and bioimaging
for a long time. Enhancement of fluorescence can amplify the signal, thus improving the
sensitivity, enabling earlier and accurate disease detection and diagnosis. Some metal
nanoparticles, such as gold and silver, can generate a strong electromagnetic field on their
surface (surface plasmon field) upon receiving photonic energy. When a fluorophore is placed
in the field, the field can affect the fluorophore electrons participating in fluorescence emission
and change the fluorescence output. The change can be from complete quenching to
significant enhancement, depending on the metal type, particle size and shape,
excitation/emission wavelengths and quantum yield of the fluorophore, and the distance
between the fluorophore and the particle surface. In this study, the effects of these parameters
on the fluorescence enhancement of commonly used fluorophores by gold nanoparticles
(GNPs) are theoretically analyzed. Experimentally, an NIR contrast agent with enhanced
fluorescence was developed by carefully tailoring the distance between Cypate (ICG based
fluorophore) and a GNP, via biocompatible spacer constructs. The effect of the GNP size
(3.7–16.4 nm) and spacer length (3.2–4.6 nm) on fluorescence enhancement was studied, and
the spacer length that provided the significant enhancement was determined. The spacer
of 3.9 nm with 16.4 nm GNP provided the fluorescence of 360% of the control. The
experimental data qualitatively agreed with the theoretical results and, thus, the theoretical
analysis can be used as a guide for significantly improving the sensitivity of existing
fluorescent contrast agents by properly utilizing GNPs and spacers.
1. Introduction
In fluorophore-mediated biosensing/imaging, fluorophores
generating higher fluorescence per fluorophore molecule are
highly desirable because they can provide better sensitivity
with higher signal-to-noise ratio. Since fluorescence is
generated by the electrons excited by photonic energy, a
localized entity affecting the electron state of the fluorophore
can change the fluorescence output [1, 2]. Nanosized metal
particles forming a strong electromagnetic (plasmon) field can
be, therefore, good candidates for this purpose [1, 3]. Noble
metal nanoparticles are known to form a strong plasmon field
around them upon receiving light in the visible range [4–7].
Gold nanoparticles (GNPs) are appropriate for the biomedical
application because they form a strong plasmon field and are
chemically stable and non-toxic. Also its surface modification
chemistry is well established [8–10].
Utilizing GNPs for enhancing the fluorescence of
fluorophores has been previously explored by several
researchers. Nakamura et al [11] studied the level of
enhancement for the fluorophore Rose Bengal with respect
to the GNP size; Kuhn et al [12] and Anger et al [13]
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